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Abstract of the Dissertation
The Role of Mature Secretory Cells in Gastrointestinal Regeneration
by
Megan D Radyk
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2020
Professor Jason C Mills, Chair
Differentiated cells exhibit the ability to adjust their cell fate and become more
progenitor-like after wide-scale tissue injury. This inherent cell plasticity is shown across many
tissues and organisms and is a conserved behavior that ensures organ function even in a chronic
injury setting. At the tissue level, the change in cell fate from a differentiated cell to one with
more progenitor properties can be identified as metaplasia. Importantly, metaplasias, like
Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) in the stomach and Acinar-to-Ductal
Metaplasia (ADM) in the pancreas, are risk factors for the development of adenocarcinoma.
Thus, understanding the cellular and molecular mechanisms of injury-induced cell plasticity will
better inform our understanding into cancer initiation.
To identify the cellular contribution to SPEM in the stomach, we used a high dose
tamoxifen injury model in mice, which phenocopies human gastric metaplasia. There is debate as
to whether stem cells or the differentiated zymogenic chief cells (ZCs) are the major contributing
cell type to SPEM. To address this question, we impeded stem cell contribution by administering
the proliferation-blocking drug 5-fluorouracil during injury, allowing only non-stem cells to
function. We found that SPEM can arise, even without stem cells, and that ZCs are the most
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likely cells of origin for SPEM. We also observed several cell transition stages as a ZC is en
route to SPEM in both our mouse model and in human metaplasia. We had strong observational
studies to support ZC involvement in metaplasia initiation, but we wanted to further interrogate
what signals prompt ZCs to undergo this cell plasticity event.
We previously showed one mechanism that differentiated cell use to become more
progenitor-like and metaplastic following damage is paligenosis. Paligenosis consists of three
sequential stages: 1. Autodegradation of mature/differentiated cell structures via lysosomes and
autophagy, 2. Expression of a progenitor/embryonic gene network, 3. Cell cycle re-entry.
Paligenosis is governed by biphasic mTORC1 activity; however, because paligenosis is a
conserved process, we hypothesized that there must be other genes that evolved to regulate the
stages. We characterized Activating Transcription Factor 3 (Atf3) as a gene necessary for
paligenosis. ATF3 is largely dispensable for development and homeostasis but is upregulated
early after injury in secretory cells of the stomach and pancreas during paligenosis Stage 1. We
found that ATF3 works to transcriptionally upregulate Rab7b, a vesicle trafficking protein
important for lysosome maturation. To determine how ATF3 controls paligenosis progression,
we used Atf3–/– mice in our stomach and pancreas injury models. We found that Atf3–/– mice fail
to induce large-scale lysosomes and autophagy in Stage 1 and fail to form many RAB7-vesicles,
overall signifying a defect in this critical stage of paligenosis. While ATF3 plays an important
role early after injury, we wanted to determine how Atf3 loss effected tissue repair and
regeneration. We found increased cell death and decreased proliferation in Atf3–/– stomach and
pancreas after injury, indicating that Atf3 loss impairs progression through paligenosis, which has
severe consequences for organ integrity and function. We also showed that ATF3 is expressed in
human gastric metaplasia, ATF3 is induced in injury models across 5 organs, and ATF3 is
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induced during Axolotl limb regeneration. These data suggest ATF3 is not only important for the
stomach and pancreas, but that ATF3 function is key for cell plasticity and paligenosis across
many tissues and organisms.
ATF3 induction is the earliest molecular event in paligenosis described thus far, but we
sought to distinguish some of the injury signals that begin paligenosis and activate ATF3. The
integrated stress response (ISR) is a pathway, conserved through yeast, that cells use to sense
stress. The ISR coordinates a response based on several stressors – like infection, amino acid
deprivation, iron deprivation, and ER stress – and ultimately works to globally reduce translation
until the stress is resolved. We found that the ISR is activated during paligenosis in the stomach
by the indication of phosphorylated eIF2α, the protein important for reducing translation. We
also observed activation of the ISR kinase, PERK (EIF2AK3), and performed studies in mice
using pharmacological inhibitors and activators of ER stress and the ISR, which altogether
suggest ER stress may be one of the inputs driving paligenosis.
Overall, these studies began with a tissue-level view of metaplasia and found that mature,
secretory cells are the main cells of origin for metaplasia. We also found that paligenosis is one
mechanism used by cells to contribute to regeneration after injury and do so by first activating
the ISR to induce ATF3. ATF3, in turn, transcriptionally regulates Rab7b and other genes
coordinating upregulation of lysosomes and autophagy to help degrade mature/specialized cell
structures allowing for expression of a progenitor-like gene network. These studies illustrate how
cell plasticity, regeneration, and cancer initiation are tightly linked fields that rely on many of the
same molecular mechanisms.

xiv

Chapter 1: Introduction
Overall, this work focuses on how mature cells in the stomach and pancreas change their
identity and demonstrate plasticity after injury. It brings together aspects of cell biology, stem
cell biology, and cancer biology to better understand the pathways activated by cells during this
identity change and further implications on cancer initiation. In this Chapter, I will touch on
basic architecture and behavior of exocrine cells of the stomach and pancreas, the emerging field
of cell plasticity, how cell plasticity and metaplasia are linked, and some newly identified
proteins (Activating Transcription Factor 3) and pathways (the Integrated Stress Response) that
contribute to cell plasticity and metaplasia in the stomach and pancreas.

1

1.1 Architecture of the Stomach and Pancreas
1.1.1 Tissue and cellular architecture of the ctomach
The stomach is composed of a single layer of epithelial cells that form glandular
invaginations. The stomach has two major compartments, the corpus (body) and the antrum. The
corpus is the acid-secreting portion of the stomach, while the antrum mainly houses pit/foveolar
cells and deep mucous cells. Scattered throughout the stomach are endocrine cells which mainly
secrete gastrin. This thesis is focused on the corpus of the stomach (Figure 1.1). The corpus unit
has surface foveolar/pit cells that face the stomach lumen which secrete mucous. Under the pit
region, is the isthmus region where the isthmal stem cell resides. Beneath the isthmus, are the
deeper gland cells including the mucous neck cell, the acid-secreting parietal cell, and the
digestive-enzyme secreting zymogenic chief cell.
Proliferation in the corpus is largely confined to the isthmus and the stem cells located
there. Early nucleotide tracing studies in the stomach suggest that the isthmal stem cell is the
multipotent progenitor for the all cells in the gastric unit (Karam and Leblond, 1993). More
recent studies suggest the deep gland cells in the corpus (neck cells and chief cells) largely
maintain their own census (Burclaff et al., 2020; Han et al., 2019; Quante et al., 2010; Willet and
Mills, 2016; Wright, 2016). There is ongoing debate as to the power of the isthmal stem cell at
homeostasis and after injury, but several genes can label the isthmal stem cell population (Phesse
and Sansom, 2017). Most recently Stmn1 and Ki67 lineage tracing shows isthmal stem cells
maintain the pit-isthmus-neck region, but not the chief cell zone (Han et al., 2019), suggesting
chief cell homeostasis is maintained differently, perhaps in a manner similar to the exocrine cells
in the pancreas.
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1.1.2 Tissue and cellular architecture of the pancreas
The pancreas has both exocrine and endocrine portions intermixed in the parenchyma,
but about ~90% of the pancreatic mass is exocrine in function (Pandiri, 2014). Interspersed
between the exocrine pancreas are islets of Langerhans made up mostly of alpha cells to make
glucagon and beta cells to make insulin. This thesis focuses on the exocrine pancreas. The
exocrine pancreas is comprised mainly of acinar and ductal cells (Figure 1.1). Acinar cells
secrete digestive enzymes and are arranged in grape-like clusters connected by ducts. Acinar
cells secrete zymogens and are morphological “cousins” to the gastric zymogenic chief cell.
The adult pancreas has no resident stem cell and pancreatic cells are specified during
embryogenesis by the expression of transcription factor PDX1 in the endoderm. Multipotent
progenitor cells proliferate to form the branches of the pancreas and eventually, by E14.5
(Heymans et al., 2019), differentiate into exocrine acinar cells. Thus, the pancreas must have
developed a mechanism to maintain tissue integrity in homeostasis and following injury. Since
pancreatic acinar cells and gastric chief cells are so similar in function and morphology, perhaps
gastric chief cells are also embryonically specified, though that has not been studied.

3

Figure 1.1: Organization of the gastric corpus and pancreatic acini.
Left – A cartoon of the stomach corpus unit where the pit cells are closest to the stomach lumen
and the chief cells are closest to the musculature. Arrows indicate direction of stem cell
contribution to mature cell types in the stomach, though new evidence indicates that chief cells
may maintain their own census. Right – A cartoon of an acinus in the exocrine pancreas. Mature
duct and acinar cells are established from an embryonic progenitor. Adapted from Willet, Lewis,
Miao et al., 2018.

1.2 Vesicle Trafficking and Scaling Factors in Exocrine Cells
1.2.1 Vesicle formation and maturation
Exocrine cells house large secretory vesicles full of zymogens and must maintain
extensive vesicle trafficking to sustain the cargo and membranes required by these secretory
vesicles. In addition, exocrine cells maintain the ability to degrade these granules and
mature/differentiated architecture via induction of lysosomes and autophagy in the case of injury.
So, not only is trafficking important for homeostasis and exocrine granules, but it is also
important for retaining cell function in injury settings.
4

Secretory and lysosomal vesicles form from membrane at the endoplasmic reticulum
(ER) where cargo proteins are folded and sorted into the vesicles. The vesicles then traffic to the
Golgi and begin to differentiate. Immature secretory granules released at the trans-Golgi are
further processed and fused together to increase in size and density (Tooze et al., 1991), a
process that is controlled by SNARE proteins (Burgoyne and Morgan, 2003). When secretory
vesicles mature and are ready to release, they dock and fuse with the plasma membrane in an
ATP-dependent process coordinated with cytoskeleton remodeling and calcium release
(Burgoyne and Morgan, 2003). From the trans Golgi, endosomes can mature into lysosomes and
increase in acidification through V-type vacuolar H+ ATPase activity (Mellman et al., 1986).
Lysosome maturation also involves the Mannose-6-Phosphate Receptor (M6PR), which binds
newly synthesized hydrolases as cargo in the trans-Golgi network and delivers them to the
maturing endosomes (Kornfeld and Mellman, 1989).
Autophagosomes are derived from the ER as well, when the ER membrane is used to
form the growing isolation membrane and omegasome, the ring-shaped structure that surrounds
cargo for eventual degradation. The site of omegasome formation is dictated in part by lipids and
specific proteins on the ER membrane, like DFCP1, FIP200, and COPII vesicle proteins
(Nakatogawa, 2020). During autophagosome formation, the Atg1/ULK complex recruits other
ATG proteins, like Atg8, to eventually aid in membrane expansion (Nakatogawa et al., 2007).
The initiation of autophagy is outside of the scope of this dissertation, so the numerous
autophagy-related proteins will not be discussed in detail here; however, it is important to note
that mTORC1 can block assembly of the autophagy-initiating complex Atg1/ULK by
phosphorylating some of the ULK complex proteins (Kamada et al., 2010). Thus, mTORC1
activation and autophagy induction do not occur at the same time.
5

Autophagy can be a random process, but the growing phagophore can interact with
proteins and organelles in a receptor-like manner. LC3B (microtubule-associated protein light
chain 3, encoded by Atg8) is one such receptor acting with adaptor molecules on organelles to
promote their uptake and eventual degradation. p62 (SQSTM1) is another known protein that
helps to select protein aggregates (Ralston, 2008).
At the final stage, the autophagosome fuses with the lysosome to form the
“autolysosome” which is not well understood, but requires the Rab7 GTPase (Gutierrez et al.,
2004; Jager et al., 2004). The autolysosome matures in a manner dependent on functional
cathepsins and lysosomal-associated membrane proteins (LAMPs) (Glick et al., 2010; Saftig and
Klumperman, 2009).

1.2.2 Rab GTPases regulate vesicle trafficking
Rab GTPases are organizers of membrane trafficking in the cell. Each stage of trafficking
is associated with and labeled by a Rab protein to specify membrane identity. They traffic
membranes by associating actin motors to vesicles in an energy-dependent manner. Rabs also
work to recruit protein complexes to membranes. One of the Rabs relevant to this dissertation is
RAB5, which is important for early endosome fusion. After further maturation, RAB7 becomes
associated with the vesicles as it transitions toward late endosome-lysosome fusion (Stenmark,
2009). Late endosomes also contain membranes for RAB9 binding to recruit RAB9 and M6PRs
(Barbero et al., 2002).
Since Rabs control position and formation of vesicles, they effectively also help dictate
the morphology of a cell and are especially important in exocrine cells like the gastric zymogenic
chief cell and then pancreatic acinar cell. RAB3 and RAB27 family proteins play key roles in
6

secretion. RAB27A and RAB27B are both expressed in secretory cells and aid in the transport
and docking of vesicles out of the cell (Fukuda, 2013). RAB3 family proteins also help with
secretory vesicle docking to the plasma membrane and RAB3D has specifically been shown to
help in maturation of large secretory granules (Tian et al., 2010). RAB8 similarly localizes to
secretory granules for their secretion (Faust et al., 2008). Other Rabs work to organize organelles
in cells, like RAB26B which localizes with lysosomes and redistributes lysosomes and
mitochondria (Jin and Mills, 2014).

1.2.3 Scaling factors: XBP1 and MIST1
During development waves of transcription factors become active to aid in maturation or
specification of a cell in a stochastic manner. Scaling factor proteins also work in cell maturation
in a manner that is like turning a dial to “scale up” or “scale down” a specific property of a cell.
There are several proteins described as scaling factors, like PGC1α which scales mitochondria
and TFEB which is a scaling factor for lysosome biogenesis (Kuiper et al., 2004; Miao et al.,
2020a; Scarpulla, 2008; Settembre et al., 2012).
X-box binding protein 1 (XBP1) is a scaling factor of ER expansion for secretion, which
in turn, increases cell size, lysosomes, mitochondria, ribosomes, and overall protein synthesis for
secretory cell function (Shaffer et al., 2004). Specific deletion of Xbp1 in acinar cells causes ER
stress, loss of granules, and apoptosis, but eventual regeneration of acinar cells in a mechanism
similar to that of Cerulein-induced pancreas injury (Hess et al., 2011). When Xbp1 is deleted in
gastric chief cells they survived, but shrank in size, had cell shape defects, and had disrupted
rough ER (Huh et al., 2010).
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One way XBP1 works to dictate cell maturation is through its target MIST1 (Bhlha15) a
bHLH transcription factor and scaling factor. MIST1 is involved in exocrine cell differentiation
(Pin et al., 2000). When chief cells are maturing, MIST1 aids in turning off progenitor markers,
establishing apical secretory vesicles, and forming lamellar rough ER (Huh et al., 2010). MIST1
is also expressed in mature secretory cells in Drosophila through humans (Lennerz et al., 2010;
Mills and Taghert, 2012). MIST1 binds to CATATG E-boxes in target genes to regulate their
transcription (Tian et al., 2010). Mist1 expression can even be forced in other cell types and
cause them to take on a more exocrine-like morphology and function (Lo et al., 2017). MIST1
has a unique function of transcriptionally regulating Rab proteins, a mechanism that is not well
studied. MIST1 binds in the first intron of targets Rab26 and Rab3d to coordinate their
expression and establish large secretory granules (Tian et al., 2010). This again demonstrates the
importance of Rabs in exocrine cells and demonstrates one mechanism of control over Rab
proteins that dictates cell function and maturation.

1.3 Defining Cell Plasticity
It has become strikingly clear that mature cells do not remain irreversible locked in a
differentiated state. In fact, mature cells demonstrate considerable plasticity and can be directed
to take on new fates in experimental settings in vitro and in vivo, which often recapitulate
disease, and natural settings (Adami, 1900; Burclaff and Mills, 2018a, b; Gurdon and Melton,
2008; Merrell and Stanger, 2016; Noble, 2015; Roy and Hebrok, 2015; Takahashi and
Yamanaka, 2006). Recently the field of cell plasticity has become popular and examples of
plasticity in nearly every organ have now been described, including studies in the stomach
(Meyer and Goldenring, 2018; Nam et al., 2010; Radyk et al., 2018), pancreas (Mills and
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Sansom, 2015; Willet et al., 2018), liver (Chen et al., 2020; Matsumoto et al., 2020; Raven et al.,
2017), intestine (Burclaff and Mills, 2018b; de Sousa and de Sauvage, 2019), lung (Tata et al.,
2013; Wang et al., 2018), skin (Burclaff and Mills, 2018b), kidney (Allison, 2020; Assmus et al.,
2020), and adipocytes (Wang et al., 2019; Zwick et al., 2018).
Plasticity is a general, umbrella term to describe cell fate or cell identity changes of adult
cells; however, the field of plasticity lacks agreed upon terminology to specifically describe the
cell fate changes (Mills et al., 2019). Since there are varied terms for the same plasticity changes,
the following are the terms and definitions that will be used in this dissertation. Dedifferentiation
describes a mature cell transition to a progenitor-like cell. Transdifferentiation is a process in
which a mature cell transitions to another specialized cell type, either directly or through a
dedifferentiated intermediate stage. Downscaling is a component of both dedifferentiation and
transdifferentiation describing how specialized cell features are reduced, often by the decreased
activity of scaling factors. A reserve stem cell or facultative progenitor cell is a
differentiated/specialized cell that can be prompted to become progenitor-like following largescale tissue injury. While these few terms defined here are generally accepted by the field, there
are several transition states that are not well defined. For example, when a cell expresses genes
from two different specialized cell lineages, it would not be fully dedifferentiated nor fully
transdifferentiated. In addition, there are no terms that exist to describe the mechanisms by which
cells undergo these state changes. Thus, there is a need for more specific and experimentally
defined terminology regarding cell plasticity.
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1.4 Plasticity and Metaplasia in the Stomach and Pancreas
Metaplasia can be pathologically defined as the emergence of a cell type in a tissue where
that cell type is not normally present (Mills et al., 2019). Metaplasias are a premalignant tissue
stage and chronic metaplasia poses the risk of progressing to dysplasia and cancer. Metaplasias
often arise in injury settings, for example, Helicobacter pylori infection in the stomach can
produce a specific type of gastric metaplasia, Spasmolytic Polypeptide-Expressing Metaplasia
(SPEM), or the pathological term “atrophic gastritis” (Meyer and Goldenring, 2018; Petersen et
al., 2017; Saenz and Mills, 2018) (Figure 1.2). SPEM is named for the expression of spasmolytic
polypeptide (or trefoil factor 2; TFF2) in gastric epithelial cells, which occurs in both humans
and mice. If H. pylori infection is chronic and left untreated, SPEM has the potential to progress
to gastric adenocarcinoma (Correa, 1988). There is debate as to which cells derive SPEM in the
stomach, but the most likely cell of origin for SPEM is the zymogenic chief cell in the gland base
which, following injury, undergoes a dedifferentiation event, acquires progenitor-like traits, and
enters the cell cycle (Burclaff et al., 2020; Leushacke et al., 2017; Radyk et al., 2018; Stange et
al., 2013; Willet et al., 2018).
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Figure 1.2: SPEM development from the gastric corpus.
Cartoon showing the change in the normal gastric corpus to Spasmolytic Polypeptide-Expressing
Metaplasia (SPEM), which can occur after H. pylori infection, autoimmune gastritis, and be
modeled in mice by high dose tamoxifen. In SPEM, mature chief cells give rise to SPEM cells.
Adapted from Willet, Lewis, Miao et al., 2018.

Like SPEM in the stomach, the pancreas demonstrates a similar metaplastic state called
acinar-to-ductal metaplasia (ADM). ADM derives from acinar cells as they dedifferentiate, begin
to acquire duct cell traits, and enter the cell cycle (Figure 1.3). ADM is formed in the setting of
chronic pancreatitis and can also be the result of a constitutively active mutation in the Kras
oncogene (Guerra et al., 2007; Hruban et al., 2006). ADM, like SPEM, is also a risk factor for
adenocarcinoma. Chronic ADM increases the likelihood for the formation of pancreatic
intraepithelial neoplasia (PanIN),which can progress to ductal adenocarcinoma (Distler et al.,
2014; Reichert et al., 2016; Zhu et al., 2007).
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Figure 1.3: ADM development from the exocrine pancreas
Cartoon showing the morphology changes of a pancreatic acini in the formation of acinar-toductal metaplasia (ADM), which can be caused from chronic pancreatitis and modeled in mice
with cerulein. Acinar cells give rise to the ADM cells observed in the duct-like structure.
Adapted from Willet, Lewis, Miao et al., 2018.

1.4.1 Evidence for metaplasia from differentiated cells
As previously stated, there is debate as to whether differentiated/specialized cells derive
SPEM, but this is also true for other examples of cell plasticity. This debate comes from the
notion that stem cells are responsible for most tissue regeneration. While this may be true at
homeostasis in many organs, after injury the stem cell may become overwhelmed and other cells
must be recruited to maintain tissue integrity. In addition, some organs, like the pancreas, lack a
resident stem cell so all regeneration must come from a differentiated cell. Observational, genetic
and lineage tracing studies, mostly in mouse models, have helped to support that metaplasia
derives from differentiated cells, rather than stem cells.
One of the most impactful studies in the stomach showing how chief cells contribute to
regeneration is from Stange et al., 2013. The authors show lineage tracing from Troy+ chief cells
can generate all lineages in the gastric epithelium and that they act as reserve stem cells upon
injury. The study also shows Mist1+ chief cells can also generate all lineages, reproducing results
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previously described in the field (Nam et al., 2010). This work was under examination when
Mist1 was proposed to be an isthmal stem cell marker (Hayakawa et al., 2015), though 100% of
MIST1 protein is expressed in mature chief cells. More recent findings supported the hypothesis
that mature chief cells derive SPEM through observational studies (Meyer et al., 2019; Radyk et
al., 2018; Willet et al., 2018) and lineage tracing studies with chief cell marker Lgr5 (Leushacke
et al., 2017) and a Runx1 enhancer element (Matsuo et al., 2017). Interestingly, other studies
even suggested that zymogenic chief cells maintain their own census in both injury and
homeostasis (Burclaff et al., 2020; Han et al., 2019).
While the adult pancreas lacks a resident stem cell, there has still been disagreement on
whether ADM comes from exocrine acinar cells or duct cells. The pancreas field has largely
concluded that acinar cells are the cells of origin for ADM with many lineage tracing studies
using from the acinar specific genes, Ptf1a and Elastase (Collins et al., 2012; De La O et al.,
2008; Desai et al., 2007). Pdx1 is also often used for lineage tracing, but Pdx1 is expressed in
both acinar and duct cells (Wescott et al., 2009), so in these studies it is impossible to say if
ADM is from acinar or duct cells, yet in either case metaplasia still arises from a differentiated
cell type.

1.4.2 Models of injury and metaplasia in stomach and pancreas
Metaplasia is a pathological state that precedes cancer, but since it is a transient state it is
difficult to find and study in patients and human samples; thus, several mouse models for
studying metaplasia have been developed and interrogated.
One of the most physiologically relevant mouse model for SPEM is infection with
Helicobacter strains, yet it takes several months to develop and the metaplasia is not
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synchronous (Petersen et al., 2017; Polk and Peek, 2010; Saenz et al., 2018). Chemical models of
SPEM are also common, like high dose tamoxifen treatment, which induces SPEM quickly (3
days), synchronously, and reversibly, which is all independent of estrogen receptor activity and
sex (Huh et al., 2012; Keeley et al., 2019; Saenz et al., 2016). The mechanism of action for
tamoxifen-induced SPEM is not well established, though it likely acts as a protonophore, killing
acid-secreting parietal cells and damaging the epithelium (Manning et al., 2020). The expression
profile after tamoxifen injury is also similar to that of an autoimmune gastritis mouse model
(Bockerstett et al., 2020) and, preliminarily, H pylori infection (unpublished data from Mills
Lab). DMP-777 is an elastase inhibitor, which also acts as a parietal protonophore, induces
SPEM in 7-14 days (Goldenring et al., 2000; Nozaki et al., 2008). This dissertation will mainly
use high dose tamoxifen (HDT) for gastric injury, of which the timeline can be found in Figure
1.4.
ADM can be modeled in mice from partial duct ligation surgery which involves suturing
a pancreatic lobe to create a buildup of digestive enzymes and pancreatitis (Watanabe et al.,
1995). Treatment with the secretagogue and cholecystokinin analog Cerulein causes acinar cell
hypersecretion, which can develop into ADM in 5-7 days of repeated injections (Adler et al.,
1985; Collins et al., 2012; Willet et al., 2018). Genetic mutations can also induce ADM, PanINs,
and cancer in mouse models, often by constitutive activation of oncogenic KRAS, which can be
accelerated in a p53 mutant or null background (Collins et al., 2012; Guerra et al., 2007). This
dissertation will mainly use Cerulein (CER) for pancreatic injury, of which the timeline can be
found in Figure 1.4.
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Figure 1.4 Tamoxifen and Cerulein injuries
A. Scheme of tamoxifen treatment. High dose tamoxifen (HDT; 5 mg/20 g body weight) by
intraperitoneal injection. Peak SPEM observed at Day 3. Orange bars indicate each stage of
paligenosis and where they correspond in the treatment timeline. B. Scheme of cerulein
treatment timeline. Six hourly intraperitoneal injections of cerulein (CER) (50μg/kg) were given
every other day for up to 7 days (peak ADM). Orange bars indicate each stage of paligenosis and
where they correspond in the treatment timeline.

1.5 Paligenosis as a Mechanism of Cell Plasticity
There are several terms used to explain cell state conversions after injury and few are
agreed on by the whole field of cell plasticity (Mills et al., 2019). Yet, there are still no terms
used to describe the mechanistic steps used in specific cell fate changes. Paligenosis emerged as
a unifying term for a mechanism by which a mature cell converts to a proliferative, progenitorlike cell following injury reliant on mTORC1 activity and cell autodegradation pathways (Willet
et al., 2018). Paligenosis is also conserved across organisms and tissues.
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1.5.1 Stepwise process of paligenosis
We have shown that the process of paligenosis occurs in three distinct stages: 1.
Autodegradation of specialized/differentiated cell features with decreased mTORC1 activity, 2.
Expression of a progenitor or metaplastic gene network, 3. Re-entry into the cell cycle
concurrent with reactivation of mTORC1. The steps of paligenosis are shown in Figure 1.5. Each
Stage of paligenosis can be blocked, forcing the cells to be “stuck” in progression and result in
decreased regeneration and metaplasia (Willet et al., 2018). Specifically, we have
pharmacologically inhibited mTORC1 with rapamycin, which halts proliferation at S-phase and
blocks progression through Stage 3. We also genetically blocked progression into Stage 2, with a
mouse lacking a functional lysosome (Gnptab–/–) because cells cannot downscale properly. The
Stage 2 checkpoint ensures that cells do not proliferate until they dedifferentiate and remove
damaged or specialized organelles.
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Figure 1.5: Stages of paligenosis progression.
Differentiated cells, like gastric chief cells and pancreatic acinar cells, revert to a progenitor-like
state following injury via three main Stages/Phases with intervening checkpoints reliant on
autophagy and mTORC1 activity. Adapted from Willet, Lewis, Miao et al., 2018.

1.5.2 Paligenosis genes
Paligenosis is a process of cell plasticity conserved across tissues and organisms; the
genes that control paligenosis are also likely to be conserved as well. Paligenosis genes should be
dispensable for homeostasis and development but required after injury and for regeneration.
Finally, putative paligenosis genes must help to regulate or associate with mTORC1 or
autodegradation pathways, since these are two major components of the process of paligenosis.
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In addition to mTORC1, two other clear paligenosis-governing genes have been
identified: Ifrd1 and Ddit4 (Miao et al., 2020b). In summary, p53 acts to repress and
downregulate mTORC1 once paligenosis is activated. In paligenosis Stage 3, mTORC1 must be
reactivated, so IFRD1 functions to repress the p53 repression of mTORC1. Failure to progress
through paligenosis Stage 3 in Ifrd1–/– results in cell death when cells would normally enter the
cell cycle, thus creating a differentiate or die decision. DDIT4 works in parallel with p53 to
repress mTORC1 early in paligenosis; therefore, Ddit4–/– mice express high levels of mTORC1
throughout paligenosis, which overrides the Stage 1 to Stage 2 checkpoint that would normally
perform quality control for differentiated cells. In turn, Ddit4–/– mice demonstrate increased
proliferation and DNA damage. Interestingly, IFRD1 and DDIT4 are expressed early in
paligenosis, though their major contribution to paligenosis is in Stage 3 when cells either
dedifferentiate normally (wild-type), die (Ifrd1–/–), or have abnormal increased proliferation
(Ddit4–/–).

1.6 Activating Transcription Factor 3 (ATF3)
Immediate early genes, or genes induced quickly in injury settings, such as the AP1/Fos/Jun family, are likely to be important for paligenosis since they are conserved across
species and tissues and already have a demonstrated role for regeneration. Our first screen of
genes induced during injury in the stomach, pancreas, liver, and kidney showed significant
upregulation of two genes: Ifrd1 and Atf3 (Lewis, 2019; Miao et al., 2020b). Ifrd1 has been
recently published as a paligenosis gene, but Atf3 has not yet been described in this context.
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1.6.1 Atf3 is conserved and functions in injury contexts
ATF3 is known as a general stress response protein in a variety of injury settings
including cerebral ischemia (Wang et al., 2012), axon regeneration (Gey et al., 2016; Hunt et al.,
2012), acute lung injury (Zhao et al., 2017), heart failure (Brooks et al., 2015), alcohol liver
damage (Tsai et al., 2015), liver ischemia-reperfusion injury (Zhu et al., 2018), stress-induced βcell apoptosis (Hartman et al., 2004), acute kidney injury (Li et al., 2010), and amino acid
depletion (Pan et al., 2007). In fitting with paligenosis, ATF3 is nearly undetectable at
homeostasis but rapidly and robustly accumulates after injury (Hai et al., 1999). ATF3 is also not
required for normal development, as Atf3–/– mice develop to adulthood and reproduce at
Mendelian ratios. Most recently, ATF3 was described to be important for Cerulein-induced
pancreatitis, albeit chronic injury was not of focus in this study (Fazio et al., 2017). Atf3 is
conserved through to sea anemone (Nematostella vectensis) and becomes upregulated in
Drosophila intestine injury (Zhou et al., 2017) as well as Axolotl limb regeneration (Gerber et
al., 2018). In each of the injuries described, loss of Atf3 is associated with exacerbated injury
phenotypes.

1.6.2 Transcription factor function of ATF3
ATF3 is a member of the ATF/CREB family of transcription factors and binds to the
ATF/cyclic AMP responsive element (CRE) consensus sequence: TGACGTCA (Chen et al.,
1996). ATF3 also shares target binding sites with AP-1 (Zhao et al., 2016). ATF3 can act as a
transcriptional repressor cooperating with histone deacetylase complexes HDAC1 and HDAC6
(Kwon et al., 2015; Li et al., 2016; Li et al., 2010). Depending on the context, ATF3 can also act
as a transcriptional activator, working closely with histone acetyltransferase p300 (Zhao et al.,
2016).
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Most ATF3 targets are genes involved in mitigating ER stress and the Integrated Stress
Response (ISR) (Jiang et al., 2004). C/EBP homologous protein (CHOP; DDIT3) is a well
described protein involved in ER stress (by activation of GADD34 (PPP1R15A) (Marciniak et
al., 2004)) and survival (by downregulation of BCL-2 (Zinszner et al., 1998)) and the best
characterized ATF3 target gene (Chen et al., 1996). ATF3 can also transcriptionally regulate
itself (Inoue et al., 2004), amplifying any injury signals for stronger induction or repression of
genes.
ATF3 regulates some genes involved in dedifferentiation and paligenosis. Studies in
pancreatic acinar cells show ATF3 can repress scaling factor Mist1 and induce metaplastic gene
Sox9 (Fazio et al., 2017). In addition, ATF3 coordinates with the ISR (Jiang et al., 2004). ATF3
induces CHOP, which activates GADD34, a phosphatase important for restoring normal protein
translation levels after an injury stimulus is resolved (Marciniak et al., 2004). When the ISR is
activated, stress response genes, like Ifrd1 can be translated (Paolini et al., 2018; Zhao et al.,
2010); therefore, ATF3 may feedback on the ISR and help control IFRD1. Recently, ATF3 was
also shown to repress Fgf21, which contributes to pancreatitis (Hernandez et al., 2020).

1.6.3 Upstream effectors of ATF3
ATF3 can be activated by several stress stimuli, but its activation can be most attributed
to the ISR, which will be detailed in section 1.7. Briefly, ATF3 is generally not transcribed
during homeostasis, but when the ISR is active the open reading frame of Atf3 is accessible,
allowing for translation (Jiang et al., 2004; Liu et al., 2016). This is also the mechanism of
activation for related transcription factor ATF4 (Ait Ghezala et al., 2012).
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ATF3 and p53 are tightly linked and in some contexts Atf3 is a p53 target. For example,
one study shows p53 activation by DNA damage can activate ATF3 (Taketani et al., 2012) and
another study shows mutant p53 represses Atf3 to protect against cell death (Buganim et al.,
2006). Literature also suggests that ATF3, in turn, can have direct protein-protein interactions
with p53, which suppresses function of mutant p53 .(Wei et al., 2014). ATF3 also stabilizes and
activates wild-type p53 by preventing its ubiquitination (Li et al., 2020; Wang et al., 2010; Yan
et al., 2005).
Finally, there is some literature to suggest ATF3 may be activated through JAK-STAT
and NFκB signaling (Kaszubska et al., 1993; Kim et al., 2010; Zhou et al., 2017), though the
mechanisms of activation are not well described.

1.7 The Integrated Stress Response (ISR)
Evolutionarily conserved in all eukaryotes, the Integrated Stress Response (ISR) is a way
cells can sense different stress stimuli and control protein synthesis until the stress has subsided
(Costa-Mattioli and Walter, 2020; Harding et al., 2003). It does so by globally decreasing
translation of “housekeeping” genes and increasing translation of genes involved in mitigating
stress. However, if the stress persists and is not dealt with, the ultimate result is cell death. The
ISR attempts to maintain cell health in an unfavorable environment.

1.7.1 The Integrated Stress Response kinases and eIF2
There are four specialized kinases that all cooperate to activate the ISR, each sensing a
different type of cellular stress. HRI (Heme-Regulated Inhibitor; EIF2AK1) responds to iron
depletion, PKR (Protein Kinase R; EIF2AK2) responds to infection and double-stranded RNA,
PERK (PKR-like ER Kinase; EIF2AK3) responds to ER stress, and GCN2 (General Control
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Nonderepressible 2; EIF2AK4) responds to amino acid starvation (Donnelly et al., 2013). Each
has a specific regulatory domain that allows them to respond to stress, for example, PKR has a
double-stranded RNA binding domain to sense viral RNAs. The kinases become activated by
dimerization and trans-autophosphorylation to phosphorylate eIF2 at the alpha subunit. Figure
1.6 schematizes the ISR and its main players.

Figure 1.6: The Integrated Stress Response
ISR kinases sense different cellular stresses and coordinate to phosphorylate eIF2α and control
translation. When eIF2α is phosphorylated, global translation is reduced except for genes that are
involved in stress responses, like Atf3. GADD34 is a phosphatase that can reestablish normal
translation after the stress signal has gone.

eIF2 is a translation initiation factor tasked with bringing the initiator Met-tRNA to the
ribosome to begin translation (Harding et al., 2000). eIF2 has three subunits α (coded by
EIF2S1), β (coded by EIF2S2), and γ (coded by EIF2S3). eIF2γ has nucleotide-bindings sites for
GTP-dependent tRNA transfer and eIF2β interacts with tRNA and mRNA. eIF2α interacts with
the GEF (guanine exchange factor) to properly charge eIF2γ. eIF2α also has a specific
phosphorylation site at Serine 51, which blocks GEF binding, inhibiting eIF2 protein activation
and reducing protein translation. The ISR kinases specifically target eIF2α-Ser51 when they are
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activated so translation is reduced. There are also phosphatases for eIF2, like GADD34
(PPP1R15A), which restores eIF2 activity by removing the inhibitory phosphate on eIF2α (Chu
et al., 2016; Costa-Mattioli and Walter, 2020).

1.7.2 The Integrated Stress Response and translation control
The ISR works to control translation through eIF2, but not all genes are equally affected.
Stress-related proteins, like those for autophagy and apoptosis are instead upregulated when the
ISR is activated and eIF2 is phosphorylated (Harding et al., 2000). Translation of genes to
mitigate stress can even be specifically upregulated when the ISR is activated. This occurs
through nontraditional means of translation initiation. ATF3, ATF4, and IFRD1 are selectively
translated during this time because they have a long 5’-untranslated region and upstream open
reading frames that normally prevent initiation at their canonical start sites (Andreev et al., 2015;
Morris and Geballe, 2000; Starck et al., 2016; Young and Wek, 2016). Proteins like p53, which
can be translated via cap-independent means through internal ribosome entry sites are also
resistant to ISR activation and translation inhibition (Ryoo and Vasudevan, 2017; Shatsky et al.,
2018). While the ISR is one way translation is controlled during times of stress, it is not well
understood how the ISR coordinates with mTORC1-regulated translation.

1.7.3 ER stress and the Integrated Stress Response
There are three main pathways cells use to moderate ER stress. The first, as briefly
described above, is through PERK. PERK sits on the ER membrane and has a binding domain
for chaperones, like BiP (Binding immunoglobulin protein; GRP-78; HSPA5). When BiP is
bound to PERK, the kinase is inactive, but in the event of excessive unfolded proteins, BiP
instead performs its chaperone functions and PERK is unbound and activated (Hetz, 2012;
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Schroder and Kaufman, 2005). PERK activation then activates the ISR to globally reduce
translation.
In addition to translation control, ER stress also activates the ATF6 (Activating
Transcription Factor 6) and IRE1 (Inositol-requiring enzyme 1) pathways to regulate XBP1 and
increase transcription of degradation genes and chaperones (Hetz, 2012). ATF6 and IRE1 are
also normally bound by chaperones, but when there is increased unfolded protein, they are
activated. ATF6 translocates to the Golgi for cleavage and activation, then transcriptionally
upregulates chaperones (Shen et al., 2002). When IRE1 is activated it works to splice Xbp1
mRNA, which functions in this context to upregulate transcription of chaperones and
degradation machinery (Calfon et al., 2002; Yamamoto et al., 2007). Therefore, the three ER
stress pathways work together to synchronize a cell response to mitigate the stress and control
any potential damage; however, just like the ISR, if ER stress persists, cells will undergo
apoptosis (Tabas and Ron, 2011).

1.8 Conclusion
Cell plasticity is an old field that has recently gained popularity, bringing new questions.
Some of these questions specifically surround mechanisms cells use to revert to a more
progenitor-like fate. Paligenosis is one such process of mature cell reversion after injury. In
paligenosis, and other cases of cell plasticity differentiated cells are called back into the cell
cycle to contribute to repair and maintain tissue integrity. There is still disagreement on how
much contribution stem cells have to plasticity in a tissue, but cases of differentiated cells
contributing to repair have been supported in several organs and organisms.
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Many are working to identify pathways and proteins that might be inputs to start cell
plasticity. We have described mTORC1, autodegradation pathways, IFRD1, and DDIT4 all
contribute to paligenosis. Yet, it is still unclear what signals, exactly, prompt a cell to undergo
such an energetically demanding dedifferentiation process and cell cycle entry. ATF3 is a likely
new target that controls paligenosis and cell plasticity and will be described in later chapters as a
paligenosis-governing gene. Moreover, the main upstream pathway to activate ATF3, the
Integrated Stress Response, is a potential pathway controlling paligenosis initiation and cell fate
decisions after injury.
We are only starting to unravel the components cell plasticity, but studies in this field
have impacts on cell biology, stem cell biology, regeneration, cancer biology, and other related
fields. Moving forward it will be important for those examining plasticity to be open to
interdisciplinary study so that new ideas can be easily interrogated across tissues and organisms.
Importantly, work in cell plasticity can be applied to human health, most easily in cancer, but
certainly also to any disease or phenomenon that causes large-scale tissue damage and may
potentially lead to new approaches for disease management and treatment.
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Chapter 2: Metaplastic Cells in the Stomach
Arise, Independently of Stem Cells, via
Dedifferentiation or Transdifferentiation of
Chief Cells

This chapter is adapted from the published work in Gastroenterology.
Radyk MD, Burclaff J, Willet SG, Mills JC. (2018). Metaplastic Cells in the Stomach Arise,
Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Gastroenterology 154(4), 839-843

44

2.1 Abstract
Spasmolytic polypeptide-expressing metaplasia (SPEM) develops in patients with chronic
atrophic gastritis due to infection with Helicobacter pylori; it might be a precursor to intestinal
metaplasia and gastric adenocarcinoma. Lineage tracing experiments of the gastric corpus in
mice have not established whether SPEM derives from proliferating stem cells or differentiated,
post-mitotic zymogenic chief cells in the gland base. We investigated whether differentiated cells
can give rise to SPEM using a nongenetic approach in mice. Mice were given intraperitoneal
injections of 5-fluorouracil, which blocked gastric cell proliferation, plus tamoxifen to induce
SPEM. Based on analyses of molecular and histologic markers, we found SPEM developed even
in the absence of cell proliferation. SPEM therefore did not arise from stem cells. In histologic
analyses of gastric resection specimens from 10 patients with adenocarcinoma, we found normal
zymogenic chief cells that were transitioning into SPEM cells only in gland bases, rather than the
proliferative stem cell zone. Our findings indicate that SPEM can arise by direct reprogramming
of existing cells-mainly of chief cells.
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2.2 Results and Discussion
Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) arises in the setting of chronic atrophic
gastritis (CAG) in humans infected with Helicobacter pylori and may be a precursor to intestinal
metaplasia and gastric adenocarcinoma1,2. CAG is characterized by chronic inflammation,
parietal cell death, and metaplastic expansion of cells coexpressing spasmolytic polypeptide
(TFF2) and zymogenic chief cell (ZC) markers. Genetic lineage tracing studies have not
definitively identified the cell-of-origin for SPEM cells. Tracing from Mist1CreERT2-expressing
cells indicated ZCs at the gland base gave rise to SPEM3–7. Another report disputed this because
occasional cells in the upper, isthmal stem cell region of the gland also expressed Mist1CreERT2,
indicating SPEM might be derived isthmally8. We use a new approach to determine if
differentiated cells can give rise to SPEM.
For an isthmal stem cell to generate a gland full of SPEM cells, its progeny must proliferate to
reach the gland base. We inhibited proliferation with the anti-mitotic drug 5-Fluorouracil (5FU)
and found one 150mg/kg4 intraperitoneal injection of 5FU was sufficient to block proliferation
for 24h with return to near-normal levels by 48h (Figure 2.1A,B).
Long-term 5FU is toxic beyond 4–5 days, thus we used a SPEM induction method shown by
multiple labs to cause maximal, synchronous SPEM within three days: high dose tamoxifen
(HDT)9,10. Our selected 5FU+HDT regimen caused no mouse mortality, but blocked nearly all
proliferation at the peak SPEM stage: <0.5 in 5FU+HDT vs. >8 cells/unit in HDT alone (Figure
2.1C).
We monitored SPEM by immunofluorescence for the ZC marker, gastric intrinsic factor (GIF;
red), and a lectin (GSII; green), which co-labels with TFF2. In control mice, GIF was located in
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ZCs at the gland base, separated from the GSII+ mucous neck cells in the middle of the gland.
Consistent with previous reports9,10, HDT caused SPEM, defined by pathognomonic GSII+GIF+
co-staining at the gland base (Figure 2.1D), yet few SPEM cells appeared at 24h (Figure 2.2).
5FU alone, or with HDT, did not significantly alter outcomes at any timepoint. At 72h, similar
numbers of SPEM cells formed in HDT and HDT+5FU: 6.0±1.5 SPEM cells in HDT, 5.6±1.0 in
HDT+5FU (Figure 2.1D,E). Additionally, 5FU vs. HDT+5FU mice displayed a similar
magnitude of GIF+ cell loss and GIF+GSII+ SPEM cell increase (Δ −3.7±1.3 GIF+ cells/unit, Δ
+5.2±0.8 GIF+GSII+ cells/unit), while GSII+ neck cells decreased only slightly (ΔG: −0.76
±0.75), implicating ZCs as the principal source for SPEM cells when proliferation is blocked.
Equivalent SPEM was confirmed in HDT±5FU mice by qRT-PCR for SPEM-associated
transcripts Mist1, Gif, He4, and Clusterin11 (Figure 2.3) and immunofluorescence for Clusterin
(Figure 2.1F).
We examined the differentiation pattern and location of occasional cells escaping the 5FU
blockade at 72h. Proliferating cells in control mice lacked neck/ZC markers, indicating
proliferation primarily in isthmal stem cells (Figure 2.4A,B). HDT mice harbored proliferating
isthmal, neck, SPEM, and occasional BrdU+ ZCs (Figure 2.3A,B). The 5FU+HDT regimen was
designed such that cells escaping 5FU blockade at 72h would be in their first cell cycle, as
gastric epithelial cells average one division per day12. As expected, <1 cell/unit was BrdU+ at 72h
5FU+HDT, and units with >1 BrdU+ cell were exceedingly rare (Figure 2.4A). Proliferating cells
could not be found prior to 72h (Figure 2.5). Proliferating cells at 72h expressed neck, SPEM, or
ZC markers (Figure 2.4B). Interestingly, the largest cohort did not label with GSII or GIF. We
suspect these cells are parietal cell progenitors based on cells, at 96h following HDT, expressing
BrdU and beginning to show the characteristic, thick apical staining of parietal cell marker,
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ezrin13 (Figure 2.6). Figure 2.4C plots zones in which proliferating cells emerged from isthmus to
base, excluding upper pit/foveolar cells (Figure 2.7A). In control mice, almost all proliferation
was in the isthmus. In HDT and 5FU+HDT, proliferating cells appeared throughout the gland.
Thus, multiple lines of evidence presented here indicate, in addition to isthmal stem cells,
multiple cell types throughout the gland exhibit plasticity and can proliferate in response to
damage.
We stained for proliferative SPEM with CD44v (CD44v9 in humans)11. HDT and 5FU+HDT
mice exhibited CD44v staining at the gland base (Figure 2.7B) and increased expression of
proliferation-associated markers Check2 and Ccnb2 by qRT-PCR, indicating basally-located
cells are poised to divide in 5FU+HDT stomachs (Figure 2.7C).
Our data suggest stem cells are responsible for pit- and neck cell-localized proliferation
following HDT; however, SPEM itself is largely derived from ZCs, supporting previous work
suggesting two foci of proliferation in the stomach14. Our mouse experiments reflect ZC to
SPEM transitions observed in humans previously extensively characterized from a large dataset
of adenocarcinoma and gastritis biopsy and resection specimens15. Figures 2.4D-F and Figure 2.8
depict representative stomach glands from 10 additional patients with gastric adenocarcinoma.
We again observe hybrid cells (cells with features of mature ZCs and SPEM cells) occurred
predominantly in the base. Specifically, we see apparent transition among a variety of cell
phenotypes from mature ZCs (expressing PGC in large apical granules) to cells expressing
abundant PGC with scant GSII (likely indicating early SPEM change) to phenotypically
complete SPEM conversion (scant PGC with abundant GSII) (Figure 2.4F). A stem cell-origin of
SPEM in humans would mean cell fate changes to SPEM cells should occur at the isthmus, and
SPEM cells would have to expand downward and replace mature ZCs to populate the base. Thus,
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the interpretation that SPEM originates exclusively from the isthmus would be inconsistent with
the presence of cells transitioning to SPEM consistently found in the base.
Differentiated cells are long-lived and may accumulate mutations that become unmasked upon
cell cycle re-entry after injury. For example, Kras mutations in ZCs or pancreatic acinar cells can
fuel tumorigenic transformation6. Therefore, our current work, highlighting how differentiated
cells are called back into the cell cycle in an acute injury model, should interest those studying
tumorigenesis and/or regeneration.
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2.3 Figures
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Figure 2.1 SPEM can occur without proliferation.
A) IHC staining for BrdU after one dose of 5FU (150mg/kg; intraperitoneal injection). Eosin Y
counterstain. B) Experimental timeline and proliferation quantification. C) 5FU+HDT
experimental timeline and proliferation quantification. D) Immunofluorescence of stomachs after
72h vehicle, 5FU, HDT, or 5FU+HDT treatment (red, GIF; green, GSII; blue, DAPI). Dotted
line: gastric unit. E) Cell populations quantified, # indicates significance compared to vehicle, *
indicates significance between treatment groups. R is significance between red columns, Y
between yellow columns. F) Immunofluorescence of stomachs (red, GIF; green, Clusterin; blue,
DAPI). *p≤0.05, **p≤0.01 ***p≤0.001, variance analyzed with ANOVA/Tukey (N ≥ 3
mice/group)
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Figure 2.2 No SPEM occurs 24h after HDT treatment
A) Immunofluorescence of stomachs after 24h of vehicle, 5FU, HDT, or 5FU+HDT treatment
(red, GIF; green, GSII; blue, DAPI). B) Quantification of cell populations, # indicates
significance of treatment compared to vehicle, * indicates significance between specified
treatment groups. G is significance between green columns. *p≤0.05, variance analyzed with
ANOVA/Tukey (N ≥ 3 mice/group)
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Figure 2.3 qRT-PCR for SPEM-associated genes
A) Transcripts of zymogenic cell markers analyzed from RNA isolated from the whole gastric
corpus of mice treated with vehicle, 5FU, HDT, or 5FU+HDT for 24 hours. B) Same RNA
described from A analyzed for markers known to increase in SPEM. C) Transcripts of
zymogenic cell markers analyzed from RNA isolated from the whole gastric corpus of mice
treated with vehicle, 5FU, HDT, or 5FU+HDT for 72 hours. D) Same RNA described from C
analyzed for markers known to increase in SPEM. *p≤0.05 **p≤0.01 ***p≤0.001, variance
analyzed with ANOVA/Tukey (N ≥ 3 mice/group)
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Figure 2.4 Metaplastic cells arise below the isthmus
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Figure 2.4 Metaplastic cells arise below the isthmus
A) Immunofluorescence of stomachs after 72h vehicle, 5FU, HDT, or 5FU+HDT (green, GSII;
red, GIF; white, BrdU; blue, DAPI; arrowheads, rare BrdU+ cells in 5FU+HDT). B)
Proliferating cell populations quantified. C) Location of BrdU+ cells below the bottom-most
AAA+ pit cell. D) Hematoxylin & eosin of early human SPEM (yellow circle) E)
Immunofluorescence on serial section from 2D (red, PGC; green, GSII; blue, DAPI; arrowhead:
SPEM cell). Yellow circle is SPEM area. F) Human SPEM within gland base showing
transitional ZC➔SPEM forms. Dotted box indicates area shown at higher magnification. Cells
outlined in colors according to cell type (red, normal ZCs; blue, hybrid SPEM; yellow, full
SPEM). *p≤0.05 **p≤0.01 ***p≤0.001, variance analyzed with ANOVA/Tukey (N ≥ 3
mice/group)
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Figure 2.5 Proliferation is sufficiently blocked over the course of injury in 5FU+HDT mice
A) Immunofluorescence of stomachs after 24h of vehicle, 5FU, HDT, or 5FU+HDT (green,
GSII; red, GIF; white, BrdU; blue, DAPI). B) Quantification of proliferating cell populations. # #
p≤0.01, variance analyzed with ANOVA/Tukey (N ≥ 3 mice/group)
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Figure 2.6 Proliferating pre-parietal cells begin to appear 96h after HDT treatment.
Timeline of treatment scheme. Immunofluorescence of stomachs after 96h of vehicle, 5FU,
HDT, or 5FU+HDT (green, GSII; red, ezrin; white, BrdU; blue, DAPI). Yellow boxes indicate
BrdU+ ezrin+ cells with basolateral surfaces of each cell outlined in dashed white line.
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Figure 2.7 Proliferation after SPEM induction
A) Immunofluorescence of stomachs after 72h of vehicle, HDT, or 5FU+HDT treatment (red,
GIF; purple, AAA (Anguilla anguilla lectin); white, BrdU; blue, DAPI). Yellow arrowheads
indicate cells that were not counted in quantification because they are in the pit zone and, thus,
above the bottom-most AAA+ cell. B) Immunofluorescence of stomachs treated with vehicle,
5FU, HDT, or 5FU+HDT for 72h (red, CD44v; green, GSII; blue, DAPI). Dotted line: outlined
unit bases. C) Transcripts of proliferative markers analyzed from RNA isolated from the whole
gastric corpus of mice treated with vehicle, 5FU, HDT, or 5FU+HDT for 72 hours.
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Figure 2.8 Human SPEM in gastric cancer patients
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Figure 2.8 Human SPEM in gastric cancer patients
A) H&E of human corpus glands with early atrophic gastritis exhibiting focal gland bases
transitioning to SPEM. Arrows refer to parietal cells in healthy glands. SPEM gland outlined in
yellow has a wide lumen and lacks parietal cells. B) Same as panel A but a different patient with
more active gastritis. Early SPEM gland outlined in yellow shows opening of lumen at gland
base (yellow arrow) and contains degenerating parietal cells (black arrows). C)
Immunofluorescence of human SPEM (red, PGC; green, GSII; blue, DAPI). Note many hybrid
forms in gland bases ranging from cells with only red PGC (mature, normal ZCs) to those
showing mature SPEM (prominent green GSII, scant red PGC). D) Immunofluorescence of the
base of yet another patient’s corpus. A mature SPEM gland is located next to a normal gland
with mature ZCs. A third gland shows hybrid forms wherein ZCs express focal, apical GSII
(yellow arrowheads). E) Table detailing the demographic aspects and pathological diagnoses of
the 10 patients analyzed in this manuscript.
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2.4 Materials and Methods
Animals and Injections
All experiments involving animals were performed according to protocols approved by the
Washington University School of Medicine Animal Studies Committee. Mice were maintained
in a specified pathogen-free barrier facility under a 12-hour light cycle. Wild-type C57BL/6 mice
were purchased from Jackson Laboratories (Bar Harbor, ME). All mice used in experiments
were females 6–8 weeks old. To induce SPEM, tamoxifen (250mg/kg body weight; Toronto
Research Chemicals, Inc, Toronto, Canada) was administered daily for 3 days by intraperitoneal
injection. Tamoxifen was dissolved in a vehicle of 10% ethanol and 90% sunflower oil (Sigma).
Previously described10. To block proliferation, 5-Fluorouracil (150mg/kg body weight; Sigma
F6627) was given by intraperitoneal injection twice daily for 2 days. 5-Fluorouracil was
dissolved in a solution containing 10% DMSO and 0.9% sodium chloride. All mice were given
an intraperitoneal injection containing 5-bromo-2′-deoxyuridine (120mg/kg) and 5-Fluoro-2′
deoxyuridine (12mg/kg) 90 minutes prior to sacrifice.
Patient Samples
Human gastric tissue was obtained with approval from the Institutional Review Board of
Washington University School of Medicine. The database of metaplastic samples showing
hybrid SPEM forms has been previously described15-17.
Immunofluorescence and Immunohistochemistry
Stomachs were excised immediately, flushed with PBS via the duodenal stub and then inflated
with freshly prepared 4% paraformaldehyde. The stub was clamped by hemostat, and the
stomach suspended in fixative in a 50 ml conical for 8–12 hours, followed by 3 rinses in 70%
ETOH, arrangement in 2% agar in a tissue cassette, and routine paraffin processing. Sections (5
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m) were cut, deparaffinized and rehydrated with graded xylenes, alcohols and water, then
antigen-retrieved in Sodium Citrate Buffer (2.94g Sodium citrate, 500ul Tween 20, pH 6.0) using
a pressure cooker. Slides were blocked in 5% Normal Goat Serum, 0.2% Triton-X 100, in PBS.
Slides were incubated overnight at 4°C in primary antibodies, then rinsed in PBS, incubated 1
hour at RT in secondary antibodies and/or fluorescently labeled lectin (Alexafluor647 made by
directly conjugating E–Y Labs lectin to Molecular Probes Alexauor647), rinsed in PBS, mounted
in ProLong Gold Antifade Mountant with DAPI (Molecular Probes). For immunohistochemistry,
steps were identical except the following. An extra quenching step was performed for 15 min in
a methanol solution containing 1.5% H2O2 following antigen retrieval. Substrate reaction and
detection was performed using ImmPACT VIP Peroxifase (HRP) Substrate Kit (Vector
Laboratories) as detailed per the manufacture’s protocol and slides were mounted in Permount
Mounting Medium.
Imaging
Fluorescence microscopy was performed using a Zeiss Axiovert 200 microscope with an
Axiocam MRM camera and Apotome II instrument for grid-based optical sectioning. Postimaging adjustments including contrast, fluorescent channel overlay, and pseudo-coloring, were
performed with Axiovision and Adobe Photoshop CS6. Histology of stomach and
immunohistochemistry were imaged using an Olympus BX51 light microscope and Olympus
SZX12 dissecting microscope w/12 MPixel Olympus DP70 camera. Images were analyzed and
post-imaging adjustments were performed with Adobe Photoshop CS6.
Antibodies
Primary antibodies used in this study were as follows: Fluorescently conjugated Anguilla
anguilla lectin (AAA; Alexa Fluor 647; 1:1000; EY Labs), goat anti–5-bromo-2′-deoxyuridine
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(1:20,000; a gift from Dr Jeff Gordon, Washington University, St Louis, MO), rat anti-CD44
v10-e16, ortholog of human v9 (1:200; Cosmo Bio, Tokyo, Japan), goat anti-Clusterin (1:100;
Santa Cruz Biotechnology), mouse anti-ezrin (1:250; Santa Cruz Biotechnology), fluorescently
conjugated Griffonia simplicifolia-II lectin (GSII; Alexa Fluor 647; 1:1,000; Invitrogen), rabbit
anti-human gastric intrinsic factor (1:10,000; a gift from Dr David Alpers, Washington
University, St Louis, MO), sheep anti-Pepsinogen C (PGC; 1:10,000; Abcam). Secondary
antibodies included AlexaFluor (488, 594, or 647) conjugated donkey anti-goat, anti-rabbit, or
anti-mouse (1:500; Molecular Probes).
Immunofluorescence and Immunohistochemistry Quantification
For counts from units expressing neck, chief, and proliferative markers all time points were
quantified with at least 3 mice. Stomach corpus slides were stained for 5-bromo-2′-deoxyuridine
(BrdU), the neck cell marker GSII lectin, and zymogenic cell marker GIF. Images were captured
as TIFF files from a Zeiss Axiovert 200 microscope with an Axiocam MRM camera with an
Apotome optical sectioning filter (Carl Zeiss, Jena, Germany). Each stomach had at least five
randomly distrubuted 20× images taken, which contained 10 or more well-oriented gastric units.
Units were counted using the neck staining, and total quantifications of proliferating cells (5bromo-2′-deoxyuridine) were averaged over the total unit numbers per mouse. For total
proliferation counts from immunohistochemistry at least 3 mice per treatment group were
quantified. Stomach corpus slides were stained with an antibody for 5-bromo-2′-deoxyuridine
(BrdU). Whole slides were scanned using a NanoZoomer 2.0 HT microscope and analyzed with
NanoZoomer Digital Pathology software (Hamamatsu; Hamamatsu City, Japan). At least 40
corpus units were analyzed and counted per stomach. Proliferation rate for each mouse was an
average of all units counted.
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qRT-PCR
RNA was isolated using RNeasy (Qiagen) per the manufacturer’s protocol. The quality of the
mRNA was verified with a BioTek Take3 spectrophotometer and electrophoresis on a 2%
agarose gel. RNA was treated with DNase I (Invitrogen), and 1 μg of RNA was reversetranscribed with SuperScript III (Invitrogen) following the manufacture’s protocol.
Measurements of cDNA abundance were performed by qRT–PCR using either a Stratagene
MX3000P detection system or a Bio-Rad CFX Connect system. Power SYBR Green master mix
(Thermo Scientific) fluorescence was used to quantify the relative amplicon amounts of each
gene (normalizing gene was TATA box binding protein). Primer design and sequence in Table
2.1.
Table 2.1 qRT-PCR primer sequences:

Graphing and statistics
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All graphs and statistics were completed in GraphPad Prism (La Jolla, CA), using 1-way analysis
of variance with the Tukey post hoc multiple comparison test to determine significance. Sample
sizes were determined based on statistical significance and practicality. A P-value of ≤0.05 was
considered significant.
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Chapter 3: ATF3 governs the initial,
autodegradative phase of paligenosis, the
conserved cellular program that converts
mature cells to progenitors

This chapter is adapted from a manuscript in review.
Radyk MD, Peña BL, Spatz LB, Brown JW, Cho CJ, Shih C-C, Fitzpatrick JAJ, Mills JC.
(2020). ATF3 induces RAB7 to govern autodegradation in paligenosis, a conserved cell
plasticity program.
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3.1 Abstact
Differentiated cells across multiple species and organs can reenter the cell cycle to aid in injuryinduced tissue regeneration by a cellular program called paligenosis. Here we show that
Activating Transcription Factor 3 (ATF3) is induced early during paligenosis in multiple cellular
contexts, transcriptionally activating the key lysosomal trafficking gene Rab7b. ATF3 and
RAB7B are upregulated in gastric and pancreatic digestive-enzyme-secreting cells at the onset of
paligenosis Stage 1, when cells massively induce autophagic and lysosomal machinery to
dismantle differentiated cell morphological features. Their expression later ebbs before cells
enter mitosis during Stage 3. Atf3–/– mice fail to induce RAB7-positive autophagic and lysosomal
vesicles, eventually causing increased death of cells en route to Stage 3. Finally, we observe that
ATF3 is expressed in human gastric metaplasia and during paligenotic injury across multiple
other organs and species. Thus, our findings indicate ATF3 is an evolutionarily conserved gene
orchestrating the early paligenotic autodegradative events that must occur before cells are poised
to proliferate and contribute to tissue repair.
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3.2 Introduction
Injury in adult organisms can trigger differentiated cells to reprogram to an embryonic-like,
progenitor state. The change from a differentiated cell to a proliferating progenitor-like cell has
been shown in nearly every organ, for example: kidney (Kusaba et al., 2014), lung (Hong et al.,
2001, Tata et al., 2013), stomach (Nam et al., 2010, Leushacke et al., 2017, Radyk et al., 2018,
Willet et al., 2018, Meyer et al., 2019), pancreas (Mills & Sansom, 2015, Willet et al., 2018),
intestine (van Es et al., 2012, Jones et al., 2019), and liver (Raven et al., 2017). As early as 1900,
it was proposed that such cellular retooling was a fundamental feature shared by cells, suggesting
an evolutionarily conserved program that mature cells could invoke to reroute their energy from
performing differentiated cell functions (like secretion of digestive enzymes) to instead undergo
mitosis (Adami, 1900).
In the last few years, we have begun to delineate the shared features of injury-induced
conversion of mature cells to regenerating proliferative cells (a process termed paligenosis)
(Willet et al., 2018). Paligenosis progresses via three distinct, sequential stages: 1)
Autodegradation of mature cell structures via lysosomal and autophagy pathways, 2) Shift to
expression of a progenitor or embryonic gene network, 3) Re-entry into the cell cycle. Much
evidence indicates metaplasias largely arise via cell plasticity (often paligenosis), in particular
Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) in the stomach and Acinar-to-Ductal
Metaplasia (ADM) in the pancreas (Storz, 2017, Burclaff & Mills, 2018, Meyer & Goldenring,
2018). Metaplasia is a lesion characterized by expression of progenitor/embryonic genes, often
with increased proliferation, ultimately leading to increased risk for tumorigenesis. Recently, it
has become clear that metaplasia in healthy organisms is an evolutionarily conserved injury
response that is usually simply a transient, regenerative state that allows tissue to recruit mature
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cells to help repair injury after large-scale damage (Goldenring, 2018, Saenz & Mills, 2018,
Saenz et al., 2018, Burclaff et al., 2020). It is likely that increased cancer risk occurs when
metaplasia is chronic and/or with repeated injury (Amieva & Peek, 2016, Giroux & Rustgi, 2017,
Storz, 2017, Jin & Mills, 2019, Wroblewski et al., 2019).
Given the evolutionarily conserved role of paligenosis as a mechanism underlying both
regeneration and tumorigenesis, we attempted to identify the core set of genes that might be
largely dedicated to executing paligenosis. Such paligenosis genes would be expected to be
evolutionarily conserved, shared across all tissue types, and required only for injury-induced
proliferation of differentiated cells but not in dedicated stem cells or during embryonic
development. We recently showed that two genes meeting those criteria are Ddit4 and Ifrd1.
DDIT4 is invoked early in paligenosis to quench mTORC1, which must be shut off for the
massive autophagy and lysosomal activity of Stage 1, while IFRD1 is essential to restore
mTORC1 activity for entry into S-phase (Miao et al., 2020a)
Here we dissect the conserved genetic program that drives the activation of the
autodegradation activity in Stage 1. We focus on mechanisms conserved across two exocrine cell
populations in two different organs: gastric zymogenic chief cells (ZCs) and pancreatic acinar
cells (ACs). These, almost entirely postmitotic, cells live months to years in the absence of
injury. Their large, polarized morphology with abundant rough endoplasmic reticulum (rER) and
numerous, large secretory granules is maintained almost entirely by a two-step transcriptional
regulation program comprising: X-box-binding protein 1 (Huh et al., 2010, Hess et al., 2011)
which transcriptionally activates the secretory granule trafficking transcription factor MIST1
(encoded by Bhlha15) (Pin et al., 2001, Ramsey et al., 2007, Lo et al., 2017, Dekaney et al.,
2019). MIST1 induces and maintains expression of numerous transcriptional targets whose gene
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products in turn coordinate cellular organization, vesicular trafficking, and stress responses
(Kowalik et al., 2007). For example, MIST1 binds to and directly upregulates the pro exocrine
secretory apparatus Rab proteins RAB26 and RAB3D by direct transcriptional upregulation of
their genes (Tian et al., 2010, Mills & Taghert, 2012, Jin & Mills, 2014). MIST1 is an unusual
transcription factor, in that it acts as a scaling factor for cell architecture and maturity by
regulating abundance of cell trafficking proteins (Mills & Taghert, 2012).
We will show that Activating Transcription Factor 3 (ATF3) is induced during
paligenotic injury in diverse organs. It effectively works to reverse the MIST1 mature cell
program early in Stage 1. ATF3 is a highly conserved transcription factor with clear orthologues
even in primitive multicellular organisms like sea anemones (Nematostella vectensis;
https://omabrowser.org/oma/) (Altenhoff et al., 2018). It is rapidly induced following injury, and
Atf3 loss in multiple organisms and tissues generally exhibits phenotypes after injury (Hartman
et al., 2004, Li et al., 2010, Wang et al., 2012, Brooks et al., 2015, Gey et al., 2016, Fazio et al.,
2017, Zhao et al., 2017, Zhu et al., 2018). It has also been shown to transcriptionally repress
MIST1 (Fazio et al., 2017).
Here we show that ATF3 also has a surprising transcriptional activation role in vesicle
trafficking: it binds and activates Rab7b (aka Rab42), which helps governs the maturation of late
endosomes to lysosomes (Yang et al., 2004, Progida et al., 2010, Stroupe, 2018). We show
RAB7 expression increases dramatically in early paligenotic exocrine cells, forming large
accumulations of vesicles and co-labeling, as expected, with autophagic and lysosomal vesicles.
Using ATF3 overexpression and knockdown constructs in human epithelial cells and Atf3 −/−
mice, we show that autodegradative machinery depends on ATF3, partly through transcriptional
regulation of Rab7b. Owing to failed autodegradative machinery in Stage 1, Atf3−/− mice also
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have markedly aberrant later stages of paligenosis with increased cell death and decreased
proliferation and regeneration in paligenosis Stage 3. We also find ATF3 expression focally in
human SPEM, suggesting ATF3 is a staple in early transitions to metaplasia across species.
These data indicate that ATF3 is a key evolutionarily conserved paligenosis gene that acts as one
of the first proteins activated in paligenotic injury. It works principally to induce autodegradation
in part, by increasing the lysosome and autophagy coordinator Rab7b.
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3.3 Results
3.3.1 Degradation of specialized cell features follows exocrine cell injury
To better characterize the early, autodegradation phase of paligenosis we identified, at
ultrastructural resolution, the organelles and trafficking features that characterize the earliest
morphological changes after injury. To induce stomach injury, we used high-dose tamoxifen
(HDT), which has been described by our lab and others to quickly and synchronously elicit a
stomach injury and induce SPEM independent of estrogen receptor activity or sex of mice (Huh
et al., 2012; Keeley et al., 2019; Leushacke et al., 2017; Saenz et al., 2016). To induce pancreas
injury, we repeatedly treated with the secretagogue cerulein, which has long been described to
cause damage to the exocrine pancreas (Adler et al., 1985; Niederau et al., 1985; Saluja et al.,
1985; Willet et al., 2018). Injury timelines and how the time points correspond to paligenosis
stages are indicated in Figure 3.1.
We analyzed the initial downscaling stage of paligenosis via focused ion beam-scanning
electron microscopy (FIB-SEM;) three-dimensional (3D) nanotomography (Figure 3.2A). FIBSEM of vehicle-treated ZCs compared to 24h HDT-treated ZCs revealed a dense accumulation
of lysosomes and/or autolysosomes in the basal region of the cell, where the cell’s rER network
and many mitochondria are concentrated. In addition to loss of rER, we saw exocrine granule
degradation as well as swelling and fragmenting of mitochondria. The ultrastructural changes
were corroborated by immunofluorescence at 6 and 24h HDT showing gradual loss of GIF+
exocrine granules coincident with increased LAMP1+ lysosomes (Figure 3.2B). Transmission
electron microscopy (tEM) showed that ZCs following 24h HDT injury harbored increased
double-membrane bound vesicles (consistent with autophagosomes) filled with cell components,
such as granules, ER, and cytosol (Figure 3.2C). Granular census was also reduced (Figure
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3.2D), consistent with downscaling of mature cell architecture and an increase in single- and
double- membraned vesicles which we summarize and quantify as autodegradation events
(Figure 3.2E). Similarly, we saw a trend towards decreased granule number and significantly
increased autodegradation events in pancreatic ACs following repeated cerulein (CER) injury for
one day (Figures 3.2F-H).
The massive autophagy and increased lysosomes occurring early in paligenosis indicated
that cellular membrane trafficking was dramatically altered and pointed to alterations in the Rab
family of small GTPases. Rabs facilitate vesicle and organelle movement and are especially
important for cells with secretory functions, like exocrine cells in the stomach and pancreas
(Faust et al., 2008; Fukuda, 2008; Jin & Mills, 2014; Johnson et al., 2014; Takahashi et al., 2017;
Tian et al., 2010). Rab5 is known to govern early endosome movement, Rab7 late endosome
traffic and transition into lysosomes, and Rab9 regulates late endosome to trans-Golgi traffic.
Rab function can be regulated at the transcriptional level in exocrine cells (Johnson et al., 2004;
Tian et al., 2010). Accordingly, we found a significant increase in Rab7b (though not Rab5 or
Rab9) mRNA at 12h HDT treatment: the time when the majority of ZCs are in Stage 1 of
paligenosis (Figure 3.2I). These data suggest that, like Rab26 and Rab3d, Rab7b is
transcriptionally controlled in exocrine cells.

3.3.2 ATF3 binds to and directly induces the Rab7b gene during paligenotic
downscaling
We next examined if the transcriptional increase of Rab7b expression across the body of the
stomach correlated with protein changes specifically within the paligenotic cells. While there
was little RAB7 expression in vehicle-treated stomach and pancreas, we observed large balloons
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and crescents of RAB7+ of vesicles during stage 1 of paligenosis (Figure 3.3A,D). We reasoned
that the transcriptional regulation of RAB7 specifically within early paligenosis might give us a
route to identify, for the first time, early transcriptional regulators of the paligenosis process. Our
previous work showed that MIST1 activates Rab transcription (eg Rab3d and Rab26) by binding
within well conserved cis-regulatory regions within the first intron. Thus, we used the MEME
Suite web server (Bailey et al., 2009) and FIMO (Find Individual Motif Occurrences) software
(Grant et al., 2011) to analyze the first intron of Rab7b. A putative ATF3 binding motif was
identified within this region. More detailed analysis using Contra v3 (Kreft et al., 2017)
(http://bioit2.irc.ugent.be/contra/v3) (Figure 3.4A-B) further corroborated that a potential ATF3
site was highly evolutionarily conserved across mammals. ATF3 was previously characterized in
the very early stages of cerulein-induced pancreatitis in mice (Fazio et al., 2017) and our insilico-predicted ATF3 binding site matched a site from Chromatin Immunoprecipitation –
sequencing (ChIP-Seq) analysis of genomic ATF3 binding early after cerulein injury from the
published dataset (Figure 3.4C). Thus, the data pointed to ATF3 as a key transcription factor
early in paligenosis, potentially activating Rab7 to facilitate the massive autophagic changes in
Stage 1.
Accordingly, ATF3 was rapidly induced specifically within ZCs and ACs following
injury (Figure 3.3A,D), and Atf3 transcript and ATF3 protein were also both increased in whole
tissue analysis of the stomach (Figure 3.3B-C). Specifically, ATF3 was dramatically increased
early in paligenosis Stage 1, but its expression returned to almost WT (Wild-type) levels in
paligenosis Stage 3. Moreover, ChIP confirmed ATF3 binding to the Rab7b gene in stomach
tissue (Figure 3.3E) via primers designed to amplify genomic DNA including the consensus
ATF3 intronic binding site described above (Fazio et al., 2017). We used an equivalent intronic
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region in the Rab9a gene (which has similar function and gene structure) (Mackiewicz &
Wyroba, 2009) as a negative control and a previously identified ATF3 binding site within the
Atf3 gene as a positive control (as ATF3 can transcriptionally regulate itself (Inoue et al., 2004).
As predicted, ATF3 specifically bound both to Atf3 and Rab7b (vs. non-specific IgG and Rab9
negative controls) with binding greatly increased very early (6h) after injury. Thus, induction of
ATF3 activity with activation of Rab7 occurs very early following injury; indeed it is the earliest
conserved molecular event we have so far identified in paligenosis.
ATF3 can act as a transcriptional activator or repressor depending on the gene and the
context (Hai et al., 1999). To confirm that ATF3 activated Rab7b and to test if their molecular
interaction was conserved across species, we used AGS cells (a human gastric epithelial line) to
generate stable cell clones that overexpressed ATF3 or repressed ATF3 using shRNAs. AGS
cells did not express substantial endogenous ATF3, though cells expressing anti-ATF3 shRNA
(ATF3-KD) still expressed less. ATF3-KD caused statistically significant decrease in RAB7B
mRNA and fewer cells with detectable RAB7 protein, and conversely when ATF3 was
overexpressed (ATF3OE), we saw an induction of RAB7 protein and mRNA (Figure 3.3G-H).
Of note, many of the ATF3OE cells showed large RAB7+ globular- and crescentic vesicular
formations phenocopying those seen in vivo in paligenotic murine cells (Figure 3.3F). Our in
vivo data suggested that ATF3 could induce autophagy in part via directly increasing RAB7
abundance. Supporting that hypothesis, we noted increased Cathepsin D (CTSD)-positive
lysosomes in cells with higher expression of ATF3 correlating consequently with increased
RAB7B (Figure 3.3F). Thus, ATF3 transcriptionally activates RAB7B to aid in autodegradation
in two different mouse models of paligenosis and in vitro in human gastric epithelial cells.
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3.3.3 Atf3 is required for massive lysosome and autophagy induction in Stage
1 of paligenosis
To determine if loss of Atf3 results in decreased Rab7 in vivo, we studied paligenosis in stomach
and pancreas of Atf3−/− mice (Hartman et al., 2004). As for WT mice, we observed scant RAB7
in vehicle tissue of the stomach or pancreas, but following injury in WT animals, we saw the
previously observed RAB7+ vesicles and large circular aggregates. These RAB7 vesicles often
encircled CTSD, indicating they were lysosomes (Figure 3.5A-B). Strikingly, low-abundance
RAB7 could still be detected in ZCs and ACs of Atf3−/− mice, but many large RAB7-positive
vesicles were lacking.
CTSD is a marker of both lysosomes and autolysosomes, so we next examined if loss of
ATF3 and RAB7 affected autophagic trafficking. We observed that the autophagic vesicle
marker MAP1LC3B (LC3) was induced in Stage 1 of paligenosis in the stomach, consistent with
previous work and our EM analysis indicating increased autophagic trafficking (Meyer et al.,
2019; Willet et al., 2018) (Figure 3.5C). Such LC3+ autophagic puncta were not induced in the
absence of ATF3. We confirmed ATF3-dependent induction of lysosomes and autophagosomes
using TEM (Figure 3.5D-E).
The results indicate ATF3 is induced rapidly in paligenosis and is required for RAB7associated autophagy/lysosomal trafficking. Thus, an ATF3→RAB7 program is critical for the
massive induction of autodegradative machinery that cells use in Stage 1 of paligenosis to
downscale much of their mature cell architecture.
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3.3.4 Atf3 loss results in less repair and more cell death after secretory cell
injury
Paligenosis is a stepwise process, progression through which can be inhibited between each
stage. We have previously shown that blocking autodegradative function during paligenosis
impairs regeneration (Willet et al., 2018). We reasoned the aberrant induction of autodegradation
in the absence of ATF3 would affect the fraction of cells able to progress to Stage 2 (expressing
metaplastic/progenitor genes) and Stage 3 (entering the cell cycle). Stage 2 is easily measured by
induction of the epitope for the lectin GS-II in ZCs, with the resultant cells (known as SPEM
cells) co-labeling with GS-II and ZC markers (like PGC or GIF). Atf3−/− mice showed profound
loss of progression to Stage 2, with only rare SPEM cells. Stage 2 failure was corroborated by a
second SPEM marker CD44v (Figure 3.6A) (Engevik et al., 2016; Khurana et al., 2013; Meyer et
al., 2019) (Figure 3.7A, Figure 3.6B-C). Moreover, as might be expected, the failure to produce
Stage 2 SPEM cells correlated with a nearly 2/3rds decrease in paligenotic, Stage 3 proliferative
cells (Figure 3.7C). Note that progenitors higher up in the gastric unit (in the isthmus and neck)
are induced to proliferate via a non-paligenotic mechanism (Choi et al., 2019; Miao et al., 2020a,
Miao et al., 2020b; Willet et al., 2018). As expected, those non-paligenotic cells were still
induced to proliferate after injury, so overall proliferation in the injured stomach was less
affected by loss of ATF3 than paligenotic proliferation specifically. (Figure 3.7B, Figure 3.8).
We noticed that the lack of paligenotic progression to Stage 2 and 3 did not indicate
mature cells were delayed in the paligenotic process, as many of the bases of gastric units, where
ZCs or their paligenotic progeny should be, were simply missing, indicating dropout of whole
gastric unit bases, a phenomenon we have previously described when there is a failure to
progress through paligenosis (Miao et al., 2020a; Willet et al., 2018). Inability to complete
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paligenosis resulted in marked base dropout with approximately 1/3rd of gastric unit bases
missing (Figure 3.7D). As might be expected, the increased base dropout in Atf3−/− correlated
with significantly increased Cleaved-CASP3 positivity, indicating cell death by apoptosis
(Figure 3.9A-B). In the pancreas, ATF3 was also required for paligenosis progression, as
Atf3−/−ACs had significantly higher Cleaved-CASP3 expression (Figure 3.7E-F) as well as
decreased Stage 3 proliferation induction (Figure 3.7G-H)
Overall, the results indicate that the failure to upregulate autodegradation in Stage 1, in
the absence of Atf3, led to the failure to progress through Stage 2 of paligenosis and finally
resulted in increased cell death in Stage 3, in two both the stomach and pancreas.

3.3.5 ATF3 is a staple in injury responses across organs
Our mouse and human work showed that ATF3 could regulate autodegradative activity in a
conserved way across tissue and species by regulating RAB7. In addition, loss of ATF3 caused
the same Stage 1 failure with associated overall paligenosis failure in two different organs,
suggesting that early ATF3 induction might be a conserved feature of paligenosis. HDT injury
producing SPEM in mice is a model of the SPEM that occurs in chronic atrophic gastritis in
humans (Peterson et al., 2017). Using human stomach samples of tissue adjacent to gastric tumor
tissue we have previously extensively characterized (Lennerz et al., 2010; Radyk et al., 2018;
Willet et al., 2018), we observed expression of ATF3 in SPEM. However, as might be expected,
given ATF3 expression was early and transient following injury in mice, and most SPEM is
chronic and mitotically quiescent in humans (Burclaff et al., 2020; Willet et al., 2018), only
scattered, potentially transitional SPEM cells were ATF3-positive (Figure 3.10A).
Morphologically normal human gastric epithelial cells lacked ATF3 expression (Figure 3.10A).
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Since ATF3 is highly conserved, even through to the sea anemone Nematostella vectensis, we
took advantage of a previously published Axolotl single cell-RNA-Sequencing analysis of limb
regeneration (Gerber et al., 2018) that shows high correlation with gene expression in mouse
paligenosis (Miao et al., 2020a). We found that, like previously identified paligenosis gene
IFRD1, ATF3 is induced during limb regeneration, and RAB7B is induced at the next time point
after ATF3 (Figure 3.11).We previously showed that regenerative proliferation in kidney and
liver occurs by paligenosis (Willet et al., 2018), and activation of muscle satellite cells following
injury (Yue et al., 2020) also appears to involve a paligenosis-like process involving emergence
from quiescence. We assayed genes whose expression was increased after paligenotic injury in
all 5 organs: stomach, pancreas, liver, kidney, muscle to determine potential core paligenosis
genes (Figure 3.10B). We found only 7 genes upregulated in all 5 datasets: Atf3, Cebpb, Hmox1,
Ier3, Ifrd1 (a recently described, highly conserved paligenosis-dedicated gene (Miao et al.,
2020a), Junb, and Zfp36. Thus, the results indicate Atf3 may play a conserved role in mediating
paligenosis across multiple tissues and species.
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3.4 Figures

Figure 3.1 Treatment Scheme
A. Scheme of tamoxifen treatment timeline. Mice were administered high dose tamoxifen (HDT;
5 mg/20 g body weight) by intraperitoneal injection up to two times and stomachs were
harvested at the respective/indicated timepoint as per the experimental details. Day 3 of timeline
is when peak SPEM is observed. Orange bars indicate each stage of paligenosis and where they
correspond in the treatment timeline. B. Scheme of cerulein treatment timeline to induce
pancreatitis. Mice were administered repeated cerulein injections by intraperitoneal injection. Six
hourly injections of cerulein (50μg/kg) were given every other day for up to 7 days (peak ADM).
Orange bars indicate each stage of paligenosis and where they correspond in the treatment
timeline.
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Figure 3.2 Secretory cell structure is dismantled rapidly and in a choreographed pattern in
paligenosis
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Figure 3.2 Secretory cell structure is dismantled rapidly and in a choreographed pattern
in paligenosis
1A. Left – Single-level electron micrograph images of zymogenic chief cells (ZCs) after 24h
vehicle or HDT treatment from FIB-SEM 3D tomography. G = representative secretory
granules; N = nuclei. Scale bar, 2μm. Right - Stacked EM images rendered into 3D projections
using Amira software. 1B. Representative immunofluorescence images of stomach unit bases at
homeostasis, 6 hour, and 24h HDT stained with GIF (red, granules) and LAMP1 (green,
lysosomes) Scale bar, 25μm. 1C. Representative TEM images of normal and injured ZCs (scale
bar, 2μm). Right (insets)- higher magnification images of boxed regions from left show
emergence of double-membraned autophagic vesicles engulfing mature granules, mitochondria,
and rER 24h after HDT injury. Scale bar, 500nm. Arrowheads mark vesicular degradation
events in the cell lacking double membranes.1D. Graph of the number of zymogenic chief cell
granules per cell in vehicle vs. 24h HDT treatment. Each datapoint=total granules in a cell in a
single TEM section with cells from 2 separate mice plotted together (datapoint colors indicate
cells from a single mouse). Red line indicates overall mean. Significance by unpaired two-tailed
t-test. 1E. Graph of the number degradation events scored and statistical significance as for
panel D. A degradation event was counted if electron dense-cargo or organelles were
surrounded by a single membrane (lysosome) or double membrane (autophagosome).
Significance by unpaired two-tailed t-test. 1F. Representative TEM images of normal and
injured acinar cells. Scale bar, 2μm. Right (insets)- higher magnification images of boxed
regions from left show emergence of double-membraned autophagic vesicles engulfing mature
granules, mitochondria, and rER 24h after cerulein (CER) injury. Scale bar, 500nm.
Arrowheads mark degradation events without double membranes. 1G. Plot and analysis as in
panel D. 1H. Graph and analysis as in panel E. 1I. mRNA expression by qRT-PCR of Rab5,
Rab7a, Rab7b, and Rab9. Significance determined by one-way ANOVA, Tukey post hoc. Each
datapoint represents the mean of triplicate technical replicates from a single mouse, n=3-4 mice
in independent experiments
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Figure 3.3 RAB7B increases early in paligenosis, is associated with large lysosomal
aggregates and is transcriptionally activated by ATF3 in mice and humans
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Figure 3.3 RAB7B increases early in paligenosis, is associated with large lysosomal
aggregates and is transcriptionally activated by ATF3 in mice and humans
2A. Top – Representative RAB7 expression in base of stomach units (ZCs) in vehicle or 24h
HDT by immunohistochemistry. Arrowheads point to RAB7 vesicle aggregates. Scale bar 20µm.
Bottom – Representative ATF3 expression in base of stomach units (ZCs) by
immunohistochemistry. ATF3 appears in nuclei following 24h HDT. Scale bar 20µm. 2B. Atf3
mRNA expression by qRT-PCR in vehicle, 24 hour, and 72 hour HDT treatment. Each datapoint
represents the mean of triplicate technical replicates from a single mouse, n=4 mice in
independent experiments. Significance determined by One-way ANOVA, Tukey. 2C. Western
blot of ATF3 expression over HDT timecourse with β-Actin loading control. 2D. Top¬ –
Representative RAB7 staining in pancreatic acinar cells. Arrowheads indicate RAB7 vesicles.
Scale bar 20µm. Bottom – Representative ATF3 expression in pancreatic acinar cells. Nuclei
express ATF3 after 24h CER injury. Scale bar 20µm. 2E. ChIP-PCR on mouse stomach tissue at
vehicle and 6 hour HDT. Chromatin probed with ATF3, Histone H3 antibodies, or a Rabbit IgG
control. Also included is the 2% chromatin input and water to control for DNA contamination.
Rab7b amplicon is from a conserved, putative ATF3-binding site in the first intron. Amplicon
from Atf3 is a positive control from a previously characterized ATF3-binding site; negative
control is from a site in Rab9a lacking putative ATF3 binding motifs. 2F. Top –
Immunoflourescence for RAB7 (red) and DAPI (blue, nuclei) in control, ATF3 knockdown
(KD), and ATF3 overexpression (OE) AGS cell lines generated using a PiggybacTM transposon
system. Arrowhead indicates aggregated RAB7 vesicular formation similar to those observed in
tissue. Bottom – Immunofluorescence for ATF3 (purple) and Cathepsin D (CTSD, green,
lysosomes) in AGS cells. Scale bar, 20um. 2G. mRNA expression of ATF3 by qRT-PCR in
AGS cell lines from 2F. Significance by one-way ANOVA, Dunnett post-hoc. Datapoint = mean
of technical triplicates in a single mouse. n=3 mice. 2H. mRNA expression of RAB7B by qRTPCR in AGS cell lines from 2F&G. Statistics and plotting as for panel G.
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Figure 3.4 Analysis of ATF3 binding sites in the mouse Rab7b first intron.
A. Rab7b gene alignment using UCSC genome browser (NCBI37/mm9). B. Regions of
predicted conserved ATF3 binding derived from ConTra v3. Orange indicates conserved ATF3
sites in one region of Rab7b and blue indicates a second region of conserved ATF3 sites
downstream, but still in the first intron. Highlighted regions are aligned to the gene in A. TFBS =
transcription factor binding sites. C. Alignment of ATF3 ChIP-seq analysis from 4h Cerulein
treated mouse pancreas published in Fazio et al., 2017 GEO accession GSE60250. ChIP-seq
peaks aligned to gene in A.
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Figure 3.5. Atf3 coordinates cellular autodegradation after injury in paligenosis stage I
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Figure 3.5 Atf3 coordinates cellular autodegradation after injury in paligenosis stage I
3A. Representative immunofluorescence images of pancreatic acinar cells after vehicle or 24h
cerulein (CER) treatment stained for RAB7 (red) and Cathepsin D (CTSD, green, lysosomes).
Top row is wild-type, bottom row is Atf3−/−. Yellow arrowhead highlights RAB7 and CTSD coexpression. White arrowhead points to an area of RAB7 expression only. Scale bar, 20μm. 3B.
Representative immunofluorescence images of gastric chief cells after vehicle or 24h HDT
treatment stained for RAB7 (red) and Cathepsin D (CTSD, green, lysosomes). Top row is wildtype, bottom row is Atf3−/−. Yellow arrowhead highlights RAB7 and CTSD co-expression.
White arrowhead points to an area of RAB7 expression only. Scale bars 20μm. 3C.
Representative immunofluorescence images of gastric chief cells after vehicle or 24h HDT
treatment stained for Pepsinogen C (PGC, red, granules) and MAP1LC3B (green, autophagy
marker). Top row is wild-type, bottom row is Atf3−/−. Scale bar, 50μm 3D. Transmission
electron micrograph images of zymogenic chief cells (ZCs) after 24h vehicle or HDT treatment
in WT (top) and Atf3−/− mice (bottom). Scale bar, 1μm. Arrowheads indicate cell components
being degraded. 3E. Quantification of degradation events per cell counted from EM images of
ZCs after 24h vehicle or HDT treatment in WT and Atf3−/−mice as shown in panel 3D. Each
datapoint=total granules in a cell in a single TEM section with cells from 2 separate mice plotted
together (datapoint colors indicate cells from a single mouse). Significance by nonparametic
Mann-Whitney U test.
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Figure 3.6 SPEM analysis in Atf3−/− stomachs
A. Representative immunofluorescence of gastric units stained for DAPI (blue), gastric intrinsic
factor (GIF, cyan), and CD44v (SPEM marker when expressed in cells at the unit base, red). WT
(top) and Atf3−/− (bottom) mice were treated with 72h HDT. Arrowhead indicates base dropout
in Atf3−/−stomach. Scale bars 20µm. B. Representative immunohistochemistry of GSII in
gastric units to mark normal mucous neck cells (vehicle) and SPEM cells (72h HDT) in WT
(top) and Atf3−/− (bottom) mice. Scale bars 50µm. Counterstained with hematoxylin. C.
Quantification of the percent of gastric units exhibiting SPEM as counted by the number of units
with GSII at the unit base over the number of units total. Each datapoint = mean of counts from
40-50 gastric glands from an individual mouse, n=5 mice per treatment group. Significance by
nonparametric two-tailed t-test.
89

Figure 3.7 Atf3 loss increases cell death and reduces proliferation after paligenotic injury
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Figure 3.7 Atf3 loss increases cell death and reduces proliferation after paligenotic injury
4A. Representative immunofluorescence images of gastric units after vehicle or 72h HDT
treatment stained for GIF (red, granules), GSII (green, neck cells and SPEM marker), BRDU
(white, proliferation) and DAPI (blue, nuclei). Top row is wild-type, bottom row is Atf3−/−.
Yellow arrowheads point to areas of base dropout where ZCs have been lost. Scale bar, 50μm.
4B. Proliferation as quantified by number of BrdU+ cells per unit in WT and
Atf3−/−vehicle±HDT. Each datapoint = mean of counts from 40-50 gastric glands from an
individual mouse, n=4 mice per treatment group. Significance by unpaired two-tailed t-test. 4C.
Plot and statistical analysis as for Panel B but quantifying BrdU+ cells only in the bottom 1/3 of
the unit, which are derived mostly from paligenosis and not from isthmal and neck stem and
progenitor cells. 4D. Death of ZCs after injury plotted by quantifying the base dropout rate,
which is the fraction of glands that do not reach the muscularis mucosa from the lumen. Each
datapoint is the mean of 80-100 glands from an individual mouse, n=4 mice per treatment group.
Significance by unpaired two-tailed t-test. 4E. Representative immunohistochemistry of
Cleaved-Caspase 3 in pancreatic acinar cells marking apoptosis in vehicle or 24h cerulein
treatment. Top row is WT, bottom row is Atf3−/−. Scale bar, 50μm. 4F. Apoptosis quantified
following 24h CER injury by the number of Cleaved-Caspase 3+ cells from a 40x field. Each
datapoint is mean of positive cells in 4-5 40x fields in an individual mouse, n=3 mice per
treatment group. Significance by unpaired two-tailed t-test. 4G. Representative
immunohistochemistry of BrdU in pancreatic acinar cells marking proliferation in vehicle or 7
days of repeated cerulein injury. Top row is WT, bottom row is Atf3−/−. Scale bar, 50μm. 4H.
Quantification of proliferation at peak ADM as counted by the number of BrdU+ cells from a
20x field following 7D cerulein treatment. Plotting and statistical analysis as per panel F.

Figure 3.8 Proliferation after injury
Representative immunohistochemistry of BrdU in WT (top) and Atf3KO (bottom) gastric units
with vehicle or 72h HDT treatment. BrdU administered 90 minutes prior to sacrifice to capture
cells in S phase. Eosin counterstain. Scale bars 50µm.
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Figure 3.9 Apoptosis after injury
A. Representative immunohistochemistry of Cleaved-Caspase 3 in gastric units of WT (top) and
Atf3KO (bottom) mice when treated with vehicle or 72h HDT. Counterstained with eosin.
Arrowheads point to ZCs with high expression of Cleaved-CASP3. Scale bars 50µm.
B. Graph of the apoptosis rate following 72h HDT injury as counted by the number of CleavedCaspase 3+ cells from a 40x field. Each datapoint = mean of counts from 40-50 gastric glands
from an individual mouse, n=4 mice per treatment group. Significance by nonparametric twotailed t-test.
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Figure 3.10 ATF3 induction during regeneration-induced injury (paligenosis) is conserved
across tissue and species
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Figure 3.10 ATF3 induction during regeneration-induced injury (paligenosis) is conserved
across tissue and species
5A. Representative immunohistochemistry of GSII (top; SPEM marker and neck cells) and
ATF3 (bottom) in serial sections of human gastric tissue. Tissue was taken from regions adjacent
to gastric adenocarcinoma. Scale bars left - 50μm right - 20μm. Arrowheads indicate strongly
expressing ATF3 cells and the corresponding region in the same gland labeled with GSII in a
serial tissue section. GSII at the base of gastric glands in the body of the stomach indicate
transition to SPEM. 5B. Intersection of transcripts upregulated by paligenotic injury in 5 tissues.
Only intersections of gene sets ≥4 and transcripts unique for that intersection are depicted.
Unique genes from each intersection are listed above the UpSet plot depicting the intersection
combination, the number of overlapping genes, and the total number of genes in the dataset. 5C.
Model of ATF3 function in paligenosis. ATF3 peaks early after injury and helps to coordinate
the induction of autodegradation by transcriptionally activating Rab7b and other targets to
increase the number of lysosomes and induce autophagy. ATF3 also functions at this same time
(Stage 1) to repress scaling and maturation factor Mist1.

Figure 3.11 Gene expression in Axolotl limb regeneration
Fraction of cells expressing ATF3, RAB7B, and IFRD1 in previously published single-cell
RNA-sequencing of regenerating cells after axolotl limb amputation. IFRD1 is a previously
published paligenosis gene known to be activated during Stage 1.
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3.5 Discussion
Our work here shows that ATF3, induced early in Stage 1 of paligenosis, is required for
induction of the autodegradative machinery. Though there are likely additional targets critical for
ATF3 actions in paligenosis, we show both in mouse paligenosis models and in human epithelial
cells, that ATF3 binds and activates Rab7b, which encodes a protein critical in turn for
trafficking autophagic vesicles and lysosomes. ATF3 is necessary for RAB7 induction and for
induction of a large complement of autophagolysosomes. ATF3 induction after paligenotic injury
is conserved across tissues and species with ATF3 increased even in human metaplasia.
The concept of an evolutionarily conserved program, paligenosis, which mechanizes cell
plasticity for mature cells, like pancreatic or gastric exocrine cells is recent. Paligenosis, as
originally defined, is a stepwise program that retools cell architecture to convert a mature cell to
a regenerative, progenitor-like phenotype. The three paligenosis stages (1. Autodegradation, 2.
Increased progenitor/metaplastic expression, 3. Cell cycle re-entry) can be genetically and
morphologically defined, and progression from stage to stage can be blocked by inhibitors or
deletion of key genes. The stepwise, conserved nature of the program allows us to determine if
there are dedicated, paligenosis genes and genetic machinery, independent of tissue and
conserved across evolutionary phyla, as is the case with other cellular programs like apoptosis.
We recently identified Ifrd1 and Ddit4 as paligenosis-governing genes and proposed that
paligenosis genes in general would be: 1) largely dispensable for normal development or
proliferative activity; 2) activated primarily during regeneration-inducing injury; 3) highly
evolutionarily conserved. We argue here that ATF3 is a gene required for paligenosis. It is
induced early in paligenosis in multiple tissues, is known to be induced by injury, is conserved
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from sea anemones to humans, and, in general, organisms null for ATF3 have phenotypes only
after injury.
We describe a model (Figure 3.10C) in which ATF3 is induced early after injury to help
transcriptionally upregulate Rab7b and other genes important for autophagy and lysosomal
induction during paligenosis Stage 1. During this time ATF3 also likely transcriptionally
represses genes involved in cell differentiation/maturation like MIST1, a relationship that has
been shown before in pancreas (Fazio et al., 2017). Shortly after Stage 1, ATF3 decreases, and
the cell progresses through the remainder of paligenosis. Without Atf3, the defects in Stage 1
(Autodegradation) obstruct the cell’s ability to become regenerative, metaplastic cells. A greater
proportion of cells die, and tissue repair is compromised. In addition, we describe a new
signaling axis for injury-induced cell plasticity by ATF3 transcriptional regulation of Rab7b
during paligenosis.
Atf3 joins the aforementioned Ddit4 and Ifrd1 as paligenosis-governing genes (Miao et
al., In Press). At the tissue level, loss of Atf3 appears most similar to loss of Ifrd1 as lack of
either gene leads to increased cell death in paligenosis Stage 3. While IFRD1 functions to
suppress p53 repression of mTORC1, allowing proliferation in Stage 3, ATF3 instead activates
autodegradation pathways for proper clearance of differentiated/specialized cell features. Though
both ATF3 and IFRD1 have different mechanisms to govern paligenosis, it is clear that failure to
clear paligenosis checkpoints, either by inability to upregulate autodegradation (Atf3−/−) or by
inability to re-activate mTORC1 (Ifrd1−/−) leads to decreased tissue recovery after injury. ATF3
and DDIT4 both function in Stage 1 to control autodegradation. Unlike Atf3, however, Ddit4−/−
mice have increased proliferation. DDIT4 functions during initial stages to deactivate mTORC1;
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hence, Ddit4−/− mice express constitutively high mTORC1 throughout paligenosis, which
overrides a checkpoint.
ATF3 is a member of the ATF/CREB family of transcription factors, and shares similar
binding sites with AP-1 (also from the ATF/CREB and c-Fos/c-Jun families), which regulates
immediate early genes following stress/injury. Atf3 has been implicated in injury settings in
many organs including cerebral ischemia (Wang et al., 2012), axon regeneration (Hunt et al.,
2012, Gey et al., 2016), acute lung injury (Zhao et al., 2017), heart failure (Brooks et al., 2015),
alcohol liver damage (Tsai et al., 2015), liver ischemia-reperfusion injury (Zhu et al., 2018),
stress-induced β-cell apoptosis (Hartman et al., 2004), ADM (Fazio et al., 2017), and acute
kidney injury (Li et al., 2010). ATF3 is also important for injury responses in Drosophila (Zhou
et al., 2017) and Axolotl (Gerber et al., 2018). In all those cases, Atf3 loss exacerbates the injury
phenotype but is dispensable for homeostasis and embryonic development, just as we observed
here in stomach and pancreas injury.
It has not been previously reported that injury-responsive ATF3 accumulation induces
autophagy and lysosomal activity, but ATF3 has been reported to interact with individual
autophagy pathway members. For example, ATF3 regulates Beclin-1 (Lin et al., 2014) and Atg5
(Sood et al., 2017). There may also exist a feedback loop because defective autophagy (Atg4b
loss) impairs ATF3 activity in a mouse lung injury model (Aguirre et al., 2014). ATF3 regulation
of Rab7b has not been previously shown as a key mechanism of ATF3 action.
Indeed, to our knowledge there are no previous reports of ATF transcription factors
transcriptionally regulating any Rabs, though potential ATF binding sites have been described to
be present in the 5’-flanking region of Rab7 (Bhattacharya et al., 2006). In fact, in general,
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transcriptional regulation of RABs or regulation of RAB function via titrating protein abundance
is usually not studied, with some few exceptions such as MIST1 scaling Rabs, and a report of cMyc helping drive melanoma by activating Rab7 (Alonso-Curbelo et al., 2014). However, an
ATF-related protein, AP-1, regulates Rab11a in B cells in mice (Lizundia et al., 2007),
suggesting that ATF/CREB transcription factors may have an underappreciated and understudied
role in transcriptionally regulating Rabs.
RAB7 is a master regulator of endosomal trafficking and maturation. It is largely
localized to late endosomes and lysosomes to aid in the autophagosome-lysosome fusion and
mitochondrion-lysosome contacts (Stroupe, 2018), events undoubtedly important during Stage 1
of paligenosis. As such, complete Rab7 loss in pancreatic acinar cells impairs autophagic and
endocytic pathways in mouse models of pancreatitis (Takahashi et al., 2017). Here we show that
Atf3-loss impairs autophagic and lysosomal pathways, further supporting the notion of ATF3
function through Rab7 during paligenosis and injury. There are few studies specifically focused
on the RAB7B (also identified as RAB42), identified because of its size and sequence similarity
to RAB7. RAB7B has similar functions as Rab7 and was, accordingly, first observed to be
associated with lysosomes in monocytes (Yang et al., 2004). More recently, Rab7b has been
shown to interact with ATG4B on vesicles and negatively regulate autophagy (Kjos et al., 2017),
indicating it also, like Rab7, regulates autophagic trafficking. There may not be complete
concordance between the two RAB7 proteins, however, as Rab7b may have an added function in
some circumstances of localizing to the Golgi and aiding retrograde transport (Progida et al.,
2010).
Recent studies have shown the importance of autophagy in regulating cell plasticity in
several organs (Saera-Vila et al., 2016, Call & Nichenko, 2020, Li et al., 2020, Romermann et
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al., 2020). We speculate that Stage 1 of paligenosis is not only required to change the cell
structure to one that is more physiologically progenitor-like but also to generate enough energy
for DNA replication and cell division. Ribosomes are an enormous pool for nucleotides, which
may be one reason we see so much degradation machinery accumulate in the rER portion of the
cell, where there may be release of nucleotides from ribosomes. As mentioned above, functional
degradation machinery may also act as a checkpoint indicating a cell is healthy enough to
commit to cell cycle re-entry. This was the case when we blocked lysosome activity during
paligenosis (Willet et al., 2018) which, like Atf3 and Ifrd1 loss, also ultimately led to increased
cell death.
ATF3 may transcriptionally regulate other targets during Stage 1 that do not control
degradation. ATF3 can repress Mist1, the secretory cell scaling factor expressed only in mature
ZCs and ACs; Mist1 downregulation is a key early step in ZC and AC paligenosis (Kowalik et
al., 2007, Lennerz et al., 2010, Karki et al., 2015, Meyer et al., 2019). It also represses Sox9
(Fazio et al., 2017), a metaplastic gene whose induction defines transition from Stage 1 to Stage
2, supporting the hypothesis that ATF3 plays several roles in Stage 1 of paligenosis. It is not
clear how ATF3 is upregulated for paligenosis and metaplasia initiation, but once it accumulates
ATF3 acts in a positive feedback loop to regulate itself. Reactive oxygen species are also
induced en route to SPEM and may contribute to autodegradation and antioxidant pathway
activation, as shown by the induction of antioxidant gene xCT, a cysteine/glutamate transporter
in SPEM (Meyer et al., 2019). Likewise, reactive oxygen species are important for ADM
induction and progression to pancreatic adenocarcinoma (Liou et al., 2016, Cheung et al., 2020).
The current study stimulates several important questions. First, how does metabolic
control affect the cell fate transitions in paligenosis? We saw dramatic physical changes in
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mitochondria during paligenosis, which likely reflect changes in metabolism; however, the
metabolism of cells as they transition from their normal state to a metaplastic state is not well
characterized. We showed a dependency on dynamic mTORC1 activity during metaplastic
(Willet et al., 2018) and recent studies show acetyl-CoA metabolism contributes to cell plasticity
in the pancreas and potentially tumorigenesis via epigenetic regulation (Carrer et al., 2019).
Epigenetics also plays a role in SPEM initiation, most recently shown by miR148a repression of
DNA methylating gene DNMT1, a pro-metaplasia gene (Shimizu et al., 2020). Second, which
cells are poised to undergo paligenosis and become metaplastic? Not all mature cells in a tissue
may have the ability to re-enter the cell cycle after injury, but organs experiencing chronic
damage (like GI organs) harbor cells that act as facultative progenitors if the injury is severe
enough, though the age of cells in the GI system is a factor for their ability to contribute to
plasticity (Engevik et al., 2016, Weis et al., 2017) and some cell types like acid-secreting parietal
cells seem unable to return to the cell cycle. Further study of general, conserved genes that
govern paligenosis in diverse contexts should help us have a better understanding of
regeneration, tumorigenesis, and also potentially how plasticity arose as a way for multicellular
organisms to use cells for both specialized, differentiated function and as progenitors after
damage.
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3.6 Methods
Table 3.1 Resource Table
Reference or Source

Identifier or Catalog
Number

C57BL/6J (M. musculus)

Jackson Lab

Stock No: 000664

Atf3–/– (M. musculus)

Hartman et al., 2004 Mol
Cell Biol

AGS cells (H. sapiens)

ATCC

CLR-1739

XL-10 Gold Ultracompetent
Cells

Agilent

Cat #200317

Human patient samples

Lennerz et al., 2010 Am J
Pathol
Capoccia et al., 2013 J Clin
Invest
Khurana et al., 2014 J Biol
Chem
Radyk et al., 2018 Gastro

Reagent/Resource
Experimental Models

Recombinant DNA
ATF3 (human)

Sequence cloned out of
Addgene #26115 and
inserted into a homemade
PiggyBac Transposon
vector for overexpression
(vector also used in Miao et
al., 2020a)

Cat #26115

Antibodies

Source

Concentration &
Application

Rat anti-CD44v10-e16
monoclonal (CD44v)

Cosmo Bio, Tokyo, Japan;
CAC-LKG-M002

1:200 - IF

Fluorescently conjugated
Griffonia simplicifolia-II lectin
(GS-II)

Invitrogen (Alexa Fluor 647)

1:2,000 - IF

Rabbit anti- gastric intrinsic
factor (GIF)

Gift from Dr. David Alpers,
Washington University in St.
Louis

1:10,000 - IF
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Sheep anti-Pepsinogen C
(PGC)

Abcam; ab9013-1

1:10,000 - IF

Rabbit anti-Cathepsin D
(CTSD)

Abcam; ab75852

1:500 - IF

Goat anti-Cathepsin D

Santa Cruz; sc-6486

1:200 - IF

Rat anti-LAMP1

DSHB; 1D4B

1:100 – IF

Rabbit anti-LC3B

Novus; NB600-1384

1:200 – IF

Rabbit anti-ATF3

Sigma; HPA001562

1:1,000 – Western
1:50 - ChIP

Mouse anti-ATF3

Abcam; ab58668

1: 200 – IF/IHC

Normal Rabbit IgG

Cell Signaling; #2729

2ug - ChIP

Rabbit anti-Histone H3

Cell Signaling; D2B12;
#4620

1:50 - ChIP

Rat anti-BrdU

Abcam; ab6326

1:200 – IF/IHC

Rabbit anti-RAB7

Abcam; ab137029

1:200 – IF/IHC

Mouse anti-RAB7B

Abnova; H00338382-M01

1:1,000 – Western

Mouse anti-β Actin

Sigma; A5441-100UL

1:10,000 – Western

Rabbit anti-Cleaved Caspase
3 (Asp175)

Cell Signaling; 5A1E;
#9664S

1:1,000 – IHC

Peroxidase AffiniPure
Donkey Anti-Rabbit IgG
(H+L)

Jackson ImmunoResearch;
Cat# 711-035-152

1:2,000 – Western

Peroxidase AffiniPure
Donkey Anti-Mouse IgG
(H+L)

Jackson ImmunoResearch;
Cat# 715-035-150

1:2,000 – Western

qRT-PCR primers

This study and others cited

Table EV1

ChIP-PCR primers

This study

Table EV2

shRNA sequence

Sequence

Source

Atf3 shRNA

ACGAGAAGCAGCATTTG
ATATCTCGAGATATCAAA
TGCTGCTTCTCG

TRCN0000329691
cloned into a
homemade
transposon system
and expressed under
a standard U6
promoter

Oligonucleotides and other
sequence-based reagents
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Genotyping primers

Sequence

Source

Atf3 primers (mouse)

Wild-type TGAAGAAGGTAAACACAC
CGTG
Common –
AGAGCTTCAGCAATGGTT
TGC
Mutant ATCAGCAGCCTCTGTTCC
AC

Pai et al., 2018 Front
Mol Neurosci

Chemicals, Enzymes and
other reagents

Source

Identifier or Catalog
Number

Tamoxifen

Toronto Research
Chemicals, Inc

Cat# T006000

Cerulein

Sigma-Aldrich

CAS# 17650-98-5

5-Bromo-2-deoxyuridine
(BrdU)

Sigma-Aldrich

Cat# B5002

5-fluoro-2’-deoxyuridine
(FldU)

Sigma-Aldrich

Cat# F0503

BSA

Sigma-Aldrich

Cat# A7906

Triton X-100

Lab Chem

Cat# LC262801

ProLong Gold antifade
mountant with
DAPI

Molecular Probes

Cat# P36930

Permount Mounting Medium

Fisher Chemical

Cat# SP150

DNase I

Invitrogen

Cat# 18047019

SuperScript III

Invitrogen

Cat# 11752050

PowerUp SYBR Green
Master Mix

ThermoFisher

Cat# A25742

RIPA Lysis and Extraction
Buffer

Thermo Scientific

Cat# 89900

Halt™ Protease and
Phosphatase
Inhibitor Single-Use Cocktail,
EDTA-Free
(100X)

Thermo Scientific

Cat# 78443
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Hartman et al., 2004

trypLE Express

Gibco

Cat# 12605-028

DPBS

Gibco

Cat# 14190-136

Isothesia

Henry Schein Animal Health

Cat# NDC116956776-2

Advanced DMEM/F12

Invitrogen

Cat# 12634-010

Penicillin-Streptomycin

Sigma-Aldrich

Cat# P4333

MEM Nonessential Amino
Acids

Corning

# 25-025-CI

Fetal Bovine Serum (FBS)

Gibco

Cat# 26140-079

Axiovision 4.9.1

Zeiss

https://www.zeiss.com/
microscopy/us/downlo
ads/axiovisiondownloads.html

Adobe Photoshop CS6

Adobe

Amira 6 3D software
package

Thermo Scientific

https://www.thermofish
er.com/us/en/home/ind
ustrial/electronmicroscopy/electronmicroscopyinstruments-workflowsolutions/3dvisualization-analysissoftware/amira-lifesciencesbiomedical.html

Prism 3

GraphPad

RRID:SCR_002798;
https://www.graphpad.
com/scientificsoftware/prism/

NDP.View2

Hamamatsu Photonics

Cat#U12388-01

SimpleChIP Plus Enzymatic
Chromatin IP Kit

Cell Signaling Technology

#9004

Vectastain Elite ABC HRP
Kit

Vector Laboratories

#PK6100

DAB Substrate Kit

Thermo Scientific

#36000

Software

Other

104

RNeasy Mini Kit

Qiagen

Zeiss Axiovert 200
microscope with an Axiocam
MRM camera and Apotome
II

Zeiss

FIB-SEM (Zeiss, Crossbeam
540

Zeiss

Olympus BX51 light
microscope with 12 MPixel
Olympus DP70 camera

Olympus

#74104

Animal Studies and reagents
All experiments involving animals were performed according to protocols approved by the
Washington University School of Medicine Animal Studies Committee. Mice were maintained
in a specified pathogen-free barrier facility under a 12-hour light cycle. Wild-type C57BL/6 mice
were purchased from Jackson Laboratories (Bar Harbor, ME). All mice used in experiments
were 6−8 weeks old. Atf3–/– mice were bred onto a C57BL/6 background and received from Dr.
Tsonwin Hai at the Ohio State University Medical Center. Atf3–/– mice were first described in
(Hartman et al., 2004)
Tamoxifen (250 mg/kg body weight; Toronto Research Chemicals, Inc, Toronto, Canada) was
administered by intraperitoneal (IP) injection to induce SPEM in the stomach (See Figure 3.1 for
timeline (Saenz et al., 2016). Tamoxifen was prepared in a 10% ethanol and 90% sunflower oil
solution by sonication (Sigma, St Louis, MO).
Pancreatitis was induced by 6 hourly IP injections of 50 μg/kg (in 0.9% saline) cerulein (Sigma‐
Aldrich) given every other day for up to 7 days (See Figure 3.1 for timeline). Mice were
sacrificed 24h after the final cerulein injection.
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All mice were given an intraperitoneal injection containing BrdU (120 mg/kg) and 5-fluoro2′deoxyuridine (12 mg/kg) 90 minutes before sacrifice to capture cells in S phase at the
experimental endpoint.
Immunofluorescence and Immunohistochemistry
Mouse tissues were excised, flushed with phosphate-buffered saline (PBS) and then inflated with
freshly prepared 4% paraformaldehyde. The stomach was clamped and suspended in fixative in a
50-mL conical overnight, followed by rinses in PBS and 70% ethanol, arrangement in 3% agar in
a tissue cassette, and paraffin processing. Sections (5 μm) were cut, deparaffinized, and
rehydrated with graded Histo-Clear (National Diagnostics), ethanol, and water, then antigenretrieved in sodium citrate buffer (2.94 g sodium citrate, 500 uL Tween 20, pH 6.0) using a
pressure cooker. Slides were blocked in 5% normal serum, 0.2% Triton-X 100, in PBS. Slides
were incubated overnight at 4°C in primary antibodies (see Table 3.1), then rinsed in PBS,
incubated 1 hour at room temperature in secondary antibodies and/or fluorescently labeled lectin
rinsed in PBS, mounted in ProLong Gold Antifade Mountant with 4′6-diamidino-2-phenylindole
(DAPI) (Molecular Probes).
For immunohistochemistry, steps were identical except the following. An extra quenching step
was performed for 15 minutes in a methanol solution containing 1.5% H2O2 before antigen
retrieval. Substrate reaction and detection was performed using ImmPACT VIP Peroxidase
(horseradish peroxidase) Substrate Kit (Vector Laboratories, Burlingame, CA) as detailed per the
manufacturer’s protocol and sections were developed with DAB for desired time and
counterstained with hematoxylin and/or eosin. Slides were mounted in Permount Mounting
Medium.
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Western Blot
Approximately 75mg mouse corpus stomach or pancreas tissue were sonicated in RIPA buffer
with 1x protease inhibitor cocktail (Thermo). Protein was separated using NuPAGE 10% BisTris gels and transferred to an Invitrogen nitrocellulose membrane. Membranes were then
blocked with 3% Bovine serum albumin (BSA) and incubated overnight at 4°C with primary
antibodies (see Resource Table for antibodies). The membranes were rinsed in tris-buffered
saline (TBS) pH 8.0, incubated 1 hour at room temperature in secondary antibody in 5% low-fat
milk. Actin antibody was used as a control to ensure equal loading of protein in each gel lane.
Secondary antibody signals were imaged and detected by SuperSignal West Pico PLUS
Chemiluminescent Substrate Kit.
Imaging and Quantifications
Fluorescence microscopy was performed using a Zeiss Axiovert 200 microscope with an
Axiocam MRM camera and Apotome II instrument for grid-based optical sectioning. Postimaging adjustments, including contrast, fluorescent channel overlay, and pseudo-coloring, were
performed with Axiovision and Adobe Photoshop CS6. Histology of stomach and
immunohistochemistry were imaged using an Olympus BX51 light microscope and Olympus
SZX12 dissecting microscope w/12 MPixel Olympus DP70 camera. Images were analyzed and
post-imaging adjustments were performed with Adobe Photoshop CS6.
Quantification of BrdU proliferation rates was done by counting 5 or more 20x fields
from a whole-slide scanned images from the Hamamatsu Nanozoomer 2.0-HT system.
FIB-SEM 3D Nanotomography
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Performed as described in (Lo et al., 2017). Mouse gastric tissues were bisected into fixative
containing 2.5% glutaraldehyde and 2% paraformaldehyde in 0.15 M cacodylate buffer
containing 2 mM CaCl2 (pH 7.4), fixed for 15 min at 37°C and then overnight at 4°C, sliced into
∼1.5-mm-thick pieces, rinsed in cacodylate buffer for 10 min at room temperature, and subjected
to secondary fixation in 1% osmium tetroxide/0.3% potassium ferrocyanide in cacodylate buffer
for 1 h on ice. The samples were then washed in ultrapure water and stained en bloc in 2%
aqueous uranyl acetate for 1 h. After staining, samples were briefly washed in ultrapure water,
dehydrated in a graded acetone series, and infiltrated with microwave assistance (Pelco BioWave
Pro) into LX112 resin, which was cured in an oven for 48 h at 60°C. Cured blocks were trimmed
and mounted onto SEM pins with silver epoxy and faced with a diamond knife. Toluidine bluestained sections (300 nm thick) were used to locate a region of interest. Blocks were sputtercoated with 10 nm of iridium (Leica, ACE 600) with rotation on a planetary stage to ensure
saturation. Regions of interest on a FIB-SEM (Zeiss, Crossbeam 540) were located by secondary
electron imaging at 10 KeV. Once a region was found, the sample was prepared using the
ATLAS (Fibics) 3D nanotomography engine. In short, a platinum pad was deposited on a 40-µm
× 40-µm region of interest with the FIB set to 30 KeV and 1.5 nA. Three vertical lines for focus
and sigmation and two angled lines for z-tracking were milled into the platinum pad at 50 pA,
and a protective pad of carbon was deposited on top of the milled platinum at 1.5 nA. Following
this, a rough trench 50 µm wide and 55 µm deep was milled at 30 nA and polished at 7 nA. Once
polishing of the block face was complete, face detection, focusing, and ztracking were all
performed on the fiducial marks that were milled into the platinum pad. Imaging was performed
at 2 KeV and 1.1 nA using the EsB (energy selective backscatter) detector with a grid voltage of
1100 V. The block was milled at a current of 700 pA with 20-nm slices, and 2000 × 1750 pixel
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images were acquired at a resolution of 20 nm/pixel with a dwell of 8 or 10 µsec and a line
average of 3 for a total z-depth of 35 µm.
3D reconstruction
Performed as described in (Lo et al., 2017). All EM serial images were imported into the Amira
6 3D software package for 3D reconstruction. Areas of interest were manually segmented into
data objects with intervening unsegmented slices (“X”) based on object volume. For organelles
with suboptimal contrast, the thresholding function was used for manual segmentation. The
interpolation function was used to highlight areas of interest between manually segmented slices.
3D models were generated from labeled objects. The “Smooth” and “Simplify” functions were
used for model generation, and pseudocoloring was used to enhance visualization for each
organelle. Animations were created with the Animation Director in the software.
Electron Microscopy
For TEM, stomachs were fixed, sectioned, stained, and imaged as previously described (Willet et
al., 2018). Briefly, tissue was collected as described above, fixed overnight at 4˚C in modified
Karnovsky’s fixative, and sectioned. Tissue was processed by the Washington University in St.
Louis Department of Pathology and Immunology Electron Microscopy Facility.
Human cancer cell culture
AGS cells (ATCC) were grown under standard conditions (Advanced DMEM/F12, 10% FBS,
Nonessential amino acids, and Pen/Strep at 37ºC and 5% CO2) and were cotransfected with a
transposon expressing shRNA against ATF3 (TRCN0000329691) under a U6 promoter as well
as a homemade plasmid expressing hyperactive PiggyBac transposase to generate stable
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incorporation of the vector into the genome. After selection with puromycin, passaged cells were
obtained for experiments within the first 10 passages. To generate ATF3 overexpression lines,
the human ATF3 sequence was cloned from Addgene #26115 and inserted into a homemade
PiggyBac transposon vector for overexpression.
For immunofluorescence experiments, cells were grown on cover slips and blocking and
staining was completed in 12-well culture plates. For imaging, the coverslips were mounted onto
slides with ProLong Gold Antifade Mountant with 4′6-diamidino-2-phenylindole (DAPI)
(Molecular Probes).
qRT-PCR
RNA was isolated using RNeasy (Qiagen) per the manufacturer’s protocol. The integrity of the
mRNA was verified with a BioTek Take3 spectrophotometer and electrophoresis on a 2%
agarose gel. RNA was treated with DNase I (Invitrogen), and 1 µg of RNA was reversetranscribed with SuperScript III (Invitrogen) following the manufacture’s protocol.
Measurements of cDNA abundance were performed by qRT–PCR using Applied Biosystems
QuantStudio 3 Real-time PCR system. Power SYBR Green master mix (Thermo Scientific)
fluorescence was used to quantify the relative amplicon amounts of each gene. Primer sequences
are located in Table 3.2.
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Table 3.2 qRT-PCR Primers
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ChIP-PCR
Approximately 25mg of stomach corpus tissue was flash frozen in liquid nitrogen until IP was
performed. The SimpleChIP Plus Enzymatic Chromatic IP Kit (Cell Signaling Technology) was
used for tissue prep and IP per the manufacturer’s protocol (see Resource table for antibody
concentrations). Tissue was fixed with PFA for 20 minutes and disaggregated with a
Medimachine (BD Biosciences). Standard PCR was used to determine ATF3 binding at the
Rab7b first intron (see Table 3.3 for primer sequences).
Table 3.3 ChIP-PCR Primers
Primer Name
Sequence (5’ to 3’)
Atf3 Forward

GAAGTGATGGATGGAAGAGGG

Atf3 Reverse

TGACTCGAGGCGTGAAAGAT

Rab7b Forward

AGAGAGAAGGCTCTCTGACC

Rab7b Reverse

CCAGGGTCATCTGAGTGTGA

Rab9a Forward

GACCTCTGCTGCCAAGTAGT

Rab9a Reverse

TCATCCACAGGTTGCTTTCGT

Human Patient Samples
Human gastric pathological tissue specimens were obtained with approval by the Institutional
Review Board of Washington University School of Medicine. Gastric clinical samples have been
previously described in (Capoccia et al., 2013; Lennerz et al., 2010; Radyk et al., 2018; Willet et
al.., 2018).
Graphing and Statistical Analysis
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Graphs and statistics were done with GraphPad Prism (La Jolla, CA). In cases involving more
than two samples to compare, significance was determined using ANOVA with post-hoc
correction: Tukey was used to assess statistical significance if multiple conditions were
compared; Dunnett post-hoc when comparing multiple samples to a single control. Otherwise,
unpaired, two-tailed Student’s t-test was used to determine significance. Data that were not
normally distributed, were analyzed by nonparametric Mann-Whitney U test. Most data (e.g. cell
counts) were first analyzed as mean values of measurements from multiple fields across multiple
sections of an organ for each animal, and then the mean of those means was plotted. A p-value of
≤0.05 was considered significant. Samples were randomized, and measurements were blinded to
prevent the introduction of experimental bias.
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Chapter 4: ATF3 Function in the Paneth Cell
Following Injury
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4.1 Introduction
The intestine has a well-defined stem cell hierarchy for continuous turnover of cells,
including quiescent, lineage restricted, and multipotent progenitor cells (Cheng and Leblond,
1974). Resident intestinal stem cells are confined to the crypt including multipotent stem cells,
known as crypt base columnar (CBCs) marked by Lgr5 expression (Barker et al., 2007). The
CBCs reside in a niche between the exocrine Paneth cells that secrete antimicrobial peptides,
which are developmental cousins of the gastric zymogenic chief cell and pancreatic acinar cell.
CBCs exit the crypt upwards, toward the gastric lumen, and create the transit amplifying zone of
the crypt where the most proliferation takes place from transit amplifying cells that generate the
enterocytes that transition up the villus. Also in the transit amplifying zone are lineage-restricted
progenitors, that give rise to goblet and Paneth secretory cells, and more quiescent +4 cells and
label retaining cells (Li and Clevers, 2010; Potten et al., 1997; Yousefi et al., 2017). This
complex organization of slow cycling, long-term stem cells and actively dividing stem cells
helps to ensure that the proliferative burden is met to maintain tissue function and barrier
function.
Several studies have shown that nearly all cell types in the small intestine have inherent
plasticity and can be recruited to replace a lost lineage. Many of these studies have been done
using genetic targeted ablation of a particular cell type, for example the intestine still remains
functional during diphtheria toxin receptor mediated ablation of Lgr5+ CBCs, which are replaced
by a “reserve stem cell” population expressing Bmi1 (Tian et al., 2011). Bmi1-marked cells are
likely part of the slower cycling stem cell population including cells also marked by lineage
tracing from Hopx, Sox9, and Lrig1 (Li et al., 2016; Powell et al., 2012; Roche et al., 2015;
Yousefi et al., 2017).
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Cells that are lineage-restricted or differentiated can even help replace lost cells given the
correct circumstances or if damage is severe enough. For example, Dll1 marks secretory
progenitor cells that give rise to all four secretory cell types in the intestine: Paneth, goblet, tuft,
and enteroendocrine cells, but can give rise to CBCs after radiation injury (Jadhav et al., 2017;
van Es et al., 2012). Even differentiated, post-mitotic Paneth cells can be prompted to develop
stem cell-like traits and give rise to enterocytes in the villus with Notch activation after injury
(Yu et al., 2018). This begs the question as to how differentiated, or lineage-restricted cells in the
intestine revert to a more stem-like cell.
Paligenosis is a conserved mechanism by which mature cells downscale, express
progenitor markers, and enter the cell cycle following large-scale injury (Miao et al., 2020;
Willet et al., 2018). Paligenosis is conserved across several tissues, including pancreas, stomach,
liver, and kidney and is conserved across species. Even though the intestine has some of the most
plastic cells in the body, paligenosis has never specifically been interrogated in the intestine.
Here, we use the established Doxorubicin (DXR) intestinal injury model (Dekaney et al., 2009;
Jones et al., 2019), which ablates intestinal stem cells and causes expansion of Paneth cells. We
observe increased ATF3 expression in Paneth cells after injury. In mice that lack the paligenosisgoverning gene Atf3, we find decreased intestinal proliferation and regeneration. We also note
delayed gastric epithelial repair in the DXR-treated Atf3−/−mice. These results suggest ATF3 may
play a role in intestinal regeneration after injury. Further studies must interrogate the timing of
potential paligenosis stages in DXR-injury, but these preliminary studies hint that paligenosis
could be one mechanism of cell plasticity used when mature cells become reserve stem cells
following intestinal damage.
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4.2 Results and Discussion
Paneth cells are developmental cousins of gastric zymogenic chief cells and pancreatic acinar
cells, and require MIST1 for their development, maturation, and function (Dekaney et al., 2019).
This makes Paneth cells a cell type that may potentially undergo paligenosis following injury.
Paligenosis can be modeled in acinar cells following their direct damage and in chief cells
following their direct damage and loss of nearby parietal cells. Taking this into consideration, we
decided to use Doxorubicin (DXR), a chemotherapeutic agent, to induce damage in the small
intestine, a model described in several studies (Dekaney et al., 2009; Jones et al., 2019; King et
al., 2013; Rigby et al., 2016). DXR causes stem cell apoptosis and mucosal damage that
increases crypt proliferation, villus height, and Paneth cell expansion. These studies showed
increased lysozyme-positive cells (Paneth cells) after 5 days of DXR.
To determine if DXR treatment might induce paligenosis in Paneth cells, we treated wildtype (WT) mice with DXR and looked for expression of newly identified paligenosis protein
ATF3. We found little ATF3 expression in vehicle treated jejunum and increased ATF3
expression in Paneth cells at 4d and 5d after DXR treatment (Figure 4.1A). To ensure this is
when Paneth cells expand and begin to take on a more proliferative and dedifferentiated
phenotype, we looked to see if some of these Paneth cells are proliferating. We observed
expression of BRDU+/LYZ+ after DXR treatment and see Paneth cells begin to expand and take
on more progenitor behavior at 4d DXR but are highly proliferative at 7d DXR (Figure 4.1B-C).
These data suggest that ATF3 may be important for Paneth cell proliferation and regeneration of
the intestine after DXR injury.
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Figure 4.1: ATF3 is expressed in Paneth cells during their expansion after Doxorubicin
injury
A. ATF3 expression in the jejunum of mice in vehicle and Doxorubicin (DXR) treatment.
Arrows point to Paneth cells with high expression of ATF3. B. Immunofluorescence of
proliferation (BRDU) and Paneth cells (LYZ) in during DXR treatment. C. Quantification of
proliferating LYZ+ Paneth cells over the course of DXR injury. n=3-4 mice per experiment.
Analysis by one-way ANOVA, Tukey.

Next, we wanted to see if Atf3 is required for the regeneration response after DXR injury.
We treated Atf3−/− and wild-type mice with vehicle or DXR and compared the jejunum histology
(Figure 4.2A). At 4d DXR we found Eosin rich crypt bases that looked to be a secretory cell
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intermediate in Atf3−/− mice, but not WT mice. At 5d DXR we saw several crypts that had very
few cells, a phenotype that was reminiscent of gland base dropout observed in injured stomachs
of Atf3−/− mice (see Chapter 3). Since loss of Atf3 reduced proliferation in stomach and pancreas
after injury, we wanted to see if there is a similar decreased in proliferation, and therefore
regeneration, in the Atf3−/− intestine after DXR injury (Figure 4.2B-C). Atf3−/− mice exhibited
significantly less BrdU+ proliferation at 4d DXR. We again, observed abnormal crypt bases in
Atf3−/− mice at 4d DXR that stained positively with the Paneth marker, lysozyme, potentially
indicating that Paneth cells are stunted in contributing to repair without Atf3. This could also be
why there is a decrease in proliferation at this stage, as Paneth cells would normally become
progenitor-like and aid in proliferation and regeneration.
Previous analysis of DXR injury in the small intestine shows decreased villus height and
increased crypt depth when regeneration begins (Dekaney et al., 2009), since fewer cells are
dividing and contributing to enterocyte production in the villus. We compared WT and Atf3−/−
intestine following vehicle or 4d DXR and preliminarily find Atf3−/− mice demonstrate shorter
villi and deeper crypts (Figure 4.2D). This phenotype is in agreement with the decreased
proliferation rate in Atf3−/− mice after injury and also suggests that there is a defect or delay in
regeneration at this timepoint without Atf3.
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Figure 4.2: Loss of Atf3 results in decreased intestinal proliferation and regeneration after
injury
A. Histology of jejunum treated with vehicle or Doxorubicin (DXR). Arrows at 4d mark
expanded secretory compartment. Arrows at 5d mark abnormal crypts with few cells. B.
Immunohistochemical analysis of small intestines with markers for proliferation (BRDU) and
Paneth cells (LYZ). C. Quantification of proliferation rates from B. n=3-4 mice. Significance by
unpaired two-tailed t test. D. Measurement of villus height and crypt depth from vehicle and
DXR treated intestines from A (n=1).
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Together our data suggest that ATF3 is important in intestinal regeneration following
DXR injury. While DXR causes a general regeneration response from several cell types in the
intestine to replace CBCs, Paneth cells and secretory progenitors play a significant and active
role in the process. Response and repair after DXR injury and seems rely, in part, on Atf3.
Without Atf3 the expansion of Paneth cells occurs, but they fail to upregulate proliferation or
give rise to other proliferative cells. Since Atf3 is a paligenosis gene, it is likely that paligenosis
occurs in this context, though the stages of paligenosis (1. Autodegradation, 2. Expression of
progenitor/metaplastic genes, and 3. Reentry to cell cycle) still need to be investigated in this
context. Since these data imply Atf3 is involved and is required for the Stage 1 to Stage 2
conversion, Paneth cells may not downscale properly and may not upregulate progenitor genes.
The next steps should characterize mTORC1 activity and autodegradation pathways through the
DXR timecourse to determine exactly how paligenosis is being affected.
Since DXR is a general chemotherapeutic and affects rapidly proliferating cells in any
tissue, we also observed some interesting phenotypes in the stomach following DXR treatment
(Figure 4.3A). We saw loss of cells in the isthmus/neck region of the gastric unit, in Atf3−/− mice
after 5d DXR, but this defect was not present in WT mice. Since DXR most likely ablated the
isthmal stem cells, nearby neck cells could be poised to replace the stem cell compartment, but
without Atf3 this does not happen at the same rate. Considering this, DXR could be a useful tool
for stem cell ablation in the stomach, perhaps like 5-fluorouracil. In addition, looking at DXR
injury in Atf3−/− mice could better answer if neck cells are capable of undergoing paligenosis.
Injured neck cells have been shown to slightly upregulate autophagy, express metaplastic genes,
and re-enter the cell cycle (Burclaff, 2019), but whether they mechanistically go through the
stages of paligenosis is not yet clear.
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Figure 4.3: Atf3 in gastric DXR injury and human intestinal metaplasia.
A. Stomach histology from vehicle and 5d DXR treated mice (n=3). B. ATF3 expression in
human intestinal metaplasia. Arrows point to goblet cells that help to define intestinal
metaplasia. Top inset shows gastric area that has completed transitioned to IM. Bottom inset
shows a transiting section of the stomach.
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Finally, we observe ATF3 expression in human gastric patient samples with intestinal
metaplasia (IM) (Figure 4.3B), yet we still need to determine if ATF3 is expressed in human
intestine tissue. Though knowing that ATF3 is expressed in IM and acutely expressed in human
SPEM (Chapter 3), it could mean ATF3 is a general marker of cell fate/identity changes. This
could also suggest that the transdifferentiation of a gastric epithelial cell to an IM cell could rely
on ATF3 and potentially paligenosis. Paligenosis has been suggested to be involved in the cell
identity transition of healthy esophageal squamous epithelium to Barrett’s esophagus (Jin and
Mills, 2019), so it could also be important for the gastric to IM transition.

4.3 Materials and Methods
Animals and Injections
All experiments involving animals were performed according to protocols approved by
the Washington University School of Medicine Animal Studies Committee. Mice were
maintained in a specified pathogen-free barrier facility under a 12-hour light cycle. Wild-type
C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice used in
experiments were females 6–8 weeks old. For Doxorubicin injury, one intraperitoneal injection
of Doxorubicin (20mg/kg; Cell Signaling) dissolved in saline was administered (Dekaney et al.,
2009). All mice were given an intraperitoneal injection containing 5-bromo-2′-deoxyuridine
(120mg/kg) and 5-Fluoro-2′ deoxyuridine (12mg/kg) 90 minutes prior to sacrifice.
Patient Samples
Human gastric tissue was obtained with approval from the Institutional Review Board of
Washington University School of Medicine. The database of metaplastic samples showing
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hybrid SPEM forms has been previously described (Lennerz et al., 2010; Radyk et al., 2018;
Willet et al., 2018).
Immunofluorescence and Immunohistochemistry
Small intestines were flushed with PBS and fixative and cut open length wise. The tissues
were pinned out and fixed overnight in 4% paraformaldehyde. The next day, tissues were rinsed
with PBS and 70% ethanol.
Stomachs were excised immediately, flushed with PBS via the duodenal stub and then
inflated with freshly prepared 4% paraformaldehyde. The stub was clamped by hemostat, and the
stomach suspended in fixative in a 50 ml conical for 8–12 hours, followed by 3 rinses in 70%
ETOH, arrangement in 2% agar in a tissue cassette, and routine paraffin processing.
Sections (5 m) were cut from intestine and stomach samples, deparaffinized and
rehydrated with graded xylenes, alcohols and water, then antigen-retrieved in Sodium Citrate
Buffer (2.94g Sodium citrate, 500ul Tween 20, pH 6.0) using a pressure cooker. Slides were
blocked in 5% Normal Goat Serum, 0.2% Triton-X 100, in PBS. Slides were incubated overnight
at 4°C in primary antibodies, then rinsed in PBS, incubated 1 hour at RT in secondary antibodies
and/or fluorescently labeled lectin (Alexafluor647 made by directly conjugating E–Y Labs lectin
to Molecular Probes Alexauor647), rinsed in PBS, mounted in ProLong Gold Antifade Mountant
with DAPI (Molecular Probes). For immunohistochemistry, steps were identical except the
following. An extra quenching step was performed for 15 min in a methanol solution containing
1.5% H2O2 following antigen retrieval. Substrate reaction and detection was performed using
ImmPACT VIP Peroxifase (HRP) Substrate Kit (Vector Laboratories) as detailed per the
manufacture’s protocol and slides were mounted in Permount Mounting Medium.
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Imaging
Fluorescence microscopy was performed using a Zeiss Axiovert 200 microscope with an
Axiocam MRM camera and Apotome II instrument for grid-based optical sectioning. Postimaging adjustments including contrast, fluorescent channel overlay, and pseudo-coloring, were
performed with Axiovision and Adobe Photoshop CS6. Histology of stomach and
immunohistochemistry were imaged using an Olympus BX51 light microscope and Olympus
SZX12 dissecting microscope w/12 MPixel Olympus DP70 camera. Images were analyzed and
post-imaging adjustments were performed with Adobe Photoshop CS6.
Antibodies
Primary antibodies used in this study were as follows: Goat anti–5-bromo-2′deoxyuridine (BrdU; 1:20,000; a gift from Dr Jeff Gordon, Washington University, St Louis,
MO), rabbit anti-lysozyme (LYZ) 1:1000 Abcam (ab108508), and mouse anti-ATF3 1:200
Abcam (ab58668). Secondary antibodies included AlexaFluor (488, 594, or 647) conjugated
donkey anti-goat, anti-rabbit, or anti-mouse (1:500; Molecular Probes).
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Chapter 5: ER Stress and the Integrated
Stress Response as Inputs to Begin
Paligenosis

This work was conducted with contribution from Lillian B Spatz.
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5.1 Introduction
Paligenosis was described as a conserved mechanism by which a mature cell downscales,
activates a progenitor-gene network, and re-enters the cell cycle after injury (Willet et al., 2018).
We have also recently described two genes, Ifrd1 and Ddit4, that help to control paligenosis in
mature exocrine cells of the stomach and pancreas (Miao et al., 2020). In this dissertation, we
also describe Atf3 as a new paligenosis gene (Chapter 3). IFRD1, DDIT4, and ATF3 begin their
activity in Stage 1 of paligenosis, which is early after an injury signal, but it is still not clear what
signals prompt initiation of paligenosis, or a cell plasticity event. Considering two of these new
paligenosis genes, Ifrd1 and Atf3, are controlled by the Integrated Stress Response (ISR) we
began to interrogate if the ISR is upstream of paligenosis initiation.
The ISR is a coordinated pathway used by all eukaryotes for sensing and interpreting
stress signals to ultimately promote translation of stress-responsive genes and reduce translation
of ‘housekeeping’ and growth genes (Costa-Mattioli and Walter, 2020). This occurs through 4
ISR kinases, each equipped with domains used to sense a different set of stress signals: HRI
(heme-regulated inhibitor; EIF2AK1), PKR (protein kinase r; EIF2AK2), PERK (PKR-like
endoplasmic reticulum kinase; EIF2AK3), and GCN2 (general control nonderepressible 2;
EIF2AK4) (Donnelly et al., 2013). This Chapter will focus on the kinases PERK, sensing ER
stress, and PKR, sensing infection and double-stranded RNA, though it is likely that any of the
kinases could be responsible for paligenosis or a cell plasticity event since there are many
different stresses a cell experiences before deciding to change their identity/behavior. The ISR
kinases work to add an inhibitory phosphate group to the α subunit of eIF2. eIF2 is important for
bringing the initiator Methionine-tRNA to the ribosome to begin cap-dependent translation,
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though when eIF2α is phosphorylated it can no longer perform this function and translation is
globally reduced (Harding et al., 2003).
There are several proteins that can still be made, even when the ISR is active and eIF2α is
phosphorylated evading the shutdown due to cap-independent translation mechanisms (like
internal ribosome entry sites: IRES) or having a long 5’ untranslated region with upstream open
reading frames (uORF) (Andreev et al., 2015; Starck et al., 2016; Young and Wek, 2016). Atf3
and Ifrd1 are two genes with an uORF that normally means they are not translated highly at
baseline (because the ribosome stalls and terminates after sensing the downstream ORF), but
become selectively translated when the ISR is active (Andreev et al., 2015). Since Atf3 and Ifrd1
are known ISR targets and they have important functions during paligenosis, we sought to study
if the ISR induces paligenosis.
We found the ISR is activated in the stomach at the same period we see low levels of
mTORC1 (paligenosis Stage 1). Importantly, this is also when we observe global translation
reduction and induction of ISR target genes (and paligenosis genes) Atf3 and Ifrd1 (Chapter 3
and Miao et al., 2020). We also performed studies with pharmacological inhibitors and activators
of the ISR to see how altering the ISR contributes to paligenosis progression. Finally, we found
slight activation of the ISR kinase, PERK, which might suggest ER stress → ISR is one mode of
paligenosis initiation, though studies to induce and mitigate ER stress did not specifically
influence paligenosis. Taken together, these data, though largely from preliminary studies,
suggest the ISR is upstream of paligenosis.
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5.2 Results and Discussion
mTORC1 controls cell growth, but also translation through phosphorylation of
downstream targets 4E-BP, S6 Kinases, and eIF4G (Fonseca et al., 2014). We have previously
shown that biphasic mTORC1 activity is a key feature of paligenosis in that mTORC1 activity
decreases during Stage 1 but increases again in Stage 3 to promote proliferation (Willet et al.,
2018). We have also shown that mTORC1 is critical for Stage 3 but is dispensable for the
autodegradation events that occur in Stage 1, even though mTORC1 is decreased at this time
(Miao et al., 2020; Willet et al., 2018). Thus, there must be another mechanism for reducing
translation in this first step of paligenosis, which leads to our interrogation of the ISR in this
context.
While we have shown the decrease in mTORC1 in paligenosis Stage 1, we wanted to
determine if the ISR is active during this same time. We performed Western blot on full stomach
tissue after vehicle and high dose tamoxifen (HDT) treatment and found increased
phosphorylation of eIF2α at 24h HDT compared to total eIF2α protein (Figure 5.1A). We also
saw decreased GADD34 (PPP1R15A) protein at 24h HDT, which is a phosphatase that helps to
restore eIF2α activity. These data suggest the ISR is indeed active during Stage 1 of paligenosis.
We wanted to make sure there was a corresponding decrease in global translation with
eIF2α phosphorylation. We used an in vivo puromycinylation assay (Liu et al., 2019). We
injected wild-type (WT) mice with puromycin one hour before sacrifice with vehicle or HDT
treatment to induce paligenosis and performed Western blot and immunofluorescence with an
anti-puromycin antibody. Puromycin incorporates into newly synthesized proteins, giving an
overall indication of how much translation is occurring during a specific timeperiod.
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Figure 5.1: The Integrated Stress Response is active during paligenosis Stage 1 when
translation is decreased.
A. Western from full stomach tissue suggesting ISR activation from eIF2α phosphorylation
increase and GADD34 decrease (n=2). B. Western from in vivo puromycin incorporation assay
showing de novo protein synthesis during tamoxifen treatment (HDT). (n=1) C.
Immunofluorescence of stomachs after in vivo puromycin incorporation assay (PURO, red) also
marking neck cells (GSII, green) and nuclei (DAPI, blue) (n=2).

We found a decrease in global protein translation during 24h HDT, or paligenosis Stage 1
(Figure 5.1B). To determine which cells are most effected by the global translation shut down,
and therefore most susceptible to ISR activation, we performed immunofluorescence on stomach
tissue after HDT treatment (Figure 5.1C). We found that the cells in the gland base have the most
translation at homeostasis and decrease protein synthesis following 24h HDT. By 72h HDT, each
cell in the unit is translating at high levels, including the base cells. Since chief cells in the base
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are most effected by the translation shutdown and are the cells that turn off mTORC1 at this
time, it is likely chief cells are most responsive to ISR activation.
Next, we interrogated the sufficiency of the ISR during paligenosis. We treated mice with
Salubrinal, a pharmacological inhibitor of GADD34 to maintain eIF2α phosphorylation and keep
the ISR active (Pallet et al., 2008; Sokka et al., 2007; Wu et al., 2011). Salubrinal (Sal) acts as a
eIF2α dephosphorylation inhibitor, thus amplifying the ISR signal. We find that treatment with
Sal and HDT for 1 day decreases injury-induced proliferation and amplifies Atf3 expression
(downstream target of the ISR) (Figure 5.2A-C). When we treated mice for 72h HDT + Sal we
also saw an exacerbated injury phenotype. The chief cells at the base in HDT+SAL mice had
very little cytoplasm and the units exhibited large open lumens at the gland base, sometimes
expanding up into the isthmus. This phenotype suggests keeping the ISR activated with Sal, may
be inhibiting proper progression of paligenosis, though further characterization of these mice will
need to be done.
Since H. pylori infection induces paligenosis and the genes expressed after infection and
during HDT treatment are similar (unpublished data from the lab), we hypothesized that maybe
HDT causes paligenosis in a manner similar to infection, and could potentially activate the PKR
arm of the ISR. We performed preliminary experiments in mice using a PKR inhibitor (iPKR;
CAS608512-97-6) (Ingrand et al., 2007; Zhu et al., 2011). Administration of iPKR alone caused
a decrease in mTORC1 activity (via expression of phosphorylated-RPS6 protein) and an
increased in autophagy (via expression of autophagy gene MAP1LC3B) (Figure 5.2E). While
this does not yet answer if PKR induction is upstream of paligenosis, it does point to a need for
PKR activity at homeostasis in the stomach, which has never been described.
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Figure 5.2: Pharmacological alteration of the Integrated Stress Response
A. Immunohistochemistry of 1D HDT (high dose tamoxifen) treatment ± Salubrinal (Sal). Chief
cells marked with pepsinogen C (PGC; red), neck cells with GSII (green), proliferation with
BrdU (white) (n=2). B. Proliferation quantified from A. C. qPCR of Atf3 expression (an ISR
target gene) with HDT injury ± Sal. D. Histology from stomachs treated for 72h with HDT or
HDT+SAL (n=2). E. Immunohistochemistry of untreated stomachs or treatment with a PKR
inhibitor (iPKR). Chief cells marked with PGC (red), mTORC1 activity marked by
phosphorylation of RPS6 (green), autophagy marked with LC3B (green), nuclei marked by
DAPI (blue) (n=2).
150

We have shown that ER is rapidly degraded during paligenosis Stage 1 (Willet et al.,
2018) and hypothesized that ER stress might be activating PERK and the ISR. We found
phosphorylaiton of PERK at 24h HDT in full tissue Western blot, suggesting PERK might be
active during paligenosis Stage 1 (Figure 5.3A). To determine if ER stress is necessary for
paligenosis, we turned to pharmacological intervention for temporal control of the ER stress
pathway during paligenosis. We used TUDCA (Tauroursodeoxycholic acid), a bile acid
derivative that has been shown to mitigate ER stress by acting as a chemical chaperone for
unfolded proteins (Hsu et al., 2017; Ozcan et al., 2006). TUDCA had little effect on injuryinduced proliferation nor on paligenosis progression since chief cells were still able to
dedifferentiate and enter the cell cycle and the histology of the gastric units behaved as HDT
treatment alone (Figure 5.3B-C).
We then wanted to determine if ER stress is sufficient for paligenosis. Mice were treated
with tunicamycin, an antibiotic that inhibits N-linked glycosylation resulting in unfolded proteins
being stuck in the ER, which can be used in mice to induce ER stress(Carlisle et al., 2014; Dai et
al., 2017; Huang et al., 2011; Marciniak et al., 2004; Rutkowski et al., 2008). Treatment with
tunicamycin (Tun) alone caused large vacuoles inside cells and holes in the epithelium, mostly in
the isthmus and base regions (Figure 5.3C). Treatment of TUN + HDT caused a decreased in
proliferation, likely due to increased cell damage (Figure 5.3B). The histology of 72h HDT +
Tun treated stomachs showed open lumens through to the gland base and shorter units, a
phenotype that looks more ‘damaged’ than 72h HDT alone (Figure 5.3C). Regardless of this
exacerbated phenotype, Tun treatment alone was not sufficient to induce paligenosis.
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Figure 5.3: Modulation of ER stress during paligenosis
A. Western from full stomach tissue of PERK phosphorylation following HDT (high dose
tamoxifen) treatment. B. Quantification of proliferation with vehicle, Tun (tunicamycin),
TUDCA, and HDT. C. Histology of stomach tissue with vehicle or 72h HDT treatment alongside
Tun or TUDCA. Yellow arrows point to vacuolated cells with Tun alone. Orange arrows point to
enlarged lumens at the gland base (n=3).
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Overall, these data suggest that the ISR is active during Stage 1 of paligenosis. While
preliminary results with Salubrinal and iPKR are promising, they do not fully get to the point of
showing if the ISR is required for paligenosis or not. To answer this question, a genetic mouse
model that has constitutive activation of eIF2 (Serine 51 to Alanine mutation) could be
developed and used. If a promising in vitro model of paligenosis is developed, eIF2 mutations
could also easily be interrogated in cell lines. It also might be possible that the dosage used in
these experiments is not the best for use in the stomach, even though they are within ranges of
published dosages used for mouse treatment.
ER stress may be one input to paligenosis, since we see large scale degradation of ER in
Stage 1, even though the experiments using TUDCA and tunicamycin have not been effective in
inhibiting and inducing paligenosis, respectively. There are several reasons why these drugs did
not have the intended effects, first of which is the mechanism of action for tamoxifen inducing
stomach injury is not well described. Recent data suggests tamoxifen acts as a parietal cell
protonophore (Manning et al., 2020), which does not directly injury the chief cells that undergo
paligenosis. Thus, TUDCA and tunicamycin may not be working as hypothesized since they do
not specifically target chief cells, so could have effects all throughout the stomach. This is clear
in tunicamycin treatment, which causes vacuolation in isthmal and base cells. Again, a genetic
model in which PERK can be specifically deleted in chief cells would be ideal for the study of
how ER stress might be an input to paligenosis. However, knowing that tunicamycin damages all
gastric corpus cells indiscriminately might be of use in future studies trying to dissect why some
injuries cause paligenosis and cell plasticity, while other injuries do not.
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5.3 Materials and Methods
Animal Studies and reagents
All experiments involving animals were performed according to protocols approved by
the Washington University School of Medicine Animal Studies Committee. Mice were
maintained in a specified pathogen-free barrier facility under a 12-hour light cycle. Wild-type
C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice used in
experiments were 6−8 weeks old.
Tamoxifen (250 mg/kg body weight; Toronto Research Chemicals, Inc, Toronto, Canada)
was administered by intraperitoneal (IP) injection to induce SPEM in the stomach (See Figure
3.1 for timeline (Saenz et al., 2016). Tamoxifen was prepared in a 10% ethanol and 90%
sunflower oil solution by sonication (Sigma, St Louis, MO). Salubrinal (Calbiochem CAS#
304475-63-6) was administered by IP injection (1mg/kg/day dissolved in 10% DMSO in
sunflower oil) to inhibit GADD34. iPKR (Millipore; CAS608512-97-6) was administered by IP
(1mg/kg/day dissolved in saline) to inhibit the kinase PKR. Tunicamycin (Sigma) was
administered by IP injection (0.5mg/day dissolved in saline) to induce ER stress. TUDCA
(Millipore) was administered by IP injections twice daily (250mg/kg doses) to act as a chemical
chaperone).
For in vivo puromycin incorporation assays, Puromycin was IP injected (200ul of 2.5mM
puromycin) one hour prior to sacrifice.
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All mice used for histology were given an intraperitoneal injection containing BrdU (120
mg/kg) and 5-fluoro-2′deoxyuridine (12 mg/kg) 90 minutes before sacrifice to capture cells in S
phase at the experimental endpoint.
Immunofluorescence and Immunohistochemistry
Mouse tissues were excised, flushed with phosphate-buffered saline (PBS) and then
inflated with freshly prepared 4% paraformaldehyde. The stomach was clamped and suspended
in fixative in a 50-mL conical overnight, followed by rinses in PBS and 70% ethanol,
arrangement in 3% agar in a tissue cassette, and paraffin processing. Sections (5 μm) were cut,
deparaffinized, and rehydrated with graded Histo-Clear (National Diagnostics), ethanol, and
water, then antigen-retrieved in sodium citrate buffer (2.94 g sodium citrate, 500 uL Tween 20,
pH 6.0) using a pressure cooker. Slides were blocked in 5% normal serum, 0.2% Triton-X 100,
in PBS. Slides were incubated overnight at 4°C in primary antibodies, then rinsed in PBS,
incubated 1 hour at room temperature in secondary antibodies and/or fluorescently labeled lectin
rinsed in PBS, mounted in ProLong Gold Antifade Mountant with 4′6-diamidino-2-phenylindole
(DAPI) (Molecular Probes).
For immunohistochemistry, steps were identical except the following. An extra
quenching step was performed for 15 minutes in a methanol solution containing 1.5%
H2O2 before antigen retrieval. Substrate reaction and detection was performed using ImmPACT
VIP Peroxidase (horseradish peroxidase) Substrate Kit (Vector Laboratories, Burlingame, CA) as
detailed per the manufacturer’s protocol and sections were developed with DAB for desired time
and counterstained with hematoxylin and/or eosin. Slides were mounted in Permount Mounting
Medium.
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Western Blot
Approximately 75mg mouse corpus stomach or pancreas tissue were sonicated in RIPA
buffer with 1x protease inhibitor cocktail (Thermo). Protein was separated using NuPAGE 10%
Bis-Tris gels and transferred to an Invitrogen nitrocellulose membrane. Membranes were then
blocked with 3% Bovine serum albumin (BSA) and incubated overnight at 4°C with primary
antibodies. The membranes were rinsed in tris-buffered saline (TBS) pH 8.0, incubated 1 hour at
room temperature in secondary antibody in 5% low-fat milk. Actin antibody was used as a
control to ensure equal loading of protein in each gel lane. Secondary antibody signals were
imaged and detected by SuperSignal West Pico PLUS Chemiluminescent Substrate Kit.
Antibodies
Antibodies for histology are as follows: mouse anti-Puromycin (Sigma) 1:200, Rat antiBrdU (Abcam) 1:200, sheep anti-PGC (Pepsinogen C; Abcam) 1:10,000, Rabbit anti-phospho S6
(Ser240/244; Cell Signaling) 1:500, Rabbit anti-LC3B (Novus) 1:200, Fluorescently conjugated
Griffonia simplicifolia-II lectin (GSII) 1:2,000.
Antibodies for Western are as follows: mouse anti-Puromycin (Sigma) 1:1,000; Rabbit
anti-phospho eIF2a (Ser 51; Cell Signaling) 1:1,000; Rabbit anti-eIF2a (Cell Signaling) 1:1,000;
Rabbit anti-GADD34 (Proteintech) 1:1,000.
qRT-PCR
RNA was isolated using RNeasy (Qiagen) per the manufacturer’s protocol. The integrity of the
mRNA was verified with a BioTek Take3 spectrophotometer and electrophoresis on a 2%
agarose gel. RNA was treated with DNase I (Invitrogen), and 1 µg of RNA was reverse156

transcribed with SuperScript III (Invitrogen) following the manufacture’s protocol.
Measurements of cDNA abundance were performed by qRT–PCR using Applied Biosystems
QuantStudio 3 Real-time PCR system. Power SYBR Green master mix (Thermo Scientific)
fluorescence was used to quantify the relative amplicon amounts of each gene. Primer sequences:
Atf3 For 5’ ACAACAGACCCCTGGAGATG 3’; Atf3 Rev 5’ CCTTCAGCTCAGCATTCACA
3’; TBP For 5’ CAAACCCAGAATTGTTCTCCTT 3’; TBP Rev 5’
ATGTGGTCTTCCTGAATCCCT 3’.
Imaging and Quantifications
Fluorescence microscopy was performed using a Zeiss Axiovert 200 microscope with an
Axiocam MRM camera and Apotome II instrument for grid-based optical sectioning. Postimaging adjustments, including contrast, fluorescent channel overlay, and pseudo-coloring, were
performed with Axiovision and Adobe Photoshop CS6. Histology of stomach and
immunohistochemistry were imaged using an Olympus BX51 light microscope and Olympus
SZX12 dissecting microscope w/12 MPixel Olympus DP70 camera. Images were analyzed and
post-imaging adjustments were performed with Adobe Photoshop CS6.
Quantification of BrdU proliferation rates was done by counting 5 or more 20x fields
from a whole-slide scanned images from the Hamamatsu Nanozoomer 2.0-HT system.
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Chapter 6: Conclusions and Future
Directions
As a whole, the work described here focuses on the dynamics of differentiated cells as
they interpret injury signals and change their state to become more progenitor-like. Many of
these studies emanated from our seminal work on paligenosis, the conserved mechanism of
mature cell reversion following injury (Willet et al., 2018). Paligenosis showed differentiated
cells could be called back into the cell cycle and contribute to repair in a tissue. In addition, we
described paligenosis as being key for the establishment of metaplasia in the stomach and
pancreas. While metaplasia is often a transient state only lasting long enough for injury repair to
occur, chronic metaplasia and chronic injury can lead to adenocarcinoma (Burclaff and Mills,
2018; Storz, 2017; Wroblewski et al., 2010; Zhu et al., 2007). As it stands, gastric cancer is the
third most common cause of cancer-related deaths in the world and pancreatic cancer the third
most common cause of cancer-related deaths in the US (Bray et al., 2018). Modeling precancerous stages and understanding what prompts cells to develop into metaplasia has important
implications for human health, as new findings could generate earlier detection methods, better
treatment options, or, at the least, inform us about disease etiology.
The stomach was the main organ used to interrogate metaplasia and cell plasticity events
(like paligenosis) because it possesses several features that make it an ideal model. First, the
stomach has an adult stem cell and several populations of differentiated cells providing the
opportunity to dissect out how much a stem cell alone can contribute to tissue repair vs. how
much a stem cell and facultative progenitors (or reserve stem cells) like the chief cell can
contribute to repair. Second, the stem cell zone and the chief cell zone are located far from each
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other, which means experiments can parse out stem cell proliferation vs. chief cell proliferation.
Third, the stomach has cells that do not demonstrate plasticity, like the parietal cell, which can
provide insight into why some differentiated cells have the potential to be progenitors and others
do not. Finally, there are several ways to induce injury in the stomach, including quick methods
with high dose tamoxifen and DMP-777 and more physiologically relevant methods like H.
pylori infection and an autoimmune gastritis mouse model (Nguyen et al., 2013).
Results from stomach experiments were accompanied by studies in the pancreas and
small intestine, showing the importance of cell plasticity throughout the gastrointestinal tract.
Pancreas and intestine models also have added advantages that contribute to the sophistication of
our findings. The pancreas lacks an adult stem cell, so all repair must come from a differentiated
cell. The intestine is a widely studied organ for plasticity since it has several stem cell
populations and nearly every cell, including differentiated cells, can contribute to repair. Thus,
showing that our findings apply to injury responses and plasticity in the stomach as well as the
pancreas and intestine help to solidify that we are studying phenomenon conserved across
tissues. Here, I will briefly summarize each Chapter and discuss new avenues for research.

6.1 Summary
In Chapter 2, we further corroborated that the zymogenic chief cell is the cell of origin
for Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) (Radyk et al., 2018). We used a
genetic-independent model to block stem cell proliferation during high dose tamoxifen (HDT)
injury. 5-fluorouracil (5FU) was administered during HDT treatment to ablate stem cells, but still
allow dedifferentiation/transdifferentiation of chief cells at the gland base. This approach hinged
on the idea that stem cells would need to divide, move down the gland, and ‘differentiate’ into
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SPEM cells while chief cells need only dedifferentiate (they would not need to divide). As
hypothesized, in HDT+5FU mice, chief cells downscaled their specialized features and began to
express progenitor/metaplastic genes, specifically genes like TFF2 aka spasmolytic polypeptide
(marked by GS-II lectin), which denotes SPEM in mice and humans. Meanwhile, the stem cells
remained stuck in the isthmus of the gland and did not develop into SPEM. We also found SPEM
transitions in human stomachs that mimicked patterns we observed in mice of individual chief
cells turning on GSII and turning off exocrine granule markers (Pepsinogen C), suggesting that
SPEM in humans is also derived from chief cells.
In Chapter 3, we continued exploring paligenosis and characterized a new paligenosis
gene: Atf3. We found that during Stage 1 of paligenosis, ATF3 is induced specifically in gastric
chief cells and pancreatic acinar cells after injury. ATF3 represses exocrine scaling factor Mist1
and induces metaplastic gene Sox9 (Fazio et al., 2017) and we identified Rab7b as an ATF3
target gene. ATF3 binds in the first intron of Rab7b and induced its expression to help upregulate
autodegradation during paligenosis Stage 1. We also characterized Atf3–/– mice, which had
decreased autodegradation in Stage 1, which ultimately resulted in cell death in Stage 3 in both
stomach and pancreas. Atf3 was also expressed in injury settings in 5 tissues and in Axolotl limb
regeneration. Finally, ATF3 is expressed in human SPEM. Altogether, these data suggest ATF3
is necessary for the progression of paligenosis and repair after injury.
Chapter 4 continues interrogating the role of ATF3, now in the small intestine. We used
Doxorubicin (DXR) injury to ablate the stem cell compartment and prompt more differentiated
cells, like the Paneth cell, to dedifferentiate and become progenitor-like. ATF3 is expressed in
Paneth cells following DXR injury, so we asked if Atf3 is necessary for repair in this model. We
found that Atf3–/– mice treated with DXR display regeneration defects, which can be attributed to
164

decreased proliferation in the crypt compartment, most likely decreased Paneth cell proliferation.
We also found that ATF3 is expressed in intestinal metaplasia in the stomach, suggesting that
ATF3 could have a general role in coordinating cell fate/identity changes.
Finally, we work to identify an upstream signaling pathway for paligenosis initiation in
Chapter 5. We again use the HDT stomach injury model to determine if the Integrated Stress
Response is activated during paligenosis. We found evidence of ISR activation in the stomach by
full tissue expression of phosphorylated eIF2α and a global decrease in translation rates. We
noted that chief cells had the most de novo protein synthesis at homeostasis but reduce
translation after HDT treatment during paligenosis Stage 1. We also began to modulate the ISR
using an eIF2α dephosphorylation inhibitor that decreased injury-induced proliferation and
worsened the HDT injury phenotype. Finally, we hypothesized that the ER stress arm of the ISR
might be activated in paligenosis due to the massive loss in ER we have previously reported
(Willet et al., 2018). While we preliminarily see activation of PERK, the eIF2 kinase that sense
ER stress, treating mice with a drug to mitigate ER stress did not affect paligenosis induction.
Furthermore, attempts to induce ER stress, did not induce paligenosis. Thus, the ER stress might
be one input to drive ISR activation and paligenosis, but it is likely that other eIF2 kinases or
stress sensors are also involved.

6.2 Future Directions
There are many questions that come out of the work presented in this dissertation. It is
my hope that some of my unpublished findings will help to advance this work further, but there
are several areas that I feel will be hot topics in the coming years. The rest of this Chapter
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focuses on future directions I believe will stem from my work and work done by others in the
field.
Paligenosis, cancer initiation, and cancer progression
Thus far, we have spent a lot of time considering how paligenosis leads to metaplasia
and, therefore, precedes cancer initiation. These studies have been critical for laying down the
foundations of paligenosis, but we are to the point that our claim of paligenosis contributing to
cancer should be supported with careful and specific experiments. Luckily, we are also in a
metaphorical ‘boom’ of new genetic tools for studying the stomach and stomach cancer. The
stomach field has suffered from the overall lack of genetic tools and the tools most used to study
chief cells, like Mist1-CreERT2, have been interpreted by investigators differently. In just the
last 5 years, new tools to mark stem cells have arisen including an inducible Cre for the Runx1
enhancer element (eR1-CreERT2) (Matsuo et al., 2017) and an inducible Cre for Stathmin1
(Stmn1-P2A-eGFP-IRES-CreERT2) (Han et al., 2019). In the same time frame, there was also
an addition of a non-variegated Lgr5-2A-CreERT2 mouse model that showed expression in and
lineage tracing from chief cells (Leushacke et al., 2017). Finally, and most recently, a large study
generated mouse models of human gastric cancer chromosomal instability and genomically
stable subtypes (Seidlitz et al., 2019).
Considering all these new tools, it will be necessary (and possible) to lineage trace from a
chief cell (that should undergo paligenosis) into cancer. Though I believe the most convincing
experiment would be lineage tracing into tumors from Atf3-CreERT2 mice (Denk et al., 2015).
Since Atf3 is a paligenosis gene, specifically expressed by cells in Stage 1 of paligenosis, lineage
tracing into cancer from these mice could be used to show paligenosis precedes cancer in several
organs. Well described and commonly used tumorigenesis models in pancreas already exist, like
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the LSL-KrasG12D/+;LSL-Trp53R172H/+; Pdx1Cre (or KPC) model (Hingorani et al., 2005), a
well-validated, clinically relevant model of pancreatic adenocarcinoma. Lineage tracing from
Atf3-expressing cells in KPC mice following an injury stimulus might provide the best insight
into how paligenosis contributes to cancer initiation. However, it has been published that loss of
Atf3 alone is enough to cause spontaneous tumorigenesis in mice (Wang et al., 2018) and
preliminary experiments in the lab show old Atf3–/– mice have stomach phenotypes (and on one
occasion a young Atf3–/– mouse) (Figure 6.1). In the future, Atf3–/– mice could be used in
chemical tumorigenesis studies (currently being established in the Mills Lab) to see if lacking a
paligenosis gene decreases the time it takes to develop tumors.
Metabolic regulation of cell plasticity
One of the key players in paligenosis is mTORC1, a central hub for cell energetics and
growth, which is repressed early after injury and becomes reactivated for cell division.
Considering this dynamic change in mTORC1, the huge energy demand needed for proliferation,
and the massive amount of autophagic and lysosomal degradation in paligenosis, there must also
be huge changes in cell metabolism. Reprogramming cell metabolism is a described hallmark of
cancer (DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016), but how metabolism
changes in precancerous stages is not well studied. The injury models described in this
dissertation would be optimal for studying how metabolism changes in cell plasticity since they
are quick, reproducible, and reversible. Tumors have to meet the high energy demands and can
do this by reprogramming bioenergetic, biosynthetic, and redox requirements. In metaplasia, the
tissue is terraformed and cells throughout the tissue are now prompted to divide, so it is likely
there must also be similar metabolic reprogramming events.
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Figure 6.1: Abnormal stomach histology in uninjured Atf3–/– mice
A. SPEM-like gastric units in young, uninjured Atf3–/– mice (n=1). Left – Columnar epithelial
cells surround an open lumen at the gland base devoid of Parietal cells. Right – Disorganization
of gland bases and accumulation of mesenchymal-looking cells. B. In two aged Atf3–/– mice,
there is atypical stomach histology with no discernable chief cells nor parietal cells. Left – Baselocated cells begin to invade the muscularis mucosa. Right – Columnar cells at the base of each
gland and potential mucous cell hyperplasia in the upper part of the unit.
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Some insight into how metabolic changes underlie metaplasia comes from studies in the
pancreas. It has been shown that oncogenic KRas mutations induce reactive oxygen species
(ROS) and development of acinar-to-ductal metaplasia (ADM) (Cheung et al., 2020; Liou et al.,
2016). Interestingly, ADM can be blocked in this model with a mitochondrial-specific ROS
inhibitor. This suggests that redox balance may be one large component of metaplasia induction,
which is not that surprising since ROS are important second messengers and can control cell fate
(Tan and Suda, 2018). Though preliminary studies suggest that ROS may be of great importance
in paligenosis, as Atf3–/– mice show high levels of ROS at homeostasis and even more just 3
hours after HDT injury (Figure 6.2) and we observe fragmented mitochondria after 24 hours of
HDT (FIBSEM; Chapter 3). It was also recently reported that the xCT cystine/glutamate
antiporter is required for chief cell plasticity to control redox balance (Meyer et al., 2019).
Autodegradation in paligenosis Stage 1 can be used for the downscaling and
dedifferentiation of mature/specialized cells. Autodegradation can also be used to release
substrates and metabolites used for cell cycle entry. A differentiated chief cell or acinar cell
mainly functions to secrete digestive enzymes, so taking on a completely different role of
“reserve stem cell” would require metabolic retooling. Perhaps increased autophagy of ER we
observe in Stage 1 is also carried out for the generation of nucleosides for DNA/RNA production
though the pentose phosphate pathway. Regardless, with the proper metabolite tracing studies,
these questions can be interrogated and yield exciting results.
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Figure 6.2: ROS accumulation after injury in wild-type and Atf3–/– mice
Fresh-frozen sections of mouse corpus stained with Dihydroethidium, a superoxide indicator,
used here as a fluorescent probe to detect superoxides and hydrogen peroxide.

170

6.3 Concluding Remarks
This dissertation is largely focused on the field of cell plasticity as it relates to human
disease. As a general feature of cancer, there is a decrease in expression of differentiation
markers and an increase in progenitor markers suggesting that cell plasticity plays a role in
cancer progression (Jopling et al., 2011; Slack, 2007). Cell plasticity also coordinates tissue
integrity following injury, especially in organs that lack an adult stem cell (pancreas, liver) or
organs that sustain a high level of damage (skin, intestine). The field of cell plasticity also
concerns cell biology questions as a differentiated, post-mitotic dramatically changes its
structure, gene expression, and function to become more progenitor-like. Thus, the observations
made in this dissertation have broad applications across the fields of cancer, regeneration, and
cell biology.
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differentiated cells by mTORC1‐dependent
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Appendix 1.1 Abstract
In 1900, Adami speculated that a sequence of context‐independent energetic and structural
changes governed the reversion of differentiated cells to a proliferative, regenerative state.
Accordingly, we show here that differentiated cells in diverse organs become proliferative via a
shared program. Metaplasia‐inducing injury caused both gastric chief and pancreatic acinar cells
to decrease mTORC1 activity and massively upregulate lysosomes/autophagosomes; then
increase damage associated metaplastic genes such as Sox9; and finally reactivate mTORC1 and
re‐enter the cell cycle. Blocking mTORC1 permitted autophagy and metaplastic gene induction
but blocked cell cycle re‐entry at S‐phase. In kidney and liver regeneration and in human gastric
metaplasia, mTORC1 also correlated with proliferation. In lysosome‐defective Gnptab−/− mice,
both metaplasia‐associated gene expression changes and mTORC1‐mediated proliferation were
deficient in pancreas and stomach. Our findings indicate differentiated cells become proliferative
using a sequential program with intervening checkpoints: (i) differentiated cell structure
degradation; (ii) metaplasia‐ or progenitor‐associated gene induction; (iii) cell cycle re‐entry. We
propose this program, which we term “paligenosis”, is a fundamental process, like apoptosis,
available to differentiated cells to fuel regeneration following injury.
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Appendix 1.2 Introduction
In 1900, George Adami wrote about the relationship between mitotic and differentiated cells,
stating that he expected mitotic cells would generally devote energy toward replication and
differentiated cells toward performing physiological functions (Adami, 1900). He also observed
that upon injury, differentiated cells had the capacity to revert to a more primitive state,
becoming mitotic again to promote tissue repair. Adami's observations on such cellular plasticity
have largely been forgotten, as the focus in the 20th century was nearly exclusively on the
unidirectional differentiation of stem cells into functional, “post‐mitotic” cells.
However, over the past decade or two, numerous examples have emerged to support
plasticity in differentiated cells. First, it became clear that normal, somatic cells could be
reprogrammed to pluripotency (Takahashi & Yamanaka, 2006). Furthermore, in tissues, injury
can induce a repair process that recruits largely post‐mitotic, differentiated cells back into the
cell cycle in most, if not all, organs and species, for example, glia (Boerboom et al, 2017;
Mindos et al, 2017); lung (Logan & Desai, 2015); heart in mammals (Wang et al, 2017) and fish
(Karra et al, 2015); in multiple gastrointestinal tract organs (Mills & Sansom, 2015). Each such
example to date has been studied essentially in isolation within the context of a particular type of
injury and a single organ; however, because the process is so widespread, we have postulated
that it may be governed by a shared, evolutionarily conserved molecular and cellular program
that is independent of tissue and species (Mills & Sansom, 2015).
It has long been known that the response of both the corpus of the stomach and the
digestive‐enzyme‐secreting (exocrine) pancreas to certain types of injury involves phenotypical
changes in cell differentiation and tissue architecture, known as metaplasia. In the acute setting,
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the metaplastic response appears to be a tissue repair mechanism and can be temporary, with full
restoration of normal tissue architecture (Nomura et al, 2005; Huh et al, 2012). Chronically,
however, ongoing damage and long‐term metaplasia are associated with and may fuel the
majority of gastric and pancreatic adenocarcinomas (Mills & Sansom, 2015; Giroux & Rustgi,
2017; Storz, 2017). In both organs, the cells of origin for the metaplastic, proliferating epithelial
cells are thought to be differentiated secretory cells (zymogenic chief cells in the stomach and
acinar cells in the pancreas) that reprogram to re‐enter the cell cycle (Mills & Sansom, 2015;
Murtaugh & Keefe, 2015; Mills & Goldenring, 2017; Radyk & Mills, 2017).
Here, we report that differentiated cells in both pancreas and stomach exhibit high levels
of mTORC1 activity during homeostasis. Proliferation‐inducing injury caused rapid mTORC1
loss and a dramatic induction of autodegradative machinery (lysosomes and autophagy). As the
functional and structural components were recycled, cells changed gene expression patterns (e.g.,
inducing the metaplastic marker Sox9); thereafter, they reactivated mTORC1 and re‐entered the
cell cycle. Such changes in mTORC1 activity were corroborated in tissues from human patients.
Also, established models of injury to differentiated cells in mouse liver (Espeillac et al, 2011)
and kidney (Chang‐Panesso & Humphreys, 2017) correlate mTORC1 activity with the recruited
proliferating cells. Blocking mTORC1 with rapamycin in murine pancreas and stomach impaired
only cell cycle re‐entry but not earlier cellular changes. Differentiated cells in autophagy‐
defective Gnptab −/− mice were blocked from both SOX9 expression and cell cycle re‐entry
phases, consistent with the upstream autodegradative phase being necessary for downstream
mTORC1‐mediated S‐phase entry.
Our results in the context of numerous previous reports on cellular reprogramming lead
us now to propose that recruiting differentiated cells into a regenerative phenotype occurs via
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stepwise metabolic and molecular phases that constitute a conserved, fundamental, cellular
program, akin to mitosis or apoptosis. This cellular program occurs during cell fate changes of
various types (e.g., reversion, dedifferentiation, transdifferentiation, reprogramming). The lack of
a standard term for the actual cellular process itself impedes finding shared features that
transcend cell types, tissues, and model systems. We propose a new, unifying term: “paligenosis”
from the Greek: pali/n/m (meaning backward or recurrence) + genea (born of, producing) + osis
(an action or process).
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Appendix 1.3 Results
A1.3.1 Diverse organs show similar changes in metabolic activity during acute
injury
To induce injury in the stomach, we employed a high‐dose tamoxifen (“HD‐Tam”) injury model
that has been used by us and others (Huh et al, 2012; Burkitt et al, 2017; Lee et al, 2017;
Leushacke et al, 2017). HD‐Tam causes loss of nearly all acid‐secreting parietal cells in the body
of the stomach (Figure A1.1 and Figure A1.2) and induces mature, differentiated digestive‐
enzyme‐secreting chief cells at the base of the unit to give rise to a proliferating cell population
(Radyk et al, 2018). These former chief cells maintain low‐level expression of some mature chief
cell markers and induce expression of wound repair‐associated genes like mucins and TFF2 (aka
spasmolytic polypeptide). The pattern of parietal cell loss and abundant, proliferative cells co‐
expressing TFF2 and chief cell markers has been called spasmolytic polypeptide‐expressing
metaplasia (SPEM) or pseudopyloric metaplasia (Schmidt et al, 1999). Maximal parietal cell loss
and proliferation stemming from chief cells occurs at 3 days after the first dose of tamoxifen
(Schematized in Figure A1.3). By 7 days, parietal cells have returned, and the entire stomach
regenerates to pre‐treatment cell censuses within 14–21 days (Huh et al, 2012). HD‐Tam is a
rapid, synchronous method to model, in a manner that lends itself to molecular analyses, the
mechanisms of stomach repair that also occurs in human stomachs infected with the bacterium
Helicobacter pylori.
To induce injury in pancreas, we used a well‐described rapid method involving daily
injection of the secretagogue cerulein. Cerulein injections cause large‐scale damage to the
digestive‐enzyme‐secreting acinar cells of the exocrine pancreas (Adler et al, 1985; Niederau et
al, 1985; Saluja et al, 1985). To repair the damage, acinar cells re‐enter the cell cycle, forming
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duct‐like structures called ADM (acinar‐to‐ductal metaplasia; schematic in Figure A1.3A). In our
protocol, ADM peaks 5 days after commencement of cerulein. Thereafter, there is continued
damage if cerulein administration is maintained, but the pancreas gradually adapts to the injury
over 2 weeks. Similar to HD‐Tam injury in the stomach, cerulein injury models a metaplastic
process that can also be a precursor for pancreatic ductal adenocarcinoma.
To determine whether the reversion from the differentiated to the replicative state
involves conserved shifts in cellular energy use, we examined metabolic activity in both tissues
using phosphorylated ribosomal S6 protein (pS6). The principal mediator of S6 phosphorylation
is the S6 kinase enzyme via the cellular metabolism hub mTOR complex 1 (mTORC1). To
confirm that S6 phosphorylation depends on mTORC1 activity, we treated mice with rapamycin,
a specific inhibitor of the mTORC1‐mediated S6 kinase activity. We used an antibody against
residues 240/244 of S6, because those sites are phosphorylated principally by pS6 kinase 1,
whereas the 235/236 phosphorylation sites can have input from other signaling pathways. For
example, 235/236 can be phosphorylated by p90 ribosomal S6 kinases that can be activated via
ERK signaling (Roux et al, 2007). Figure A1.1 shows that rapamycin, which is a specific
inhibitor of mTORC1‐mediated S6 Kinase activity, abolished pS6 240/44 staining, which was
normally abundant in gastric pit cells nearer the stomach lumen and in gastric chief cells.
Rapamycin also blocked S6 phosphorylation efficiently during the HD‐Tam protocol (Figure
A1.1). Antibodies against 235/236 also showed strong phosphorylation at peak metaplasia as
well as a similar abrogation of staining in the presence of rapamycin (Fig A1.1). As anti‐240/244
antibodies have stronger signal in our experiments and are more specific for mTORC1‐mediated
phosphorylation, we will use anti‐240/244 pS6 as a surrogate for mTORC1 activity for the
remainder of the manuscript unless otherwise mentioned.
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HD‐Tam or cerulein caused dramatic changes in pS6 expression. In stomach, pS6 was largely
lost by 12h. By 3 days, when SPEM is maximal in this system, the entire gastric unit expressed
abundant pS6 (Fig A1.1B). Molecular and cellular changes in the stomach following HD‐Tam
are sufficiently synchronous across the whole stomach that quantitative, molecular approaches
can be used (Huh et al, 2012). Quantitatively, phosphorylation status of both pS6 240/244 and
235/236 in the corpus of the stomach was decreased by nearly half within the first 4h and
returned to at or above baseline by 48h (Fig A1.1C). In pancreas, despite a slower and less
synchronous time course, the same pattern of mTORC1 activity could be observed by
immunofluorescence. pS6 was abundant in acinar cells at baseline, was nearly undetectable by
24h, and recovered in many cells by day 5, when ADM is maximal (Fig A1.1D).
Thus, both tissues, when recruiting proliferative cells for repair, undergo a well‐defined
pattern of changes in mTORC1 activity. During homeostasis, the organs are replete with
differentiated secretory cells that are not dividing but are energetically active in synthesizing
protein using their elaborate secretory apparatus (Mills & Taghert, 2012; Lo et al, 2017). When
replicating cells must be recruited from those differentiated cells, the cells shut off mTORC1
temporarily, then re‐induce it at the time of maximal regenerative proliferation.
To further assess whether the upregulation of pS6 is a common feature during the
recruitment of differentiated cells to regenerate damaged tissue, we examined liver (two‐thirds
partial hepatectomy) and kidney (tunicamycin‐induced acute injury) for changes in S6
phosphorylation. Both injury models have previously been shown to involve recruitment of
differentiated cells back into the cell cycle (Newberry et al, 2008). In kidney, as expected,
tubules in the cortex and outer medulla are damaged as evinced by vacuolation (Fig A1.4). Non‐
damaged tubules show increased BrdU as cells re‐enter the cell cycle (Fig A1.4). The
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proliferative tubules show marked increase in pS6. Similarly, the well‐known recruitment of
hepatocytes into the cell cycle 48h following partial hepatectomy is also accompanied by
increased S6 phosphorylation (Fig A1.4).

A1.3.2 mTORC1 is required for injury‐induced proliferation
During SPEM and ADM, expression of genes encoding secretory cargo (like digestive enzymes)
is scaled down, whereas wound repair and progenitor‐associated genes are scaled up (Capoccia
et al, 2013). Many such scaled up genes (e.g., Cd44 and Sox9) are increased in both pancreas and
stomach during the recruitment of differentiated cells back into the cell cycle. To determine
whether blocking mTORC1 affected response to injury, we subjected mice to HD‐Tam or
cerulein and examined the effects of blocking mTORC1 with rapamycin (Fig A1.2). Figures
A1.1 and A1.2 show that parietal cell death occurred in HD‐Tam even without mTORC1
activity. The gastric units also remodeled as expected with chief cells assuming the ductular
morphology, characteristic of SPEM (Fig A1.2).
We next examined the effects of rapamycin on induced proliferation. We noted that in
control experiments, without HD‐Tam, proliferation of the cells in the isthmus (the narrow zone
between pit and upper neck, Fig A1.3A), where there is active mitosis in homeostasis, was not
affected markedly by rapamycin (Fig A1.5A and C). However, rapamycin decreased the injury‐
induced proliferation by nearly half (P < 0.001; Fig A1.5C). The lack of proliferation did not
affect SPEM induction, as defined by cells co‐stained with GSII and the chief cell marker, GIF
(Fig A1.5A and B). Indeed, the SPEM marker SOX9 was induced in reprogramming chief cells
to levels at least as high as those observed in HD‐Tam without rapamycin (Fig A1.6). That cells
expressing molecular features of metaplasia can arise in the absence of proliferation is consistent
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with multiple previous reports showing that chief cells can give rise directly to SPEM cells
without contribution from the isthmal stem cell (Nam et al, 2010; Radyk et al, 2018).
Rapamycin had equivalent effects on the pancreas. Metaplastic induction of SOX9 was
not affected (Fig A1.6); however, cell proliferation was even more substantially blocked than in
the stomach (Fig A1.5D and E). This may be because the pancreas is entirely dependent on
reprogramming acinar cells as a source for proliferation, whereas the stomach also has a
constitutive stem cell that continues to proliferate even in the presence of rapamycin (Fig
A1.3A). Continued HD‐Tam injections kill mice, so we cannot study adaptation of stomachs;
however, we have maintained cerulein injections for up to 2 weeks by which point wild‐type
pancreas usually adapts to the injury. Thus, we used the pancreas to determine whether
mTORC1‐dependent proliferation was required for pancreatic repair. Figure A1.2 shows that 2‐
week cerulein with mTORC1 blocked led to tissue loss relative to cerulein treatment alone.

A1.3.3 Changes in mTORC1 also characterize human metaplasia
To determine whether mTORC1 activity is modulated in human disease states, we first examined
a database of stomach tissues from human patients exhibiting metaplastic response to H. pylori
infection, previously compiled at Washington University (Lennerz et al, 2010; Radyk et al,
2018). A representative region from this dataset is shown in Fig A1.7A. As in mice,
morphologically normal chief cells showed high pS6. In regions of SPEM, pS6 abundance
varied. In lesions that had histological features of cells undergoing acute conversion to SPEM
(what we have previously termed “hybrid SPEM” (Lennerz et al, 2010; Radyk et al, 2018) based
on examination of a large dataset of SPEM lesions), pS6 levels were high (Fig A1.7A). In
regions where basal cells showed more uniform metaplasia (“established SPEM”), pS6 levels
were lower. In humans, SPEM is thought to be either transient and rapidly resolve (as in the
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mouse HD‐Tam model) or chronic and persist for decades, involving large patches of the
stomach (Peterson, 2002). In the chronic case, SPEM is equivalent to the lesion pathologists call
chronic atrophic gastritis (Rugge et al, 2008). In addition, SPEM is thought to progress to (or
predate) another, proliferative, pre‐cancerous lesion, intestinal metaplasia (Yoshizawa et al,
2007; Correa & Piazuelo, 2012; Spechler et al, 2017) and to increase risk for progression to a
cytologically atypical lesion, dysplasia, as well as to cancer itself.
To further clarify the link between mTORC1 activity and metaplastic changes in humans,
we analyzed pS6 levels in gastric tissue microarrays (Table A1.1) comprising tissue cores
representing the following histological phenotypes: normal mucosa, SPEM, IM, dysplasia, and
gastric adenocarcinoma. pS6 showed consistent, mid‐level expression in nearly all normal
mucosal samples, in agreement with our smaller sample showing expression of pS6 in normal
chief cells and with our mouse data (Fig A1.7B). Both cancer and dysplastic lesions showed
higher average pS6 expression, though there was also more variability in that over a third of such
lesions showed much stronger expression than normal tissue, while about a third showed lower
expression (Fig A1.7B). On average, intestinal metaplasia pS6 levels were close to those of
normal mucosa (Figs A1.7B and A1.8). SPEM lesions showed a clear biphasic pattern with the
majority like the “established SPEM” with low‐to‐no detectable pS6 (cf. Figs A1.7A and A1.8)
but with some SPEM lesions having much stronger pS6 (Figs A1.7 and A1.8).
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Table A1.1 Patient Demographics

SPEM lesions with lower pS6 activity tended to express abundant mucin as well as
epitope for the SPEM‐identifying lectin GSII (Fig 1.7A); nuclei tended to be flat and eccentric
(Fig A1.8). pS6‐expressing SPEM cells were more cuboidal columnar, resembling the SPEM
cells in the acute, proliferative mouse SPEM that resolves in a few days after HD‐Tam. We
hypothesized that SPEM with increased pS6 represented metaplastic cells that are actively
proliferating (like D3 HD‐Tam in mice) to repair an injury, whereas the decreased pS6 lesions of
established SPEM may be mitotically quiescent. Hence, we divided the SPEM lesions into
mitotically active (“proliferative SPEM”) and inactive (“quiescent SPEM”) based on Ki‐67
staining of the same tissue core on another microtome section (Fig A1.8 and then correlated
those phenotypes to the previously scored pS6 expression for that lesion. Proliferative SPEM
was far more likely to be associated with pS6 expression, whereas quiescent SPEM was largely
negative for pS6 (Fig A1.7C, P < 0.001 by χ2). Thus, pS6 is low‐moderate in normal,
physiologically active mucosa and high in most lesions that have increased proliferation
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(proliferative SPEM, IM, dysplasia, cancer). We conclude that metabolic activity correlates with
differentiation state and recruitment into the cell cycle in humans as well as mice.

A1.3.4 Loss of mTORC1 inhibits cell cycle progression at S‐phase
Because gastric chief cells respond to injury more synchronously than pancreatic acinar cells, we
are able to perform molecular analyses based on changes of gene expression. We used this
approach to determine specifically where the block in cell cycle re‐entry occurs when mTORC1
activity is inhibited. We analyzed Affymetrix GeneChips of whole gastric corpora ±HD‐Tam
(3D) ±rapamycin by Gene Set Enrichment Analysis (GSEA) with a combination of both a
publicly available and custom gene sets. In a control experiment to validate our approach, we
dissociated gastric epithelial cells from Atp4b‐Cre; ROSA26mTmG mouse stomachs and used flow
cytometry to isolate parietal cells (GFP+) from other epithelial cells (Tomato+). Expression of
isolated, amplified RNA applied to GeneChips was analyzed by Partek Genomics Suite, and the
94 genes whose expression was enriched ≥ eightfold in parietal cells vs. other epithelial cells was
computed. As expected, GSEA showed that these PC‐enriched genes were highly preferentially
expressed in control stomachs vs. HD‐Tam stomachs; the addition of rapamycin did not affect
this pattern (Fig A1.9). Thus, global gene expression profiling with GSEA can detect the loss of
parietal cells that epitomizes HD‐Tam‐induced metaplasia and also shows that parietal cell loss
is independent of mTORC1, consistent with the histological data. In another control experiment,
we performed GSEA of a published gene set of mature chief cell enriched genes (Capoccia et al,
2013) and contrasted HD‐Tam vs. HD‐Tam + rapamycin. There was no substantial effect of
rapamycin, suggesting that the change in chief cell gene expression induced by injury is also not
substantially affected by loss of mTORC1 (A1.9).
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On the other hand, although many transcripts from a previously published gene set of
SPEM‐associated genes (Nozaki et al, 2008) did not show particular changes when rapamycin
was administered in HD‐Tam, there was a cluster of genes enriched only when mTORC1 levels
were normal (Fig A1.9). Injury that causes metaplasia induces both wound‐healing‐associated
genes (e.g., Clu, Sox9, CD44v) and proliferation‐associated genes. Given that rapamycin blocks
proliferation specifically in our histological analysis, we next examined the effects of rapamycin
on the cell cycle using GSEA. Figure A1.10A shows that, indeed, rapamycin induces a marked
de‐enrichment of cell cycle gene expression in HD‐Tam. The block appears specifically at the S‐
phase and beyond, as gene sets for G1‐S, S, G2, and G2‐M showed that G1‐S genes were
relatively similarly distributed regardless of mTORC1 activity, whereas genes expressed during
the later stages in the cell cycle were skewed toward the HD‐Tam alone condition (Fig A1.10B–
E). We used a slightly different approach to further investigate the interaction of mTORC1 with
cell cycle stage by first determining the top 20 genes skewed most toward the HD‐Tam (vs.
vehicle‐treated controls) in each cell cycle stage gene set. We then determined the average
increased expression of those genes in both HD‐Tam and HD‐Tam + rapamycin vs. vehicle
controls. Figure A1.10F shows that rapamycin decreased expression of the 20 top G1/S‐phase
HD‐Tam‐enriched genes by only 16 ± 3%, whereas gene expression at other cell cycle stages
was inhibited substantially more. Expression of G2/M‐phase genes was decreased by 49 ± 3%
with rapamycin treatment (P < 0.001, HD‐Tam vs. HD‐Tam + rapamycin in G2‐M genes; P <
0.05 for G2‐M vs. G1‐S).
To independently validate the GeneChip findings, we performed qRT–PCR that showed
that the expected decreases in a parietal cell (Atp4b) transcript and increase in a non‐cell‐cycle
SPEM transcript (Clu) were not affected by rapamycin (Fig A1.10G). Also matching the
188

GeneChip results, the G1 transcript, Ccnd1, was increased similarly regardless of mTORC1
status. As expected, a G2/M‐phase transcript cohort was uniformly increased in HD‐Tam but not
in HD‐Tam + rapamycin (Fig A1.10 H). Thus, molecular analysis indicates that inhibition of
mTORC1 activity does not substantially affect chief cell G1‐phase entry from the quiescent, G0
state but slows S, G2, and M‐phase progression. BrdU uptake and incorporation into DNA
occurs during S‐phase; thus, the block in BrdU seen histologically corroborates the molecular
data suggesting that mTORC1 is required for G1 to S transition.

A1.3.5 Autodegradative machinery is massively upregulated early following
injury
We so far have observed that mTORC1 activity is rapidly extinguished within hours of inducing
injury. Later, as cells re‐enter the cell cycle, mTORC1 is rekindled. Blocking re‐emergence of
mTORC1 activity inhibits induced proliferation in both stomach and pancreas. In pancreas,
where repair is entirely dependent on reprogramming, loss of mTORC1 activity blocks tissue
regeneration. We hypothesized that the scaling down of mature cell architecture to “retool” a cell
for more efficient proliferation would likely involve activation of lysosomes and autophagic
machinery. The autodegradation of cellular structure could then liberate key macromolecules
(nucleotides, amino acids, lipids) that would both stimulate mTORC1 reactivation and provide
building blocks for replication. Figure A1.11 shows that there is a massive increase of lysosomes
(by luminal marker Cathepsin D, Fig A1.11A) and autophagosomal puncta (by LC3‐GFP, Fig
A1.11C) early following injury in gastric chief cells. Figure A1.11B quantifies a large spike in
lysosomes, as a percentage of their PGC+ (pepsinogen C; chief cell marker) cell area, by 12–24h
of HD‐Tam that begins to resolve by later stages, when many cells have re‐entered the cell cycle.
Increased lysosomes, autophagosomes, and autolysosomes can also be seen at the ultrastructure
level (Fig A1.11D and E) on transmission electron microscopy (tEM). tEM analysis shows that
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rER, mitochondria, and secretory granules are all targeted for recycling during these early stages.
The pancreas also shows an equivalent time course of changes in autodegradative machinery,
with a spike in lysosome and autophagic puncta 8–24h following cerulein, followed by
decreasing, but still elevated levels, at D3 and near baseline levels at the time of maximal
proliferation and pS6 activity (Fig A1.11F, Fig A1.12).

A1.3.6 Autodegradative machinery is required for normal progression to later
stages
We next sought to address whether autodegradative machinery activation is both
upstream of and required for metaplasia formation and proliferation. To do this, we used mice
defective in lysosomal hydrolase trafficking that have been shown previously to have defects in
autodegradative function specifically in exocrine secretory cells like chief and acinar cells
(Boonen et al, 2011). Gnptab −/− mice are deficient in an enzyme required for the addition of
mannose‐6‐phosphate to lysosomal enzymes to ensure their proper trafficking. We treated
Gnptab −/− and littermate controls (Gnptab −/+ and Gnptab +/+) with HD‐Tam or cerulein. HD‐Tam
treatment in Gnptab −/− mice caused the expected loss of parietal cells; however, chief cell
reprogramming was dramatically compromised (Fig A1.13). Most units did not show loss of
large chief cells with eccentric nuclei at all (red arrowhead, Fig A1.13), suggesting
reprogramming did not occur, whereas some gastric units showed complete loss of the base zone
where chief cells normally reside (green arrowhead, Fig A1.13), indicating chief cells were
aberrantly lost instead of reprogrammed. Rarer gastric units seemed to complete the
reprogramming (yellow arrowhead, Fig A1.13). In pancreas, we detected almost no ADM in
Gnptab −/− mice (Fig A1.13) by D5. Rather, cells remained in an aberrant acinar morphology with
considerable loss of eosinophilic cytoplasm but no decrease in size. By 2 weeks, whereas wild‐
type controls had largely adapted to the cerulein injury, in Gnptab −/− mice, the exocrine pancreas
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comprised only scattered ducts and SOX9− acinar cells, still organized in typical lobules.
Cytologically, these remnant cells were characterized by generous pale cytoplasms ranging from
foamy to hyaline and lacking nearly all distinguishing features.
We next examined the molecular phenotype of the block in Gnptab −/− mice. In control
stomachs in response to injury, reprogramming cells in the base showed the expected abundant
increase in metaplastic genes like Sox9 (Fig A1.14A) and the epitope for GSII (Fig A1.14C).
Proliferation in the base of the unit, where chief cells were reprogramming, was nearly
equivalent to the rate of proliferation in the normal stem cell zone in the neck (Fig A1.14B and
D). The bases of gastric units in Gnptab −/− mice were markedly compromised in both metaplastic
changes and proliferation (Fig A1.14A–D). In Gnptab −/− mice, chief cells in the base remained
both BrdU‐ and SOX9‐negative (Fig A1.14E and F). They also failed to reactivate mTORC1, as
pS6 in these mice was largely not detectable in the base (Fig A1.15).
In the pancreas, there was a similar defect in both BrdU (Fig A1.14G and I) and Sox9 (Fig
A1.14H). The remnant acinar cells that remained in Gnptab −/− mice following 2weeks of
cerulein treatment expressed E‐cadherin and low levels of amylase but were not positive for
other mature acinar nuclear markers like GATA4 or metaplasia markers like CK8/18 (Fig
A1.16).
Finally, to determine whether the dropout of gastric bases was due to increased cell death in the
absence of lysosomal hydrolase activity, we examined tissue for cleaved caspase 3. In wild‐type
mice (either with or without rapamycin), we did not detect substantial apoptotic death of the
chief cells, consistent with our previous observations that death in HD‐Tam is essentially
confined to parietal cells (Huh et al, 2012; Radyk et al, 2018; Fig A1.1). In Gnptab −/− mice,
however, we frequently observed multiple cells in some bases of gastric units that were
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undergoing apoptosis (Fig A1.17). Thus, in stomach, aberrant autodegradative function leads
either to stalling of the chief cell reprogramming process or cell death. In pancreas, we observed
a pattern of scattered apoptosis of acinar cells in wild‐type mice ±rapamycin following cerulein
treatment. Loss of GNPTAB did not seem to affect this basal rate of death, which is consistent
with the survival of many acinar cell remnants out to 2weeks, as discussed above.
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Appendix 1.4 Figures
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Figure A1.1 pS6 is an accurate proxy for rapamycin‐sensitive mTORC1 activity and shows
that loss of mTORC1 does not affect parietal cell death or induction of metaplastic gene
expression in reprogramming chief cells
A. Injection schemes for injury experiments with rapamycin in stomach (left) and pancreas
(right). B. Representative epifluorescence images of the distribution of pS6 in the normal and
injured stomach ±rapamycin treatment. pS6 is restricted to the chief cell zone (base) and pit zone
of the normal corpus unit. At peak (HD‐Tam day 3) SPEM stages, it is located at high level
throughout the unit. Upon rapamycin treatment, all pS6 staining is lost throughout the normal
and injured corpus unit. The characteristic induction of GSII staining in reprogramming chief
cells at the base of gastric units (indicating SPEM) occurs at least as markedly in the presence of
rapamycin, indicating mTORC1 is not required for metaplastic gene induction. Green, pS6;
white, GSII; blue, DAPI. Scale bars: 50 μm. C. At peak metaplasia stages, pS6 235/6 is
upregulated in the stomach epithelium and rapamycin treatment at this stage abolishes all
staining. Scale bars: 50 μm. D. Representative epifluorescence images of the loss parietal cells
(marked by ezrin) upon injury and rapamycin treatment. Treatment with HD‐Tam caused the loss
of the vast majority of parietal cells throughout the corpus. Rapamycin does not rescue that
injury. Green, GSII; white, ezrin; blue, DAPI. Scale bars: 50 μm.
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Figure A1.2 Histological changes in the injured stomach and pancreas with and with
rapamycin treatment
A. Representative hematoxylin and eosin counterstained images of HD‐TAM stomach tissue
±rapamycin. Treatment with tamoxifen causes acute loss of parietal cells (large eosinophilic
cells) by 12–24 h post‐injury. By 3 days, chief cells have reprogrammed into SPEM cells. The
general pattern of loss of parietal cells and conversion of chief cells to metaplastic cells is not
affected by rapamycin (right panels). Scale bars, 50 μm. B. Representative hematoxylin and
eosin counterstained images of pancreas tissue injured with cerulein at various stages
±rapamycin. Cerulein injury causes mosaic, asynchronous conversion of acinar cells into
proliferative, acinar‐ductal metaplastic cells with maximal features of the process at day 5 in our
protocol. By 2 weeks, the pancreas has compensated for the continuous injury and recovers a
relatively normal morphology. Dual treatment with rapamycin and cerulein does not rescue the
metaplastic response by day 5 and impedes normal tissue compensation by 2 weeks injury, with
most of the tissue continuing to show abundant metaplastic forms. Scale bars, 50 μm.
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Figure A1.3 mTORC1 activity undergoes dramatic changes during stomach and pancreas
metaplastic injury response
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Figure A1.3 mTORC1 activity undergoes dramatic changes during stomach and pancreas
metaplastic injury response
A, B. Digestive‐enzyme‐secreting (zymogenic) mature cell populations in the stomach (A) and
pancreas (B) are recruited back into the cell cycle to fuel metaplasia in response to large‐scale
injury. Digestive enzyme expression (red) decreases, and markers of mucous neck cells (green,
stomach) or duct cells (green, pancreas) increase in metaplastic, proliferating cells (red + green =
yellow). Stomach is further characterized by loss of acid‐secreting parietal cells (blue). (B)
Representative epifluorescence images of mouse gastric corpus glands during homeostasis, early
after injury (HD‐Tam 12 h) and at maximal metaplastic response (HD‐Tam Day 3), stained for
mTORC1 activity using a downstream target, pS6 as a proxy. Green, pS6; red, GIF (gastric
intrinsic factor, a chief cell marker); white, GSII (a mucous neck cell marker); blue, DAPI.
Right—higher magnification images of boxed areas on left focus exclusively on the base of the
unit where the digestive‐enzyme‐secreting cells are reprogramming. Yellow dashed area outlines
the base of a single gastric unit. Scale bar, 20 μm; boxed area pull out, 10 μm. C. Western blot of
pS6 (red) and β‐tubulin control (green) from whole corpus protein extracts at various injury time
points; pS6 (240/244 or 235/6) vs. tubulin fluorescent intensity from replicate blots quantified
below (error bars = standard deviation). *P < 0.05, ***P < 0.001. Statistical analysis with both
antibodies was done using ANOVA with a post hoc Dunnett's test. D. Representative
epifluorescence images of pS6 staining of pancreas during homeostasis, acute injury (cerulein 12
h), and maximal injury (cerulein day 5). Green, pS6; red, amylase; blue, DAPI. Boxed areas on
left depicted at higher magnification on right. Scale bar, 20 μm; boxed area pull out, 10 μm.
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Figure A1.4 Acute kidney injury and partial hepatectomy both cause upregulation of
mTORC1 activity during proliferative phases
A. Upon injury with tunicamycin, tubule cells in the kidney are damaged (white arrowhead) and
surviving tubule cells (yellow arrowhead) upregulate pS6. Scale bars: 100 μm. B. Upregulation
of the pS6 is associated with increased proliferation in this injury model as seen by BrdU+
nuclei. Scale bars: 100 μm. C. Two‐thirds partial hepatectomy causes a pronounced upregulation
of pS6 in the remaining hepatocyte mass. Scale bars: 20 μm. D. The pS6+ hepatocytes are highly
proliferative at this stage. Scale bars: 20 μm.
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Figure A1.5 Recruitment of proliferating cells during stomach and pancreas metaplastic
injury depends on mTORC1
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Figure A1.5 Recruitment of proliferating cells during stomach and pancreas metaplastic
injury depends on mTORC1
A. Representative immunofluorescence images of stomach tissue ± metaplastic injury ±
rapamycin treatment. Green, neck cells (GSII); red, chief cells (GIF); white, proliferating cells
(BrdU); blue, nuclei (DAPI). Scale bars 20 μm; 10 μm for bottom images. Bottom—boxed areas
from top pictures are shown at higher magnification with individual bases of gastric units (where
reprogramming occurs) outlined by dashed lines and proliferating cells by arrowheads. B. Cells
of each differentiation type, following scheme in Fig 1A, are quantified by scoring
immunofluorescence images from multiple experiments. Metaplastic injury induces a massive
accumulation of yellow (SPEM) cells and loss of red (Chief) cells (compare vehicle–vehicle with
vehicle‐Tam, D3) that is not significantly affected by rapamycin treatment (compare vehicle‐
Tam D3 with Rap‐Tam D3). C. Proliferative cells are quantified as for panel (B). Injury induces
massive proliferation (compare vehicle–vehicle with vehicle‐Tam D3) significantly inhibited by
rapamycin (compare vehicle‐Tam D3 with Rap‐Tam D3). D. Top panel arrowheads indicate rare
proliferative acinar cells during homeostasis with or without rapamycin treatment. Cerulein
induces proliferation of acinar cells recruited into the cell cycle that is inhibited by rapamycin.
Boxed areas are magnified in insets. Note multiple BrdU+ cells (green) staining with amylase
(red) a digestive enzyme, indicating acinar cell origin. BrdU+ cells following rapamycin +
cerulein treatment are often not co‐stained with amylase. Blue, DAPI (nuclei). Scale bars 20 μm;
10 μm for insets. E. Quantification of multiple experiments with mice treated as in panel (D).
Data information: ***P < 0.001; N.S. = not statistically significant; data displayed as mean ±
SEM from 3 independent experiments with quantification from up to 13 low‐power fields, from
each of 4–5 total mice; significance determined by ANOVA with Tukey's post hoc test.
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Figure A1.6 mTORC1 is not required for increased SOX9 during metaplasia
A. Representative eosin counterstained IHC images of normal or metaplastic gastric tissue
stained for SOX9. SOX9, in control tissue, stains the isthmal and mucous neck cells, which are
proliferative progenitors (yellow arrowheads), of the corpus units and is generally excluded from
the base of units. Upon injury with HD‐TAM, SOX9 expression is induced in the base of units
(yellow arrowheads). Treatment with rapamycin does not alter either the normal or metaplasia
distribution of SOX9 (yellow arrowheads). Scale bars, 50 μm. B. Representative hematoxylin
counterstained IHC images of normal or metaplastic pancreatic tissue stained for SOX9. SOX9
expression in normal pancreatic tissue is restricted to the duct (see inset in top left panel which is
a high magnification view of the boxed area). At peak metaplasia stages, SOX9 becomes
expressed in dedifferentiating acinar cells (see bottom left inset). Treatment with rapamycin in
normal (see top right inset) or injured (see bottom right inset) does not alter SOX9 expression.
Scale bars 50 μm; inset 25 μm.
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Figure A1.7 mTORC1 activity correlates with stages of metaplasia during human gastric
tumorigenesis
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Figure A1.7 mTORC1 activity correlates with stages of metaplasia during human gastric
tumorigenesis
A. Immunofluorescent images of human gastric tissue from a patient with intestinal‐type gastric
adenocarcinoma elsewhere. In this non‐carcinoma containing region of the gastric corpus,
various states of metaplasia can be observed that reflect mouse injury models. Extensive
previous work (Lennerz et al, 2010) of a dataset of such resection specimens and of biopsies
showing SPEM in a non‐cancer setting has indicated likely stages of progression of SPEM from
essentially normal wherein large, pyramidal‐columnar cells at the base express only chief cell
markers like pepsinogen C (PGC, green) to “hybrid SPEM” (yellow arrowhead, inset) where
smaller, cuboidal columnar cells label with varying degrees of PGC and the neck/SPEM cell
marker GSII (purple) to “established SPEM” characterized by cells that label extensively with
GSII and have scant PGC; established SPEM cells are mucus‐stuffed, with peripheral, basal,
flattened nuclei (blue, DAPI). Higher magnification of each cellular phenotype is shown by
color‐coded box on right. As parietal cells are lost in SPEM, the remnant one in the yellow
boxed area (labeled “PC”) is consistent with the normal chief cell phenotype (representative
individual cells outlined by white dashed lines). Note that there is consistently high expression of
pS6 (red) throughout the cytoplasm of such normal chief cells but that this pS6 varies in the
hybrid SPEM lesion and is largely scaled down in the established SPEM region (note pS6 only
around the nuclei of these cells). Scale bar, 20 μm; pullouts 10 μm. B. Analysis of a human
gastric tissue microarray with normal, metaplastic, and cancer tissue all represented from patients
with resections for gastric cancer. Serial tissues sections of the array were stained by
immunohistochemistry with pS6 or Ki67, counterstained with hematoxylin, and visually graded
by blinded observers, supervised by a human pathologist, for staining intensity (from score 0
meaning undetectable to 3 most intense). Top—average histological score is plotted for each
phenotype. Bottom—the relative fraction of tissue cores with each score is plotted (total scores
of each type provided at the top of each column. C. Given the biphasic nature of the SPEM
histological score and given that established SPEM, as observed in panel (A), shows decreased
pS6, we separated all the SPEM lesions into Ki‐67+ (“proliferative”) and Ki‐67− (“quiescent”)
and replotted as for panel (B).
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Figure A1.8 Representative IHC images from human tissue microarray
A. Intestinal metaplasia (“IM” indicating the glands to upper left of red dashed line) is generally
proliferative as evinced by frequent Ki‐67+ cells (left) and is strongly pS6 positive. Most SPEM
has a quiescent phenotype (glands labeled on “qSPEM” side of panels) characterized by cells
with abundant mucus, flattened basal nuclei, and a lack of both Ki‐67 and pS6 staining Scale bar,
200 μm. B. Rare SPEM lesions show cells with cuboidal columnar morphology. These lesions
show Ki‐67 positivity usually associated with pS6 positivity. Boxed regions are shown at higher
magnification below. Scale bar, 200 μm; pullout, 50 μm.
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Figure A1.9 GSEA of microarray data shows that Rapamycin does not affect injury
induced changes in parietal and chief cell gene expression but causes aberrant expression
of a cohort of genes typically induced in SPEM.
A, B GSEA and Genechip analyses were performed as for Fig.4, except panels A and B depict
comparisons of a parietal cell specific gene set performed by flow cytometric purification of
parietal cells (see Methods) with panel A showing how parietal cell gene expression is greatly
enriched in vehicle control vs. HD-Tam and panel B showing that adding rapamycin with or
without HD-Tam does not affect this pattern. C Direct comparison of rapamycin+HD-Tam vs.
HD-Tam shows that loss of parietal cell gene expression after HD-Tam treatment is not affected
by rapamycin; if anything, rapamycin causes even more parietal cell injury as there is some
enrichment of parietal cell gene expression in HD-Tam alone. D Previously published chief cellspecific gene set also shows no relative enrichment in HD-Tam vs. HD-Tam+rapamycin,
indicating chief cell paligenosis is not affected by rapamycin. E On the other hand, a previously
published SPEM gene set shows enrichment in a specific subcluster of genes in HD-Tam vs.
HD-Tam+rapamycin, indicating rapamycin blocks induction of a certain subset of SPEM
genes.IM, intestinal metaplasia; pSPEM, proliferative SPEM; qSPEM, quiescent SPEM.

205

Figure A1.10 mTORC1 activity is required predominately for progression through S‐, G2‐,
and M‐phases during metaplastic induction of proliferation
A–E Microarrays of stomach corpora at D3 ± HD‐Tam ± rapamycin were analyzed using GSEA
“Difference of Classes” function comparing rapamycin + HD‐Tam (“Tam+Rap”) vs. rapamycin
vehicle + HD‐Tam (“Tam”). Whitfield Gene Sets specific for either overall cell cycle genes or
specific phases of cell cycle are depicted. Note that rapamycin correlates with decreased cell
cycle gene expression that is largely due to decreased S‐G2 phase gene expression.
F The dot plots are of the actual average expression levels (in rapamycin + HD‐Tam and HD‐
Tam alone Genechips) of the top 20 genes enriched in various Whitfield Gene Sets GSEA
comparisons of HD‐Tam vs. vehicle controls (both without rapamycin). Expression levels of
HD‐Tam and HD‐Tam + rapamycin for all genes were normalized to expression level in vehicle
control Genechip to facilitate plotting and expressed as Log2 such that 1 = 2‐fold enriched vs.
control. Note that average expression of G1‐phase genes is only somewhat reduced by rapamycin
(by t‐test of Tam vs. Rap‐Tam, *P < 0.05, **P < 0.01; ***P < 0.001), whereas later phases of the
cell cycle are substantially reduced (decrease in G2/M‐phase relative to G1‐phase by ANOVA
with Dunnett's post hoc test is ***P < 0.001). G, H qRT–PCR of select transcripts. Control
genes known to be increased or decreased in SPEM (G) and genes associated with specifically
with G2‐M cell cycle phase (H). Expression was normalized to housekeeping gene Tbp, then
vehicle control samples for each gene were set at 1, and HD‐Tam and HD‐Tam + rapamycin
expression was normalized to the control sample (statistics for the entire set of cell cycle genes
among the different treatments are shown in legend, ***P < 0.001 by ANOVA with Tukey's post
hoc test; data represented as mean ± SEM of the means from 3 replicates from a total of 3
independent experiments).
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Figure A1.11 Lysosomal and autophagic pathways are upregulated acutely following
stomach and pancreas injury
A. Injured zymogenic cells upregulate Cathepsin D+ puncta (green) 24 h follow HD tamoxifen.
Red, chief cells (GIF); blue, nuclei (DAPI). Boxed areas are shown at higher magnification at
right of each panel. Scale bars 20 μm; 10 μm for pullouts. B. Quantification of Cathepsin D+
area in chief cells at various stages following injury. **P < 0.01; ***P < 0.001 by ANOVA with
Dunnett's post hoc test. Each datapoint is an individual counted cell. C. LC3 puncta (detected by
GFP fluorescence in Lc3‐gfp mice) shows increased autophagosomal puncta paralleling
Cathepsin D+ results. Green, LC3‐GFP; red, GIF; blue, DAPI. Boxed areas are shown at higher
magnification and differing fluorescence channels in insets. Scale bars 20 μm. D. Transmission
electron micrographs of a normal zymogenic cell. Yellow arrowhead indicates a rare lysosome
seen during homeostatic conditions. E. Transmission electron micrographs of corpus units 24 h
follow tamoxifen injury. Various selected pullouts highlight double membrane‐bound structures
attacking cytosolic components in reprogramming chief cells. F. Acinar cells in pancreas have
increased LC3‐GFP+ puncta following acute injury with cerulein. Green, LC3‐GFP; red, GIF;
blue, DAPI. Scale bar 20 μm.
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Figure A1.12 LAMP1 time course during cerulein injury shows a pattern of increased then
decreased activation similar to that of stomach
Upon injury LAMP1 vesicles are induced in acinar cells starting around 8 hours and peak around
24 hours. By 3 to 5 days, the vesicles in exocrine cells begin to decrease back towards levels
seen at homeostasis. Boxes in top panels are magnified to highlight acinar cells in bottom panels.
Scale bars: 20 µm
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Figure A1.13 Histological appearance of Gnptab −/− stomach and pancreas tissue at injury
time points
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Figure A1.13 Histological appearance of Gnptab −/− stomach and pancreas tissue at injury
time points
A. Representative hematoxylin and eosin counterstained images of Gnptab +/− and Gnptab −/−
stomach tissue. Gnptab −/− chief cell cytoplasms have a hypertrophic, frothy appearance
compared to control zymogenic cells. Loss of parietal cells (fried‐egg appearing eosinophilic
cells) following HD‐Tam is not affected by loss of GNPTAB; however, the base zones in Gnptab
−/− mice at day 3 HD‐Tam are usually resistant to dedifferentiation (red arrowheads) with large,
frothy chief cells remaining largely non‐reprogrammed. Another, less common phenotype is that
all chief cells are lost such that most of the base of the unit disappears (green arrowheads). Rare
units partially undergo morphological metaplastic changes, though usually those are also
associated with loss of basal cells (yellow arrowheads). Higher magnification views are to right
of each panel, with white bracket delineating particular region of interest in Gnptab −/− stomach
Scale bar 50 μm; pullout, 25 μm. B. Representative hematoxylin and eosin counterstained
images of Gnptab −/+ and Gnptab −/− pancreas. Similar to the stomach zymogenic cells,
pancreatic acinar cells also have a hypertrophic, frothy appearance. Whereas control samples
treated with cerulein show diffuse, asynchronous acinar‐to‐ductal metaplasia, Gnptab −/− mice
have acinar cells that simply become less eosinophilic and foamy over time without undergoing
ADM. By 2 weeks, wild‐type pancreas has largely adapted to cerulein, whereas Gnptab −/−
pancreas parenchyma comprises only lobules of excessively pale (hyaline), frothy acinar cells
and scattered reactive ducts. Scale bar 50 μm; pullout, 25 μm.
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Figure A1.14 Lysosomal function is required for metaplasia‐associated gene expression and
increased proliferation
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Figure A1.14 Lysosomal function is required for metaplasia‐associated gene expression and
increased proliferation
A. Immunohistochemical analysis of SOX9 expression at peak SPEM stages following gastric
injury. In control and Gnptab −/+ mice, SOX9 becomes expressed in reprogramming chief cells
in the bases of the corpus at SPEM stages, but not in Gnptab −/− mice. Color‐coded boxes shown
at higher magnification shown at right for panels (A and B). Scale bar, 50 μm; 25 μm pullout. B.
S‐phase, cell cycle marker BrdU is incorporated throughout the gastric corpus unit at peak SPEM
stages in control WT or Gnptab −/+ mice. In Gnptab −/− mice, the gastric unit bases, where
proliferation is recruited from chief cells, show a marked relative deficit in BrdU+ cells. Scale
bar, 50 μm; 25 μm pullout. C. Immunofluorescence analysis of injured gastric tissue from
Gnptab −/− and control mice. GIF/GSII co‐expression is the hallmark of SPEM. In control mice,
the vast majority of corpus unit bases are converted to GIF/GSII co‐expression state. In Gnptab
−/− mice, bases are resistant to conversion and remain as GIF single positive cells. Red, GIF;
green, GSII. Scale bar, 20 μm. D. Quantification of randomly sampled 20× fields stained with
BrdU. Distribution of BrdU in neck region vs. base region (note total = 100%) is plotted. Note
control mice have equivalent amounts of BrdU‐labeled cells in the neck and base (˜50% in each),
whereas Gnptab −/− mice BrdU‐labeled cells substantially shifted away from the paligenotic
base of units and into the isthmal‐neck region, where the constitutive stem cell is active. E.
Quantification of randomly sampled 20× fields stained with BrdU in control and Gnptab −/−
mice. Gnptab −/− mice have significantly more BrdU‐negative base cells compared to control
animals. F. Quantification of control and Gnptab −/− corpus units stained for SOX9 scored for
the amount of SOX9‐negative chief cells per unit at peak SPEM stages. Gnptab −/− mice have
significantly more SOX9‐negative bases compared to control animals. G. Representative
immunofluorescence images of injured control and Gnptab −/− pancreatic tissue at cerulein 5
days. Red, amylase; green, BrdU; blue, DAPI. White arrows show proliferating, amylase+
acinar‐derived cells (note these are not seen in Gnptab −/− mice). Yellow arrowheads show
proliferating stromal cells that are not affected by loss of GNPTAB. Scale bar, 20 μm. H.
Representative immunohistochemistry of SOX9 stained control and Gnptab −/− pancreatic tissue
at cerulein 5 days. Gnptab −/− tissue has reduced metaplastic phenotype and reduced expression
of SOX9. Scale bar, 50 μm. I. Quantification of amylase+BrdU+ cells of control and Gnptab −/−
tissue in randomly sampled 20× fields at 5 days of cerulein injury.
Data information: **P < 0.01; ***P < 0.001 by t‐test with unequal variance; data represented as
mean ± SEM of the means from 10 low‐power fields each from 3 independent experiments.
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Figure A1.15 Lysosomal activity is required to re‐activate mTORC1 following HD
tamoxifen injury
A. At peak metaplasia stages in Gnptab −/+ tissue, pS6 is re‐expressed throughout the stomach
epithelium, including intense staining within the pit and metaplastic base. Scale bars: 50 μm;
pullout, 25 μm. B. In Gnptab −/− tissue, pS6 is not reactivated in the base, indicating lysosomal
activity is required for mTORC1 re‐activation at later stages following injury. Boxed regions are
shown at higher magnification at right with a representative base (in which pS6 remains inactive
without lysosomal activity) outlined by dotted line. Lysosomal activity appears dispensable for
pit cells (at top of gastric unit) mTORC1 activity. Scale bars: 50 μm; pullout, 25 μm.
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Figure A1.16 - Gnptab−/− acinar cells after 2 week cerulein treatment remain cryptically
acinar
A Comparison of amylase staining between Gnptab−/− and Gnptab−/+ following 2 weeks of
cerulein treatment. In Gnptab−/− tissue, only scattered acinar cells remain highly positive for
amylase (red arrowhead), with the vast majority only retaining weak positivity (yellow
arrowheads). Scale bar: IF, 20 µm; IHC, 50 µm. B Survey of metaplasia (CK8/18), mature acinar
(GATA4), and epithelial markers (E-cadherin) on Gnptab−/− tissue. Gnptab−/− acinar tissue
does not stain for the metaplasia marker CK8/18 or the mature acinar nuclear marker Gata4. The
poorly differentiated acinar cells are positive for E-cadherin. Scale bar: IF, 20 µm; IHC, 50 µm
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Figure A1.17 Apoptotic cells death during HD tamoxifen or cerulein-induced injury.
A At HD tamoxifen day 3 with or with rapamycin treatment, the stomach epithelium lacks
apoptotic cells, indicating the main atrophy stage – in which parietal cells, but not chief cells, die
by apoptosis – occurred earlier. In Gnptab−/− tissue, apoptotic cells can be found located at the
base of some units consistent with the increased dropout of basal cells described in the results.
Scale bar, 100 µm. B During Cerulein at day 5, scattered apoptotic cells are seen in all
experimental conditions, indicating the atrophy in this more asynchronous injury model is still
occurring during this time window. No qualitative increase in cleave caspase positive cells were
seen in rapamycin or Gnptab−/− tissue. Scale bar, 100 µm
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Appendix 1.5 Discussion
There has been a recent burgeoning of examples of cellular plasticity in tissue in response to
injury, not to mention a growing, already large literature on in vitro systems for reprogramming
cells back to progenitors. The instances of such plasticity span numerous species and nearly all
tissues. Despite the breadth of examples of cellular reprogramming, studies focusing on the
specific molecular mechanisms responsible for the process are still relatively scant. This is
particularly true in studies of cells in tissue, likely because investigators have focused more on
the outcome of cellular reprogramming—regeneration or tumorigenesis—than on the stepwise
mechanisms differentiated cells use to contribute to those outcomes. Here, we have speculated
that there could be a shared cellular program that governs the many diverse examples of
differentiated cells changing their fate to facilitate repair. There have been many terms that either
focus on the outcome of the program or are overly broad: “dedifferentiation”,
“transdifferentiation”, “reversion”, “reprogramming”. We now propose “paligenosis” as a
specific term describing the cellular process differentiated cells use to re‐acquire regenerative
capacity. We highlight that paligenosis may be a conserved cellular process with shared
molecular and cellular regulation akin to other basic cellular processes like mitosis and
apoptosis.
To support our assertion that there may be a shared program for recruiting differentiated
cells, we have analyzed the cellular and molecular changes that occur during injury‐induced
reprogramming in two distinct organs. Upon injury, both the stomach and pancreas have the
capacity to repair tissue damage through the recruitment of fully differentiated cells into a less
differentiated, proliferative state to replenish cell numbers. This pattern of change in cell
phenotype is known to pathologists as metaplasia. We find that the cellular and molecular
216

changes that characterize cells undergoing such metaplastic injury response in either stomach or
pancreas are remarkably similar. Specifically, we found that acutely following injury,
autodegradative pathways increase alongside a decrease in mTORC1 activity (Fig 7). As the
injury progresses, we observed the induction of genes that are known to occur during metaplasia
followed by the rise of mTORC1 activity and increased proliferation (Fig 7). A similar pattern of
changes in mTORC1 activity relative to metaplasia and the differentiated vs. proliferative
phenotype was observed in human patients. We found that mTORC1 activity was specifically
required for progression through S‐phase. Previous literature has also shown that mTORC1
activity is critical for S‐phase progression of cancer cells following DNA damage, as mTORC1
is needed to generate pyrimidines in a nutrient‐poor environment (Robitaille et al, 2013; Silvera
et al, 2017; Zhou et al, 2017). mTORC1 activation is also needed for yeast to pass through G1
into S‐phase as they emerge from quiescence (Dhawan & Laxman, 2015; Moreno‐Torres et al,
2015). Using an animal model of lysosomal dysfunction, we uncovered that normal lysosomal
function after injury is required for cell phenotype and gene expression changes associated with
metaplasia. In pancreas, where constitutive stem cells are not available for regeneration, loss of
either autodegradative function or mTORC1 activity compromised eventual organ repair.
Recent advances in the understanding of how mTORC1 is controlled have described a
role for the lysosome as an activator of the pathway through the release of nutrients like key
amino acids (Zoncu et al, 2011). Thus, our current working model is that due to injury‐induced
stress, autodegradative pathways are upregulated, and flux increases. The activation of
autodegradative pathways appears to act in parallel with loss of the mature gene regulatory
network, as forcing expression of key mature‐cell‐promoting transcription factors like MIST1
(BHLHA15) impairs the injury/repair process (Direnzo et al, 2012; Lo et al, 2017). MIST1
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controls a cassette of genes that help direct a cell's energy toward secretion and away from
lysosomal activation and autophagy (Mills & Taghert, 2012). We reason, as did Adami over a
century ago, that to convert from the differentiated state (structurally complex, energetically
active) to the replicative state (structurally simple, energetically active), cellular energy use must
be repurposed as an autodegradative program is activated to convert differentiated cell structure
into building blocks for replication. The release of nutrients through the lysosome is sensed in
cells during the autodegradative phase, resulting in reactivation of mTORC1, which, once the
cell has reached sufficient energy levels, subsequently facilitates cell cycle progression and
growth to replace cells lost during the injury.
Pancreatic adenocarcinoma and—to a lesser extent—gastric adenocarcinoma are
commonly driven by oncogenic mutations in Kras. In mouse models in both the pancreas
(Hingorani et al, 2005) and stomach (Choi et al, 2016), Kras G12D mutations, in concert with
tissue inflammation, promote changes in gene expression and cell phenotypes resembling injury‐
induced metaplasia. In the pancreas, genetically disabling autophagy in the context of K‐Ras
mutations prevents K‐Ras from driving high‐grade lesions (Rosenfeldt et al, 2013). Furthermore,
cells unable to phosphorylate S6 in the context of activating K‐Ras mutations also exhibit less
pancreatic cancer progression (Khalaileh et al, 2013). A similar critical role for mTORC1
downstream of another key driver oncogene pathway, Wnt activation mediated by APC
mutation, has been described in intestinal carcinogenesis (Morran et al, 2014). Thus,
tumorigenesis in diverse tissues may also involve modulating lysosomal activity and mTORC1,
similar to what we observe in our injury models here. Other pathways downstream of K‐Ras,
such as PI3K/Rac1 signaling (Heid et al, 2011; Wu et al, 2014), also play similar roles in injury‐
induced metaplasia.
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If there truly is a shared cellular program, paligenosis, underlying the process of
recruiting mature cells to become regenerative cells, we would expect the general features we
have described here in stomach and pancreas to be recapitulated in many other tissues and
species. Obviously, it will be important to conduct new studies in other systems to begin to
support that assertion; however, we can at this point re‐examine the extant literature to determine
whether roles for lysosomes/autophagy and/or mTORC1 in the process of cellular
reprogramming to a regenerative state have previously been described. One such previous study,
using a different injury protocol, with the endpoint to determine the role of mTORC1 and
autophagy in severity of pancreatitis, similarly showed a pattern of early autodegradation
followed by mTORC1 activation (Hu et al, 2015). The authors also found that rapamycin
worsened severity of pancreatitis. In liver, it has long been known that the earliest phase of
hepatocyte response to partial hepatectomy is massive activation of autophagy/lysosomes
(Becker & Lane, 1965). mTORC1 is required for the later stages of the process, when
proliferation is maximal, consistent with observations we make in the current manuscript (Jiang
et al, 2001; Nelsen et al, 2003; Buitrago‐Molina et al, 2009; Espeillac et al, 2011). In kidney, the
reprogramming process involves mTORC1 (Kato et al, 2012), and we show here that mTORC1
activity is increased specifically in the tubular cells, which are the cell population called back
into the cell cycle to regenerate damaged tissue. To our knowledge, lysosomes/autophagy has not
been examined in regenerating kidney. In mature glial cells that dedifferentiate following axonal
injury, activation of autophagy/lysosomes is a well‐established early event (Jessen & Mirsky,
2016). To our knowledge, mTORC1 activity has not been examined in the process. Furthermore,
in tissue culture cellular reprogramming models to generate induced pluripotent stem cells, there
is an emerging literature that an early autophagy phase is followed eventually by mTORC1
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activation. Inhibition of either autophagy or prolonged inhibition of mTORC1 reduces
reprogramming efficiency (He et al, 2012; Wang et al, 2013; Wu et al, 2015). Hence, the stages
and checkpoints appear to be the same as the ones we examine in the current manuscript.
Thus, there are numerous reports indicating that the pattern we show here systematically
of autodegradation first, then mTORC1 activation may be universal. Moreover, teleologically, it
makes sense that a mature cell would first recycle cellular components required for physiological
function to use them as substrates for subsequent synthesis of components needed for
proliferation. In organs like the vertebrate pancreas or liver, where there are no constitutively
active stem cells, repair would likely depend in large part on paligenosis. In tissues with
constitutive stem cells, like stomach and intestines, the tissues would have the choice of
regenerating with either constitutive stem cells or paligenotic cells, depending potentially on
type, extent, and location of injury.
Not all differentiated cells are likely to be able to undergo paligenosis. In the stomach, for
example, we have never observed this phenomenon in mature parietal cells (Huh et al, 2012;
Mills & Sansom, 2015). Cells that are constitutively undifferentiated and replicative like those of
the isthmus of the stomach or LGR5+ crypt‐base columnar cells should not need any stage of
paligenosis (Fig 7). They may acquire the building block nucleotides and amino acids from the
blood and/or extracellular environment, given that, by definition, their lack of differentiation
means they contain limited non‐nuclear components to recycle. Other cells, such as mucous neck
cells in the stomach or +4 cells in the intestine (van Es et al, 2012; Roth et al, 2012; Buczacki et
al, 2013), may be able to respond to injury but are less well differentiated and thus may be able
to skip the autodegradative phase and go directly to the activating mTORC1 and cell division
phase of paligenosis.
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Paligenosis may be beneficial for its potential to provide lifelong tissue repair in adult
organs, but this capacity also seems inherently tied to increased risk for tumorigenesis. Chronic
injury of the type that repetitively induces paligenotic/metaplastic events has long been known to
increase risk for acquisition of mutations and progression to neoplasm. We have proposed that
the reason that risk increases with age is that cycles of paligenosis and subsequent
redifferentiation allow accumulation of mutations that may be stored in long‐lived, differentiated
cells. Eventually, a critical mutation may be unmasked during paligenosis, and a clone of cells
that is unable to redifferentiate arises. We have termed this the “cyclical hit” model of
tumorigenesis (Mills & Sansom, 2015; Saenz & Mills, 2018).
There are numerous questions that our current study prompts. What molecular events
underlie the competence to pass through each stage of paligenosis? What is the relationship
between paligenosis and chronic injury, and what causes the increased risk for cancer? Why are
some cells able to undergo paligenosis, whereas others are not? We expect that the framework of
sequential phases of paligenosis that we introduce here, along with the potential checkpoints that
serve as molecular barriers between each stage of the process, can serve as a starting point for
future questions.

Appendix 1.6 Materials and Methods
Animal studies and reagents
All experiments using animals followed protocols were approved by the Washington University
School of Medicine Animal Studies Committee. WT C57BL/6 mice were purchased from
Jackson Laboratories (Bar Harbor, ME). Tg(Atp4b‐cre)1Jig/JcmiJ (Atp4b‐Cre) (Syder et al,
2004), Gt(ROSA)26Sortm4(ACTB‐tdTomato,‐EGFP)Luo/J (ROSA26mtmg) (Muzumdar et al,
2007), Gnptab (Gelfman et al, 2007), and LC3‐GFP (Mizushima et al, 2004) mice were
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previously described. Gnptab mice were a kind gift from Dr. Stuart Kornfeld of Washington
University. Tamoxifen (5 mg/20 g body weight; Toronto Research Chemicals) was injected
intraperitoneally (IP) daily for 2–3 days to induce maximal gastric injury (Huh et al, 2012; Saenz
et al, 2016). Tamoxifen was prepared by first dispersing in 100% ethanol by sonication and then
emulsifying in sunflower oil (Sigma‐Aldrich) 9:1 (oil:ethanol). Pancreatitis was induced by 6
hourly IP injections of 50 μg/kg (in 0.9% saline) cerulein (Sigma‐Aldrich) given every other day
for up to 2 weeks. Mice were sacrificed 24 h after the final cerulein injection. Rapamycin (60
μg/20 g body weight; LC Laboratories) was injected IP in 0.25% Tween‐20, 0.25% polyethylene
glycol in PBS for 3–7 days prior to starting and throughout injury time course. Tunicamycin
(Carlisle et al, 2014) and two‐thirds partial hepatectomy (Blanc et al, 2010) injuries were
performed as previously described. Mice were given an IP injection containing
5‐bromo‐2′‐deoxyuridine (BrdU; 120 mg/kg) and 5‐fluoro‐2′‐deoxyuridine (12 mg/kg) in sterile
water 90 min before sacrifice for all BrdU labeling experiments.
For parietal cell isolation, stomachs were harvested and washed several times with PBS.
The forestomach and antrum were carefully removed and the remaining corpus minced with a
razor blade. The tissue was mechanically dissociated using a 50 μm Medicon (Beckman) for two
30‐s pulses. Chunks of tissue were further dissociated by incubating in 10 ml HBSS with 5 mM
EDTA and 1 mM DTT with vigorous shaking for 1 h at 37°C, and then, the solution was run
through a 100‐μm filter. Single cells were allowed to rest at 37°C, while filtered chunks were
incubated in 10 ml RPMI 1640 with 5% BSA (Sigma) and 1.5 mg/ml Dispase II (Stem Cell
Technologies) with vigorous shaking for 1.5 h at 37°C and then filtered again. Dissociated cells
were pelleted and washed with cold HBSS three times and then resuspended in PBS with 1%
BSA and 5 mM EDTA. Cells were sorted into a parietal cell population (GFP) and all remaining
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cells (tdTomato) using a MoFlo FACS machine (Dako/Cytomation)
Imaging and tissue analysis
Mouse tissues were immediately excised and flushed with phosphate‐buffered saline and fixed
overnight in 4% paraformaldehyde in PBS. Tissues were washed, embedded in 3% agar, and
then underwent routine paraffin processing. Sections prepared for immunofluorescence or
immunohistochemistry underwent standard deparaffinization and rehydration protocols, were
blocked in 5% normal serum, and left overnight with primary antibodies. Sections were washed
in phosphate‐buffered saline and incubated for 1 h with secondary antibodies and then washed
prior to mounting. For antibodies used in this study, see Table A1.2.
Immunofluorescence images were taken on a Zeiss Apotome or LSM710 confocal
(Zeiss). Bright field images were taken on a Nanozoomer (Hamamatsu) whole slide scanner or
DP70 microscope (Olympus). Counting of stomach cell populations and proliferation was done
as previously described (Burclaff et al, 2017), except for analysis of Gnptab−/− mice. To account
for frequent gland loss in the base of these mice, a different approach was taken. For chief cell
quantification (SOX9+ and BrdU+), 10 random, 20× fields were chosen in three Gnptab−/− and
three control animals, and chief cells scored in slides from SOX9 or BrdU immunostained
sections. For BrdU, distribution, the 10 fields were further subdivided into two rectangular
regions: a basal one 100 μm perpendicular and 450 μm parallel to the muscularis mucosa and a
region of the same size immediately adjacent and encompassing the neck of the gastric unit. All
BrdU+ cells were scored and the proportion in each zone calculated. Quantification of
proliferation in the pancreas was done by counting 10 randomly sampled whole 20× fields per
condition. Cathepsin D+ area was calculated by generating a region of interest around PGC+
zymogenic cell cytoplasms and using particle counting analysis in ImageJ (NIH) to calculate
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Cathepsin D+ area relative to total cytoplasmic area. Tissue preparation and imaging for electron
microscopy was done as previously described (Ramsey et al, 2007).
Table A1.2 Antibodies

Human tissue studies
Human gastric pathological tissue specimens were obtained with approval by the Institutional
Review Board of Washington University School of Medicine. Figure 3A is a representative
image from a qualitative analysis of 44 separate curated gastric clinical samples that have been
previously described (Lennerz et al, 2010; Radyk et al, 2018). The study of tissue microarray
cases included in this paper was also approved by the China Medical University First Hospital
Institutional Review Board and Ethics Committee. This patient cohort was initially treated at the
China First Medical University, and routine standard of care specimens was obtained from
patients treated between 2005 and 2009. Tumor, metaplastic, and uninvolved normal tissue from
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each patient was formalin‐fixed and paraffin‐embedded. Staining was scored on the following
scale: 0, no staining; 1, minimal staining; 2, moderate to strong staining in at least 20% of cells;
3, strong staining in at least 50% of cells. The scoring system was designed, and independently
verified, by a human pathologist.
Bioinformatics, microarray, qRT–PCR, and statistical analyses
For qRT–PCR and microarray analyses of mouse stomach ±rapamycin, two independent
experiments were run and a total of two to three separate mice and corresponding microarrays
were generated for each condition. All mice were harvested 3 days after first injection and
treated as per protocol in (Figure A4.1). Conditions were Veh‐Veh (rapamycin vehicle regimen +
3 days of tamoxifen vehicle), Veh‐Tam (3 days of rapamycin vehicle regimen + 3 days of
HD‐Tam), Rap‐Veh (rapamycin regimen, 3 days of tamoxifen vehicle); Rap‐Tam (rapamycin
regimen + 3 days of HD‐Tam). RNA for microarray and qRT–PCR analysis was isolated as
previously described (Lo et al, 2017). For microarray, samples were processed and hybridized to
Affymetrix Mouse Gene 2.0 ST per the manufacturer's instructions by the Washington
University Genome Technology Access Core (GTAC). GeneChips were analyzed with Partek
Genomic Suite 6.6 (Partek, Inc.) analysis software using default settings (Lo et al, 2017).
Mapping to Gene Symbols was done either via GSEA (Subramanian et al, 2005) or GenePattern
software (Reich et al, 2006). GSEA was done using default 3.0 settings. GMX files were made
using previously published microarray data in the case of laser‐capture micro‐dissected chief
cells (Capoccia et al, 2013), generated de novo or acquired from GSEA molecular signatures
database. For the list of parietal cell‐specific genes generated de novo for the current manuscript,
flow cytometry was used to sort parietal cells and control cells into 500 μl RNA protect reagent
(Qiagen). RNA was isolated using the RNeasy Micro Kit (Qiagen) following the manufacturer's
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instructions. Mouse Gene 2.0 ST Array (Affymetrix) was used to analyze gene expression, and
the gene set whose expression was enhanced at least eightfold (96 separate genes) in parietal
cells vs. control was determined by Partek. For primers used in qRT–PCR, see Table A1.3.
Statistics for cell counts and qRT–PCR were done by Student's t‐test (in the case of pair‐wise
analysis of significance) or ANOVA (if multiple conditions were compared). For determining
statistically significant differences among various conditions in ANOVA, the post hoc tests were
either Tukey's (for multiple crosswise comparisons of means) or Dunnett's (for comparisons of
multiple experimental samples to a single control). For the tissue microarray, a χ2 analysis was
performed.
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Table A1.3 qRT-PCR Primers

Western blot
Approximately 100 mg mouse corpus stomach tissue was lysed in urea buffer (8 M urea, 1%
SDS, 150 mM Tris–HCl, pH = 7.0) with 1× protease/phosphatase inhibitor cocktail (Thermo).
Protein concentration was determined using the DC protein assay (Bio‐Rad). Protein (30 μg) was
separated using a 10% SDS–PAGE gel and transferred to PVDF membranes (Millipore).
Membranes were incubated overnight at 4°C with Rabbit polyclonal pS6 240/244 or 235/236
(1:1,000 diluted, CST) and Rabbit polyclonal beta‐tubulin antibody (1:1,000 diluted, CST) and
then incubated with infrared fluorescent dye‐conjugated secondary antibodies (LI‐COR
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Biosciences). Protein signal intensities were normalized against a tubulin loading control for
each sample. Fluorescent intensity values were determined and quantified on Western blots at
non‐saturating exposures using the ImageJ software. Statistical analysis with both antibodies was
done using ANOVA with a post hoc Dunnett's test.
Data availability
All analyzed microarray data have been deposited in NCBI GEO under accession GSE103570.
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Appendix 2: A chief source of cancer and
repair in stomachs

The following was published as a News & Views article in The EMBO Journal.
Radyk MD, Mills JC. (2017) "A chief source of cancer and repair in stomachs.” EMBO J
15;36(16):2318-2320.
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A2.1 Abstract
Differentiated cells had long been thought to be non-dividing, though we now know many can
proliferate after injury. A new study by Leushacke et al (2017) shows how injury recruits mature,
Lgr5-expressing gastric chief cells to become stem cells that can either regenerate damaged
tissue or fuel precancerous lesions.
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A2.2 Discussion
During homeostasis, all epithelial cells lining the main portion (corpus) of the stomach are
thought to be maintained by stem cells. These stem cells are in the isthmus region, located below
the mucous pit cells covering the stomach surface and above the long gastric gland that dives
down deeper toward the musculature. The gland comprises two main differentiated cell types:
acid-producing parietal cells and digestive-enzyme-secreting chief cells. Upon certain types of
injury, for example, in some patients infected with the bacterium Helicobacter pylori, mature
parietal and chief cells are replaced by proliferating cells secreting mucins and wound repair
proteins in a lesion known as spasmolytic polypeptide-expressing metaplasia (SPEM). A recent
study by Leushacke et al (2017) uses mouse models to reveal that SPEM is derived from a
subpopulation of chief cells expressing the Wnt target gene Lgr5 (Figure A2.1). These LGR5+
chief cells are recruited back into the cell cycle to serve as stem cells that in the short term repair
glandular damage and in longer term can also fuel SPEM that persists as a precancerous lesion.
Lgr5 in other tissues, for example, in the intestine, tends to mark rapidly dividing stem
cells (Barker et al, 2007); however, stem cell identity is proving to be dynamic. For instance, in
intestine, differentiated cells can be recruited as stem cells if LGR5+ stem cells are lost (Mills &
Sansom, 2015). Stem cell dynamics in the gastric corpus are still unclear. Previous studies have
shown that chief cells expressing Mist1, Troy, or elements from the Runx1 promoter (designated
eR1) can form SPEM and also, occasionally, serve as stem cells (Nam et al, 2010; Stange et al,
2013; Matsuo et al, 2017). It has also been shown that both isthmal and chief cells proliferate
during the metaplastic response (Burclaff et al, 2017; Matsuo et al, 2017). In contrast, one report
suggests that the isthmal stem cell is not only the source of normal homeostatic stem cell activity
but also transdifferentiates to become the sole source for SPEM (Hayakawa et al, 2015).
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Leushacke et al (2017) use an existing mouse pedigree expressing the human diphtheria
toxin receptor and fluorescent GFP under control of the Lgr5 promoter. GFP-expressing (i.e.,
LGR5+) cells in the corpus are a subpopulation of chief cells enriched for Wnt pathway-related
genes. Ablating the LGR5+ chief cells with diphtheria toxin caused some cystic changes in the
mucus-secreting surface cells, but parietal cells and the remaining non-LGR5+ chief cells
remained unaffected. Glands from mice depleted of LGR5+ cells also showed reduced potential
for generating organoids (complex, multicellular three-dimensional cultures). Organoids derive
both from isthmal stem cells (Hayakawa et al, 2015; Matsuo et al, 2017) and from chief cells
recruited back into the cell cycle (Stange et al, 2013; Matsuo et al, 2017). Next, the authors used
a new mouse line engineered to express Cre recombinase in Lgr5-expressing cells in a broader
manner truer to endogenous Lgr5 expression than the famous Lgr5Cre-iRes-EGFP allele used in
many previous studies. The new allele allowed them to show that occasional whole gastric units
could be derived from LGR5+ cells. Thus, Lgr5-expressing chief cells can be recruited to serve
as stem cells for organoids and, occasionally, in the gastric epithelium, but they do not seem to
be an active, homeostatic stem cell.
Leushacke et al (2017) then explored LGR5+ cell behavior following injury by inducing
SPEM using the high-dose tamoxifen protocol (Huh et al, 2012). They found that proliferating,
metaplastic cells were derived from LGR5+ chief cells that had reentered the cell cycle.
Moreover, following recovery from tamoxifen, they noted that many gastric units were fully
labeled, indicating that LGR5+ cells eventually served as stem cells to regenerate all epithelial
cell lineages. In short, Lgr5-expressing chief cells can dedifferentiate to a multipotent
proliferative state and act as “reserve” stem cells upon gastric injury. The authors found that the
two most differentially expressed genes in injured vs. uninjured LGR5+ chief cells are both Wnt242

related: Mmp7 and Sostdc1. Inducing expression of Mmp7 in organoids increased Lgr5 and
Axin2 expression, and induced Sostdc1 decreased Lgr5 and Axin2 expression. Thus, Wnt
signaling may be important for activating “reserve” chief cells to contribute to epithelial
regeneration.
Previously published work has shown that expressing activated Kras in chief cells using
Mist1 or eR1 causes formation of SPEM glands which eventually progress to more chronic
intestinal-type metaplasia (Choi et al, 2016; Matsuo et al, 2017). Leushacke et al (2017) show
Lgr5 can also drive chief cells into such chronic metaplastic lesions and further that LGR5
expression correlates with tumors in humans. Thus, multiple reports now confirm chief cells in
the gastric corpus may be a cell-of-origin for metaplasia and possibly human intestinal-type
gastric cancer.
The authors of the current study clarify and expand upon a rapidly expanding field. First,
they confirm that chief cells are “reserve” stem cells that rarely proliferate at homeostasis but,
upon injury, can act as a reservoir of recruitable stem cells for repair (Burclaff et al, 2017;
Matsuo et al, 2017). Second, they show for the first time that targeted chief cell ablation is
insufficient to induce SPEM, mirroring previous results showing that parietal cell ablation alone
is insufficient to cause SPEM (Burclaff et al, 2017). Third, they show that the stomach corpus
exhibits plasticity similar to other tissues. Fourth, they help clarify how LGR5+ cells in the
corpus resemble those in the antrum. As in the corpus, antral LGR5+ cells are in the gland base,
where differentiated antral cells reside—not in the isthmus where the fastest dividing cells reside
(Barker et al, 2010). Antral LGR5+ cells, however, seem to have more stem cell activity without
injury than those in the corpus. Perhaps either they are more stem-like than their cousins in the
corpus, or the antrum is simply more plastic in its stem cell dynamics overall.
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Tissue regeneration from differentiated cells has been observed in many organs such as
lung, pancreas, and intestines. The Leushacke et al (2017) work highlights how the stomach
corpus might have at least one advantage for studying stem cell recruitment. Similar to the
intestines, there are both constitutively active stem cells and cells with stem cell potential,
equivalent to stem cells formerly known as “+4” in the intestines. Unlike the intestines, however,
the base where chief cells reside is physically separate from the isthmus, whereas in the intestinal
crypt, stem and recruitable stem cells are virtually intermixed. Leushacke et al (2017) also add
another example of how differentiated cells, called back into the cell cycle, can serve as cells of
origin for cancer. In pancreas, similar experiments have shown that mutant Kras expressed in the
enzyme-secreting cousins of chief cells, the acinar cells, has little effect until acinar cells are
recruited back into the cell cycle by injury-induced metaplasia. Metaplastic acinar cells
expressing mutant Kras can no longer redifferentiate and can progress to neoplasia (Mills &
Sansom, 2015).
Why might recruiting differentiated cells be so important in tumorigenesis? One
possibility is that differentiated cells are long-lived, so they can store mutations. Cycles of
induced proliferation could cause gradual accrual of mutations that are “stored” long term as
long as the cells can redifferentiate. We have proposed the importance of differentiation–
dedifferentiation cycles as the “cyclical hit” model of how mutations accumulate until they result
in cancer (Mills & Sansom, 2015). Key questions persist. For example, do specific chief cell
subsets serve stem cell functions? Recent work has shown that more mature chief cells may have
less potential to convert to SPEM (Weis et al, 2017). Another big question is: What are the
mechanisms dictating how differentiated cells “know” to re-enter the cell cycle? Are those
mechanisms conserved across tissues and species? One thing that is becoming clear is that the
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fields of cancer biology and regenerative medicine may be related as the plasticity of
differentiated cells seems to be playing a leading role in fueling both repair and tumorigenesis.
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Figure A2.1 Lgr5-expressing chief cells in the gastric corpus can repair the stomach and
are sources of metaplasia and precancerous lesions after injury. At homeostasis, Lgr5expressing chief cells remain in the base of the corpus unit and are not proliferative, while active
stem cells in the isthmus give rise to all other epithelial cell types. However, after metaplasiainducing injury (as can be induced in the laboratory setting with high doses of tamoxifen; Huh et
al, 2012), Lgr5-expressing, “reserve” stem cells in the bottom part of the gland activate Wnt
signaling, become metaplastic, and re-enter the cell cycle in a reprogramming event. Without
incurring additional damage, Lgr5-expressing cells have potential to generate all epithelial cells
in the gastric gland. If chief cells acquire oncogenic mutations (e.g., activate Ras; Choi et al,
2016), they can form dysplastic lesions, thus being a precursor cell to gastric cancer formation.
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